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Abstract 
 
Targeting of DNA secondary structures, such as G-quadruplexes, is now 
considered an appealing opportunity for drug intervention in anticancer therapy. So 
far, efforts made in the discovery of chemotypes able to target G-quadruplexes 
mainly succeeded in the identification of a number of polyaromatic compounds 
featuring end-stacking binding properties. Against this general trend, we were 
persuaded that the G-quadruplex grooves can recognize molecular entities with 
better drug-like and selectivity properties. 
Therefore, to achieve an enhanced knowledge on the structural and 
conformational requisites for quadruplex groove recognition, distamycin A, the only 
compound for which a pure groove binding has been proven, has been chemically 
modified. Isothermal titration calorimetry (ITC) and NMR techniques have been 
employed to characterize the interaction between a dicationic derivative of 
distamycin A (compound 1) and the [d(TGGGGT)]4 quadruplex structure. 
Interestingly, the structural modifications of compound 1 decrease the affinity of 
the ligand toward the duplex, enhancing the selectivity for the quadruplex 
structures. Further, structural and thermodynamic studies revealed that the 
absence of coulombic interactions inferred in compound 3, results in an 
unprecedented binding position in which both the groove and the 3’ end of the DNA 
are occupied. 
In this scenario, with the aim of finding brand new molecular scaffolds able 
to interact with the groove of the DNA quadruplex [d(TGGGGT)]4, we performed a 
successful structure-based virtual screening (VS) campaign. As a result, six 
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molecules were found to be somehow groove binders. NMR spectroscopy 
experiments combined with molecular modelling studies, allow for a more detailed 
picture of the interaction between each binder and the quadruplex DNA. 
Noteworthy, isothermal titration calorimetry (ITC) measurements on the above-
mentioned compounds revealed that 2, 4, and 6 besides their relatively small 
dimensions bind the DNA quadruplex [d(TGGGGT)]4 with higher affinity than 
distamycin A, to the best of our knowledge, the most potent groove binder 
identified thus far.  
Among them, the promising derivative 6 (renamed 1a) was used as a seed 
for searching similar entities in several commercially available databases and NMR 
experiments allowed to identify a small focused library of structural analogues with 
G-quadruplex binding properties. By a back and forth approach, the structural 
features responsible for G-quadruplex groove recognition were delineated, while 
isothermal titration calorimetry (ITC) measurements allowed for the identification 
of chemotypes featuring a tighter binding than distamycin A. Differently from 
distamycin A, the best binders were also proved to be G-quadruplex selective over 
duplex. These results propelled the biological characterization of the new ligands 
demonstrating their ability to induce selective DNA damage at telomeric level and 
induction of apoptosis and senescence on tumor cells. 
Structural variations from the canonical Watson-Crick double helix have 
specific roles in many important cellular processes, such as DNA packaging, 
replication, transcription and recombination. These DNA structures are sequence-
directed and constitute an alternative layer of the genetic code. Therefore, 
revealing new DNA structural motifs provides the molecular bases to elucidate 
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novel functional mechanisms of cell and the way to interact with them. By 
combining advanced state-of-the-art computations and experiments, a study 
conducted also under the supervision of Prof. Bertini (CERM, Sesto Fiorentino) led 
to the identification of a new DNA structural motif, named “G-triplex”. G-triplex can 
be formed in guanine-rich regions of the genome and is characterized by the 
formation of G:G:G triad planes stabilized by an array of Hoogsteen-like hydrogen-
bonds. This discovery further expands the structural complexity of the genome 
highlighting once more the high polymorphism of the DNA polymers. This is the first 
time that DNA is found to assume this kind of topology and the abundant presence 
of guanine-rich regions in the genome makes imperative to investigate its biological 
role in the near future. 
In a study conducted in Conte’s lab. (King’s College, London) the interactions 
between human LARP4 and poly-A15 RNA have been investigated. Human LARP4 
(HsLARP4) is a cytoplasmic, polyribosome-associated protein involved in promoting 
mRNA translation and able to bind to oligo(A) RNA and the poly(A) binding protein 
(PABP). The RNA recognition is mediated by the La module, the conserved feature 
in all LARP families. However, human LARP4 is notably distinct from genuine La 
proteins and other LARPs for the lack of conservation of few amino acids that in 
human La were shown to be critical for 3’-UUUOH interaction, suggesting a divergent 
mode of RNA recognition. Here, five highly conserved residues in the La module of 
HsLARP4 were identified through sequence alignment with HsLa, and three of them 
(Q126, D139, M160) were mutated to Alanine through point mutation. ITC 
experiments revealed that  the mutation of residues 126, 139 and 160 to Alanine in 
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the La module of HsLARP4, decreased its binding affinity to poly-A15, hence, 
indicating that these residues of HsLARP4 play key roles in the interaction with RNA. 
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NUCLEIC ACIDS ARCHITECTURE: 
CANONICAL AND NON-CANONICAL 
STRUCTURES 
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1) General overview of nucleic acids 
 
Nucleic acids are the biological macromolecules that store and transmit 
genetic information in living organisms. This information ensures the normal 
development and functioning of an organism. Nucleic acids comprise of two main 
classes: ribonucleic acids (RNA) and deoxyribonucleic acids (DNA). The structure of 
DNA plays an essential role in DNA’s ability to store and transmit genetic 
information. DNA is a polymer of simple units, and the genetic information is 
encoded in the sequence of these monomeric units, the nucleotides. Nucleotides 
combine together to form DNA strands, and complementary strands of DNA bind 
together to form a double stranded helix. The integrity of the genetic information is 
maintained within this DNA structure. This information is converted via several 
processes (transcription and translation) into various structural, regulatory and 
functional components in vivo1. Consequently, understanding the factors that 
influence the structure of DNA is significant for understanding the processes that 
compromise this information such as through DNA damage. A nucleotide is a 
chemical compound that consists of three components: a heterocyclic base, a sugar 
and one o more phosphate groups. The bases of DNA are divided into two groups: 
purines [adenine (A) and guanine (G)] and pyrimidines [thymine (T) and cytosine 
(C)]. In RNA, thymine is replaced by uracil (U). Purines consist of a six-membered 
and a five-membered nitrogen-containing ring, fused together; pyrimidines have 
only a six-membered nitrogen-containing ring (Figure 1.1)1. 
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Figure 1.1: Structure of purine and pyrimidine bases. 
 
The sugar component of nucleic acids is a pentose, DNA contains the           
2'-deoxyribose, while RNA contains ribose. The molecule comprising the pentose 
sugar joined to a base is called nucleoside. In a nucleoside, sugar and base are 
covalently bound by a N-glycosidic bond between the C1’ of the sugar and the N9 or 
N1 of purines or pyrimidines, respectively. Rotations about this glycosidic linkage 
add structural diversity to the DNA molecule. The two main conformations that are 
formed about the glycosidic bond are either syn or anti (Figure 1.2). The syn 
conformation is formed when the C1’-O4’ bond is cis to the N9-C4 purine bond, and 
cis to the N1-C2 of pyrimidine. This occurs when the bulk of the purine base is facing 
towards the sugar or the C2 carbonyl is on top of the sugar ring. The anti 
conformation is formed when the bulk of the base is rotated away from the sugar. 
This occurs when the C1’-O4’ bond of the sugar is trans to the N9-C4 bond of the 
purine base. In pyrimidines, the anti conformation is formed when the C2 carbonyl 
faces away from the sugar. This occurs when the C1’-O4’ bond is trans to the N1-C2 
pyrimidine bond. 
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Figure 1.2: Rotation about the glycosidic bond. 
 
A nucleoside is converted into a nucleotide by attachment of a phosphate 
group to the C5' carbon of the sugar. The nucleotides are connected by 
phosphodiester bonds to form single-stranded DNA. The phosphodiester bond is 
formed by the 5’ phosphate of one nucleotide attaching to the 3’ hydroxyl of the 
next nucleotide. This attachment lends directionality to DNA. The DNA sequence is 
usually read from the 5’ to 3’ direction. The 5’ end commonly has a phosphate 
group attached to it while the 3’ end contains just the sugar hydroxyl.  
The bases of DNA (or RNA) can form non-covalent bond couplings called 
base pairs. The most common base pairing pattern found in DNA is the Watson-
Crick base pairing. In the canonical Watson-Crick base pairing, adenine forms a base 
pair with thymine, as does guanine with cytosine in DNA2. The base pairs are held 
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together by hydrogen bonds between covalently bound hydrogen atoms and 
hydrogen bond acceptor atoms such as carbonyl oxygen atoms or nitrogen atoms. 
Adenine and thymine (A:T) base pairs are held together by two hydrogen bonds, 
whereas guanine and cytosine (G:C) base pairs are held by three hydrogen bonds. 
Although Watson-Crick base pairing is more commonly found in DNA, Hoogsteen 
base pairing has been observed in several DNA structures such as parallel, triplex 
and quadruplex DNA structures. Hoogsteen base pairing alters the normal base 
pairing pattern by base pairing through the N7 position.  
Usually, DNA assumes a double stranded helix structure (DNA duplex). The 
most common DNA duplex conformation is the B-form, which is a right-handed 
helix2. The two complementary strands are anti-parallel, one strand is oriented in 
the 5’-3’ direction while the other strand is oriented in the 3’-5’ direction. The bases 
are within the helix, forming base-pairs that are perpendicular to the axis of the 
helix. B-DNA has two distinct grooves within its edges due to the orientation of the 
base pairs: a major groove and a minor groove. The double helix is stabilized and 
held together by several different forces. Firstly, hydrogen bonding between the 
bases on the complementary strands stabilizes the DNA duplex. Secondly, 
hydrophobic base-stacking interactions between the aromatic rings of adjacent 
base pairs also contribute to stability. Thirdly, water molecules cooperatively bind 
along the grooves of the DNA adding further stability to the duplex structure. 
Finally, metal cations surround the negatively charged phosphate groups in the 
sugar-phosphate backbone adding more stability to the DNA duplex. Over and 
above B-form, DNA duplex can also assumes, under different conditions, a number 
of other different conformations such as the A-form and Z-form1 (Figure 1.3). 
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Figure 1.3: Possible forms of DNA duplex: B-form (a), A-form (b), Z-form (c). 
 
2) Non-canonical DNA structures 
 
2.1 Triplex 
 
The existence of the DNA triple helix structure is known since 19573, four 
years after the discovery of the DNA double helix structure2, but only recently the 
triple-helical forms of DNA have received the due attention. The interest in triple 
helices of DNA is in large part due to the potential biomedical applications for 
specific controlling gene expression at both transcriptional and replicational levels4.  
Canonical triple helix formation relies upon hydrogen bonding interaction 
between a homopyrimidine oligonucleotide and homopurine-homopyrimidine 
duplex already engaged in Watson-Crick hydrogen bonds. The third oligonucleotide 
strand (often called TFO, acronym of Triplex Forming Oligonucleotide) occupies the 
major groove of the double helix forming Hoogsteen hydrogen bonds5 with the 
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purines of the Watson-Crick type base pairs (Figure 1.4). This recognition process is 
extremely simple, specific and efficient. Specificity is derived from thymine (T) 
recognition of adenine-thymine base pair (A⋅T) and protonated cytosine (C+) 
recognition of guanine-cytosine base pair (G⋅C). The efficiency of the single strand 
binding depends on several factors, such as pH, cation concentration, composition 
and length of the third strand. NMR6, infrared spectroscopy7 and fiber diffraction 
studies8 convincingly demonstrated that the original double helix within the triplex 
adopts a B-like rather than A-like structure as was initially concluded by Arnott and 
Selsing in 19749. 
 
 
Figure 1.4: Example of G-triplex strucutre (PDB: 149D). 
 
2.2 G-quadruplex 
 
G-quadruplexes are higher-order DNA and RNA structures formed from      
G-rich sequences that are stabilized by tetrads of hydrogen-bonded guanine bases 
(G-quartets) (Figure 1.5)10. Stacking of G-quartets and coordination of metal cations, 
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preferentially Na+ and K+, between two adjacent G-quartet planes yield a stable       
G-quadruplex structure11. Variations in the molecularity, topology, strand 
orientation, and glycosidic conformation of the G-quadruplex DNA provide a diverse 
array of structures12. 
 
 
Figure 1.5: (A) Lateral view of a G-quadruplex structure; (B) top view of a G-tetrad. 
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1) G-quadruplex structures 
 
1.1 Fundamentals of G-quadruplex structures 
 
G-quadruplexes can be formed from one, two or four separate G-reach 
strands of DNA (or RNA) and can display a wide variety of topologies, which are in 
part a consequence of various possible combinations of strand direction, as well as 
variations in loop size and sequence1. They can be defined in general terms as 
structures formed by a core of at least two stacked G-quartets (or Gtetrads), which 
are held together by loops that are not involved in the quartets themselves.  
The G-quartet consists of a planar arrangement of four guanine bases 
associated through a cyclic array of Hoogsteen-like hydrogen bonds in which each 
guanine base both accepts and donates two hydrogen bonds (Figure 1.1)2. 
 
Figure 1.1: Top view of a G-tetrad.  
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The G-tetrads are not stacked linearly, but adopt a right-handed helix. The 
combination of the number of stacked G-quartets, the polarity of the strands and 
the location and length of the loops would be expected to lead to a plurality of G-
quadruplex structures, as indeed is found experimentally3,4. 
G-quadruplexes can be classified on the basis of: 1) the number of strands 
(one, two or four); 2) The pattern of strand orientation (parallel, antiparallel); 3) the 
conformation of guanine glycosidic torsion angles (anti or syn); 4) the orientation of 
the loops (lateral, diagonal or propeller) (Figure 1.2)5. 
 Unimolecular quadruplexes are generated by a single oligonucleotide strand 
whose G-tracts are involved in intramolecular G-tetrad interactions. Potential 
unimolecular G-quadruplex-forming sequences can be described as follows: 
GmXnGmXoGmXpGm where m is the number of G residues in each short G-tract, 
which are usually directly involved in Gtetrad interactions. Xn, Xo and Xp can be any 
combination of residues, including G, forming the loops. This notation also implies 
that the G-tracts can be of unequal length, and if one of the short G-tracts is longer 
than the others, some of the G residues will be located in the loop regions. 
Bimolecular and tetramolecular quadruplexes are formed by association of 
two and four strands, respectively, and, in principle, they can be formed from the 
association of non-equal sequences. However, almost all bimolecular quadruplexes 
reported to date are formed by the association of two identical sequences 
XnGmXoGmXp, where n and p may or may not be zero. 
Tetramolecular quadruplexes may be formed by four XnGmXo or GmXnGm 
strands associating together. 
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X-ray and NMR structures revealed that all the strands of tetramolecular 
quadruplexes are in a parallel orientation. All parallel quadruplexes have all guanine 
glycosidic angles in an anti conformation6,7. Quadruplexes are defined antiparallel 
when at least one of the strands is antiparallel to the others. Antiparallel 
quadruplexes have both anti and syn guanine glycosidic torsion angles and their 
distribution along the strand depends on distinctive topological arrangements, since 
different topologies have the four strands in differing positions relative to each 
other8-10. 
Three types of loops have been observed in quadruplex structures: lateral, 
diagonal or propeller loops. In general, lateral loops join adjacent G-strands, 
whereas diagonal loops join opposite Gstrands; in the third type of loops, propeller 
loops, the loop joins the bottom G-tetrad with the top G-tetrad5. In general, 
unimolecular quadruplexes present all the three types of loop and a variety of 
antiparallel strand orientations, although parallel strand orientations were also 
found12,13.  
Bimolecular quadruplexes can form different structures depending on even 
small changes in sequence. For example, the telomeric sequence d(G4T4G4) of the 
cyliate Oxytricha nova forms in solution a symmetric bimolecular structure with 
parallel/antiparallel strands orientation, diagonal loops formed by opposite strands 
and alternating anti/syn guanine glycosidic angles14-17. Both sequences d(G3T4G4) 
and d(G4T4G3) with a missing guanine at the 5’ or 3’ end with respect to the 
Oxytricha nova sequence, form an asymmetric bimolecular quadruplex. However, 
the first structure shows one lateral and one diagonal loop18, whereas the second 
structure shows two diagonal loops19. 
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Figure 1.2: Some possible topologies for tetramolecular, bimolecular and unimolecular 
quadruplexes. The nomenclature indicated is based on a recently proposed topological classification 
of quadruplexes in which structures are ordered in four main families according to their relative 
strands orientation (capital letters) and the loops connectivities (Arabic numbers)11. 
 
1.2 G-Quadruplex groove widths 
 
All quadruplex structures have four grooves, defined as the cavities bounded 
by the phosphodiester backbones. A consequence of variations in the glycosidic 
torsion angles is the altering of the spacing between the DNA strands of the G-
quadruplex, resulting in varying groove-widths along the side of the quadruplex20. In 
cases where a guanosine in the syn conformation donates hydrogen bonds to a 
neighboring guanosine in the anti conformation, the groove formed between the 
two is extremely narrow, with a phosphate to phosphate distance as small as 7-9 
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Å21. In contrast, when the hydrogen bonding polarity between adjacent syn- and 
anti-guanosines is reversed, a very wide groove is formed21. An intermediate width 
groove results when adjacent guanosines adopt the same glycosidic conformation21. 
Indeed, in a parallel four-stranded quadruplex, where all the guanine bases are in 
the anti conformation, the four grooves are approximately the same medium width 
(Figure 2.2A). For example, in a symmetric bimolecular structure having lateral 
loops, the G-tetrads are formed from guanosines of alternating anti-syn-anti-syn 
conformation, with each syn-guanosine donating hydrogen bonds to an adjacent 
anti-guanosine, and accepting hydrogen bonds from the other adjacent 
guanosine22. This results in a rectangular G-tetrad core with grooves of alternating 
wide-narrow-wide-narrow widths (Figure 2.2B). In contrast, a bimolecular 
quadruplex with diagonal loops, has guanosines that adopt the syn-syn-anti-anti 
conformations, which results in G-tetrads that adopt a parallelogram arrangement 
and the formation of alternative wide, medium, narrow, medium width grooves 
between strands (Figure 2.2C).  
Groove dimensions are then variable, and depend on overall topology and 
the nature of the loops. Grooves in quadruplexes with only lateral or diagonal loops 
are structurally simple, but, in contrast, grooves that incorporate propeller loops 
have more complex structural features that reflect the insertion of the variable-
sequence loops into the grooves. 
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Figure 2.2: Variations in glycosidic torsional angles and their effects on groove width in G-quadruplex 
structures. All anti (A), anti-syn-anti-syn (B), and syn-syn-anti-anti (C) G-tetrads. 
 
1.3 G-Quadruplex metal ion binding 
 
When one or more G-tetrads are stacked, a cylindrical central cavity is 
produced23. This cavity, lined with the guanine O6 carbonyl oxygens, forms a 
specific binding site for metal ions24. The coordination of potassium25, sodium26, and 
strontium27 all provide both thermodynamic and kinetic stability to the G-
quadruplex structure. Experiments demonstrate that the G-quadruplex is stabilized 
by the alkali series in the following order: K+>>Na+>Rb+>NH4+>Cs+>>Li+, and for the 
alkaline earth series in the order: Sr2+>>Ba2+>Ca2+>Mg2+ indicating that the atomic 
radii of 1.3 Å of potassium and strontium fit best in the coordination site between 
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adjacent G-tetrads28,29. The precise location of the cations between the tetrads is 
dependent on the nature of the ion. Na+ ions within the channel have been 
observed in a range of geometries; in some structures, a Na+ ion is in plane with a 
G-tetrad whereas in others it is between two successive G-tetrads7. K+ ions are 
always equidistant between each G-tetrad plane, interacting equally with each of 
eight carbonyl oxygens in a bipyramidyl antiprismatic coordination geometry30. 
The selectivity of G-quadruplex DNA for K+ versus Na+ ion has been studied 
by Feigon and coworkers by 1H-NMR, using the bimolecular quadruplex formed by 
d(G3T4G3) as a model system31. In this system, the G-quadruplex binds two K+ or 
Na+ ions, corresponding to one metal ion sandwiched between each pair of G-
tetrads. Using competition NMR experiments, Feigon and coworkers determined 
that there is only a modest difference in free energy of 1.7 kcal/mol favouring the 
binding of K+ versus Na+ ions. They suggest that this modest free energy difference 
is a result of the contributions of the relative free energies of hydration, which 
favors K+ binding31. 
A biologically significant aspect of metal ion binding is related to the 
observation of different conformation in the presence of different cations. There 
are a number of well-established examples where the change from Na+ to K+ 
induces profound structural alteration, implying high conformational flexibility for 
these particular quadruplexes. For example, studies on the DNA sequence 
[d(GGCT4GGGC)]2 in the presence of either K+ or Na+ show distinct differences. In 
the presence of K+ ion, two G-tetrads are stacked in an antiparallel form bimolecular 
quadruplex32. 
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The smaller Na+ ion, however, allows for the formation of non-Watson-Crick 
G:C base pairs in the connecting loop region. These GCGC stabilized tetrads stack on 
the flanking ends of the G-tetrads with Na+ ions coordinated between the G-tetrad 
and its neighboring GCGC tetrad33. 
On the other hand, it is equally clear that some quadruplexes, have very 
stable and unique topologies. For example, the X-ray structure of the bimolecular 
quadruplex formed by the Oxytricha nova sequence d(G4T4G4) in the presence of 
K+ ions17, shows identical quadruplex topology to the NMR structures in                
Na+-containing solution34-36, which is itself identical with the NMR structure in       
Tl+-containing solution34. 
 
2) Biological interest of G-quadruplexes 
 
Recently, there has been growing interest in the study of quadruplexes 
because of their possible involvement in many biological processes. Telomeric DNA 
in a variety of eukaryotic organisms is organized in tandem repeats of short G-rich 
sequences35-41 (Table 2.1) that were shown to form G-quadruplex 
structures12,21,42,43. The intramolecular G-quadruplex formation observed in the 
human telomeric sequence d[TTAGGG]4 can inhibit telomerase activity44-46. As in 
vitro telomerase induction can transform healthy cells into malignant ones47, 
telomerase inhibition by targeting G-quadruplex leads to telomere shortening and 
senescence in tumor cells48-57. G-quadruplex structures have been shown to exist in 
vivo in Stylonychia lemnae macronuclei58 and recently in human cells59. 
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Table 2.1: Sequences and length of Telomeric repeats (Taken from Burge et al. NAR 2006)15 
 
Quadruplex-forming G-rich sequences are also found in a number of cancer-
related genes such as c-myc60-63, c-kit64,65, HIF-1α66, VEGF67, BCL-268,69, KRAS70, 
Rb71,72 and RET protooncogene73. The evidence for the involvement of G-
quadruplexes in transcriptional control of the c-myc oncogene has been shown71. 
The overexpression of this oncogene is associated with a variety of human 
malignancies, including breast, colon, cervix, small-cell lung carcinomas, 
osteosarcomas, glioblastomas, and myeloid leukemias74-77. In addition, c-Myc 
protein can induce telomerase activity by increasing the transcription rate of 
hTERT78. The nuclease hypersensitivity element (NHE) III1 upstream of the P1 
promoter of c-myc controls up to 90% of the transcriptional activation of this 
gene61,79-83. The element NHE III1 can form transcriptionally active and silenced 
forms84. The guanine-rich segment of this element is part of the silenced form and 
can adopt a quadruplex structure that is critical for transcriptional silencing61,63.     
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G-quadruplex interacting agents with specificity for binding to silencer element can 
be good anticancer agents85. 
G-quadruplexes are also important because they have been implemented in 
the design of novel aptamers aimed at binding and inhibiting particular proteins86-
88.For example, the sequence d(GGTTGGTGTGGTTGG) (TBA: thrombin binding 
aptamer) was found to be a potent inhibitor of thrombin in a fibrinogen clotting 
assay89,90. Furthermore, quadruplex forming oligonucleotides have resulted to be 
potent inhibitors of the HIV-1 integrase, the enzyme responsible for the insertion of 
viral DNA into the host genome91. Recently, several non-telomeric or telomeric      
G-tail oligonucleotides have been found to exhibit antiproliferative activity against 
many tumor cells in culture92. 
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1) G-quadruplexes: an attractive anti-cancer target 
 
Molecular recognition is a very important phenomenon in biology and 
chemistry, and the molecular basis of interaction between small ligands and 
biological macromolecules is the subject of numerous investigations aimed at the 
rational design of molecules with specific biological activities. In particular, during 
the last years, a great number of manuscripts have appeared in the literature 
dealing with the development of low molecular weight agents specifically 
interacting with DNA1. Since now, most of the investigations were focused on 
targeting duplex DNA. Only recently, upon the identification of G-quadruplex motifs 
as biologically crucial structures, a certain number of studies about ligand/DNA-
quadruplex interactions have been reported2.  
Sequences with propensity to form G-quadruplexes have been identified in 
biologically significant genomic regions such as telomeres or oncogene promoter 
regions3,4, which have emerged as potential targets for anticancer drug 
development. 
The biological importance of telomeric G-quadruplex structures arises from 
the evidence that high telomerase activity (not present in somatic cells) has been 
implicated in about 85% of tumours5. The telomerase elongates the G-rich strand of 
telomeric DNA, leading the cancer cells to infinite lifetime. For that reason, the 
inhibition of telomerase has become an interesting strategy for the anticancer 
therapy6. Since the formation of G-quadruplexes by telomeric DNA inhibits the 
activity of telomerase, small molecules that stabilize the G-quadruplex structures 
could potentially be effective chemotherapeutic agents7. In this scenario, the 
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identification of new ligands that are specific for G-quadruplex structures is 
emerging as a promising approach to develop new anticancer drugs. Despite the 
fact that the structures of G-quadruplexes differ considerably from the double helix, 
the design of selective quadruplex ligands is very difficult, because the structure of 
G-quadruplexes varies in several different ways, including number and orientation 
of strands, grooves width, and loops topology8. Nevertheless, a number of G-
quadruplex binding agents has been proposed so far and some of these have been 
demonstrated to be effective telomerase inhibitors9.  
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2) G-quadruplex groove binders: a story that starts with    distamycin A 
 
So far, most of the reported G-quadruplex binding agents bind to DNA by 
interacting with the wide π-surface of the G-tetrads at the edges of the quadruplex. 
Groove-binding mode to quadruplex structure was first proposed by our research 
group for the distamycin A1, and, up to now, this is the only molecular entity for 
which a pure groove binding mode has been experimentally proven.  
The interest in the groove binding recognition is mainly fueled by the 
chemical and conformational differences existing between quadruplex and duplex 
grooves. Unfortunately, the understanding of the chemical, structural and 
conformational features responsible for G-quadruplex groove binding is still in its 
infancy. In this scenario, discovery of new distamycin A analogues could greatly 
contribute to linking structural features and groove binding properties.  
Analysis of the distamycin A/[d(TGGGGT)]4 interaction patterns revealed 
that this ligand binds, as antiparallel dimer, the quadruplex groove by adopting a 
crescent shape and by establishing four H-bonds with the G bases1 (Figure 2.1). 
Moreover, strong coulombic interactions are established between positively 
charged amidinium moiety of the ligand and the backbone phosphate groups of the 
quadruplex. 
In a previous study, we investigated the importance of the crescent shape 
extension by varying the pyrrole units number in distamycin A2. Experiments reveal 
that the presence of one additional pyrrole unit affects the binding of the molecule 
and varies its stoichiometry, whereas, the addition of two pyrrole units lead to a 
total loss of affinity of the new derivative for [d(TGGGGT)]4.  
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Figure 2.1: 3D structure of the complex 4:1 distamycin A (cyan)/ [d(TGGGGT)]4 (orange). 
 
In section 3 and 4 of the present dissertation, the description of new 
chemical modifications on the structure of dystamicyn A is reported. Particularly 
NMR analysis, ITC experiments and Molecular modeling studies were used to 
investigate the interaction of two new distamycin A analogues with the quadruplex 
structure formed by [d(TGGGGT)]4. 
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3) Selective binding of distamycin A derivative to G-quadruplex 
structure [d(TGGGGT)]4  
 
3.1 Introduction 
 
In this work, we report a calorimetric and NMR study of the interaction 
between the [d(TGGGGT)]4 quadruplex and a new distamycin A derivative 
(compound 1, Figure 3.1), where the initial formamide group is replaced by a 
charged N-formimidoil moiety.  
 
 
Figure 3.1: Chemical structures of netropsin (A), distamycin A (B) and compound 1 (C). 
 
In addition, since compound 1 can also be considered as an analogue of 
netropsin because it presents one pyrrole unit more than netropsin (three instead 
of two), but two cationic ends like it (even if different groups), we compare the 
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binding of compound 1 to [d(TGGGGT)]4 with the binding of netropsin to the same 
target. Finally, to investigate the selectivity of compound 1 for the G-quadruplex 
relative to duplex, we also performed a study of the interaction between the drug 
and the selfcomplementary DNA duplex d(CGCGAATTCGCG)2. This symmetric 
dodecamer was chosen because (a) it contains the central AATT core, which is 
considered the specific binding site for distamycin A and netropsin; (b) the 
interaction with netropsin is well characterized in literature, from both structural 
and thermodynamic point of view1-4. 
 
3.2 Results and Discussion 
 
Distamycin A and netropsin have been recognized for decades as non 
intercalative DNA binding ligands that show specificity for the minor groove of        
dA・dT base pairs5,6. The binding of the drugs to duplex DNA involves an 
electrostatic component from the cationic ends, hydrogen bonds from the amide 
NH groups, and van der Waals interactions with the wall of the groove. Some years 
ago, NMR studies indicated that, depending on DNA sequence, some binding sites 
can accommodate two distamycin A molecules side-by-side in an antiparallel 
orientation7. In this 2:1 complex each ligand molecule preserves all the molecular 
recognition elements of groove binders. In contrast to distamycin A, the dication 
netropsin binds only as a single molecule per binding site, suggesting that the side-
by-side arrangement of two molecules is inhibited by charge repulsions. Both drugs 
have been shown little or no affinity for single-stranded DNA or RNA or for double-
stranded RNA or DNA RNA hybrids as well as they do not bind to the A helix or the 
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left-handed Z-DNA6-8. Surprisingly, distamycin A has recently been shown to interact 
also with four-stranded parallel DNA quadruplexes9,10. Particularly, we have proved, 
by using NMR and ITC methodology, that distamycin A is able to interact with the 
quadruplex [d(TGGGGT)]4. We showed that four ligand molecules bind as 
antiparallel dimers to the quadruplex in two opposite grooves, establishing 
hydrogen bonds with the guanine bases and strong coulombic interactions between 
the positively charged amidinium moiety of the ligand and the backbone phosphate 
groups of the quadruplex10. On the other hand, netropsin turned out to possess a 
lower affinity (NMR data) towards the quadruplex [d(TGGGGT)]411, even if, till now, 
this has never been confirmed by ITC. Interestingly, it seems that netropsin is not 
able to bind the quadruplex in dimeric form, most probably due to the doubly 
charged nature of molecule that prevents a side-by-side arrangement into the 
grooves.  
 
NMR experiments. In order to evaluate the binding properties of derivative 
1, and to perform a direct comparison with the binding behaviour of distamycin A 
and netropsin, [d(TGGGGT)]4 has been titrated with 1 at the same experimental 
conditions (buffer, temperature, DNA concentration) used for distamycin A11. As far 
as distamycin A is concerned, below 2:1 ligand : quadruplex stoichiometry, the 
addition of distamycin A to [d(TGGGGT)]4 caused gradual changing in chemical shift 
of the signal of the quadruplex, whereas further addition of drug caused the 
appearance of a new set of proton signals, whose intensities rose by increasing the 
amount of drug with the concomitant falling off of the original signals which 
completely disappeared at a ratio of 4:1 drug-DNA. Differently, the NMR titration 
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profile of 1 (Figure 3.2) turned out to be very different from that observed in the 
case of distamycin A. The titration was virtually completed at ligand : DNA ratio of 
2:1. The four strands resulted to be magnetically equivalent throughout the 
titration, since no splitting of resonances was observed at any stage. Furthermore, a 
single set of signals was present for derivative 1 protons throughout the whole NMR 
titration, which only grew in intensity and did not show any significant change in 
chemical shift values by increasing ligand concentration. This result clearly suggests 
that derivative 1 binds the quadruplex in a fast process on the NMR time scale, very 
similarly to the NMR titration profile observed for netropsin11.  
 
 
Figure 3.2: NMR titration of [d(TGGGGT)]4 with derivative 1 (700 MHz, T = 25 °C). 2 mM (8 mM single 
strand concentration), in 0.2 ml (H2O/D2O 9:1) buffer solution having 10 mM KH2PO4, 70 mM KCl, 0.2 
mM EDTA, pH 7.0. Equivalents of the drug are reported on the left of each spectrum. 
 
In order to preliminarily evaluate the binding site of derivative 1, a 
comparison of resonances of some protons of the uncomplexed DNA and the 
complexed one has been done. In particular, we report the Δδ values (chemical 
shifts of the complex minus free DNA) of aromatic, methyl, and imino protons in 
Figure 3.3. Interestingly, all analyzed DNA resonances shifted. Nevertheless, the 
signal of the protons of T1 residue shifted the least, whereas the ones of residue T6 
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the more. In any case, a general shift of the aromatic and imino signals could be 
observed also for the G2, G3, G4, and G5. This means that, basically, derivative 1 is 
able to recognize most of the molecule surface.  
 
Figure 3.3: Difference in chemical shifts (Δδ) of DNA upon binding of 1 (complex 1:DNA minus DNA 
alone) with [d(TGGGGT)]4. Δδ values are reported for imino (light gray), aromatic (dark gray) and 
methyl (black) protons. 
 
We also studied the interaction of compound 1 with the DNA duplex 
d(CGCGAATTCGCG)2 containing the central AATT core, which is considered the 
specific binding site for distamycin A and netropsin, to evaluate a possible 
selectivity of this analogue. The 1H-NMR spectrum (700 MHz, T = 25 ◦C) of 
d(CGCGAATTCGCG)2 turned out to be consistent with the assignment already 
published by Hare et al. (taking in due account the different temperature at which it 
has been assigned)12. The NMR titration of d(CGCGAATTCGCG)2 with 1 is reported in 
Figure 3.4. In this case, most of the DNA resonances turned out to be not affected 
by the addition of ligand, but some resonances of residues C1, A5, A6, T7, T8, C9. In 
particular, at 2:1 (drug/DNA) molar ratio the aromatic protons of residue C1, A5, A6, 
T7, T8, C9 residues underwent to a shift of only 0.03, 0.01, 0.01, 0.02, 0.03, and 0.01 
ppm, respectively, indicating a very poor affinity towards the dodecamer. 
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Figure 3.4: Expanded region of the 1H-NMR titration of d(CGCGAATTCGCG)2 with derivative 1 (700 
MHz, T = 25 °C). 1 mM (4 mM single strand concentration), in 0.2 ml (H2O/D2O 9:1) buffer solution 
having 10 mM KH2PO4, 70 mM KCl, 0.2 mM EDTA, pH 7.0. Equivalents of the drug are reported on 
the left of each spectrum. Residues that are slightly affected by the binding are indicated. 
 
Isothermal Titration Calorimetry. ITC is an useful methodology for a 
complete understanding of drug-DNA interactions, and it has been applied many 
times to determine the thermodynamic properties of drug-quadruplex interactions. 
Indeed, ITC is the only technique that directly measures the binding enthalpy 
change for the formation of a complex, allowing the free energy change to be 
dissected into the enthalpic and entropic contribution to the association process. 
This reveals the nature of the forces that drive the binding and can provide insight 
into the nature of the intermolecular contacts formed and even into changes in 
solvation9. The understanding of those factors can be helpful in both screening 
among various drugs and optimizing the drug-target interactions, to direct the 
design of new drugs. ITC experiments reveal that both compound 1 and netropsin 
bind to the investigated quadruplex. Examples of the raw ITC and integrated heat 
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data for the titration of [d(TGGGGT)]4 quadruplex with netropsin and compound 1 
are shown in Figure 3.5. The ITC data for drugs binding to [d(TGGGGT)]4 indicate, in 
both cases, the formation of a 2:1 (drug:quadruplex) complex with good affinity. 
The raw data for the titration of drugs with [d(TGGGGT)]4 (insets in Figure 3.5) 
indicate an exothermic interaction, based on the positive values observed for the 
peaks. With each injection of ligand, less and less heat release was observed until 
constant values were obtained, reflecting, in both cases, a saturable process. The 
thermodynamic results obtained from fitting the ITC data for netropsin and 
compound 1 binding to [d(TGGGGT)]4 are given in Table 3.1.  
 
 
Figure 3.5: Raw ITC data (insets) and binding isotherms for titration of [d(TGGGGT)]4 with netropsin 
(A) and with compound 1 (B). 
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Ligand n Kb (x 106 M-1) ∆bH° (kJ mol-1) T∆bS° (kJ mol-1) ∆bG° (kJ mol-1) 
compound 1 2.0 ± 0.1 1.9 ± 0.2 -11.0 ± 2.0 25 ± 2 -36 ± 2 
netropsin 2.0 ± 0.1 1.2 ± 0.1 -10.6 ± 1.0 23 ± 2 -34 ± 2 
Table 3.1: Thermodynamic parameters for the interaction of compound 1 and netropsin with 
[d(TGGGGT)]4 determined by ITC at 25 °C and pH 7.0 
 
The values of the binding constants and the Gibbs energy changes (−34 kJ 
mol−1 and −36 kJ mol−1 for netropsin and compound 1, resp.) indicate that, from a 
thermodynamic point of view, the interactions with the quadruplex molecule are 
favoured at 25 ◦C. The values of ΔH◦ and TΔS◦ show that in both cases the 
interactions are associated with a favourable binding enthalpy (−10.6 kJmol−1 and 
−11.0 kJmol−1 for netropsin and compound 1, resp.), however, the binding 
processes are always entropically driven (23 kJmol−1 and 25 kJmol−1 for netropsin 
and compound 1, resp.). In the case of the interaction of distamycin A with 
[d(TGGGGT)]4, similar results were obtained (entropically driven process with a 
small favourable enthalpic contribution), except for stoichiometry and magnitude of 
binding constant. 
As reported in the literature many times, a groove binding is generally 
characterized by a large favourable increase of entropy and a small favourable or 
unfavourable enthalpy change. This could be mainly due to the fact that the 
association reaction is driven in large part by a hydrophobic effect and the favorable 
entropy is derived from the release of bound water molecules from the DNA and 
drug upon complex formation as well as release of counterions upon binding of 
cationic ligands. Interestingly, the entropically driven interactions of the compound 
1 and of netropsin suggest a groove-binding mechanism also in these cases, as 
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observed for distamycin A. Additionally, in contrast to many other groove binders, 
netropsin binding to duplex DNA is accompanied on average by a favourable 
enthalpy change. This is the result of both electrostatic interactions and hydrogen 
bonds formation between netropsin molecule and DNA. A favourable enthalpy 
change is observed by ITC for netropsin binding to [d(TGGGGT)]4 as well as for 
compound 1, suggesting once again a similar groove binding mode.  
As stated before, the stoichiometry obtained for the association of the 
investigated ligands to [d(TGGGGT)]4 is 2:1 (drug : quadruplex), while for distamycin 
A a stoichiometry of 4:1 was found. This finding is consistent with the observation 
that the distamycin A molecules are able to bind as dimers, while netropsin (and 
probably also compound 1) is not able to dimerise because of charge repulsions. 
Notably, in the distamycin A-[d(TGGGGT)]4 complex, each distamycin  A dimer 
expands its bounded groove (similarly to that observed with duplex DNA), with 
concomitant reduction of the size of the adjacent ones, preventing a further 
interaction with other ligand molecules. In the binding of netropsin to duplex DNA 
the minor groove is widened by 0.5–2.0 Å by the entry of the drug6. We can 
speculate that the binding of the two netropsin molecules to [d(TGGGGT)]4 could 
similarly expand the bounded grooves, reducing the size of the adjacent ones and 
preventing more interactions. 
Finally, we also performed experiments on the interaction of compound 1 
with the DNA duplex d(CGCGAATTCGCG)2 containing the central AATT core, which is 
considered the specific binding site for distamycin A and netropsin, to evaluate if 
the structural modifications of compound 1 influence the binding. An example of 
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the raw ITC data for the titration of the d(CGCGAATTCGCG)2 duplex with compound 
1 is shown in Figure 3.6.  
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Figure 3.6: Raw ITC data for titration of d(CGCGAATTCGCG)2 duplex with compound 1. 
 
Resolvable binding isotherm was never obtained for the interaction of 
compound 1 with duplex using any combination of reactant concentrations, 
suggesting low affinity of the molecule for the investigated duplex. On the contrary 
it is well known that both distamycin A and netropsin have a high binding constant 
(between 106 and 108M−1) for that target containing the specific binding site. This 
finding demonstrates that the structural modifications of compound 1 decrease the 
affinity of the ligand toward the duplex, enhancing the selectivity. 
 
3.3 Conclusions 
 
In summary The combination of calorimetric and NMR methodologies has 
enabled us to demonstrate that netropsin and compound 1 are able to bind to 
[d(TGGGGT)]4 with good affinity, forming, in both cases, a 2:1 (drug : quadruplex) 
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complex. Very interestingly, this study shows that the structural modifications of 
compound 1 do not influence, compared to netropsin, the interaction with the 
quadruplex, but such modifications decrease the affinity of the ligand toward the 
duplex, enhancing the selectivity. 
 
3.4 Materials and Methods 
 
Materials. The d(TGGGGT) and d(CGCGAATTCGCG) oligonucleotide 
sequences used for this study were purchased from the Primm Company (Milan, 
Italy). Quadruplex and duplex samples were prepared by dissolving the lyophilised 
compound in a buffer solution containing 20 mM phosphate with 70 mM KCl, 0.1 
mM EDTA at pH 7.0. The resulting solutions were annealed by heating at 95 ◦C for 5 
minutes. The solutions were then slowly cooled to room temperature and 
equilibrated for 1 day at 4 ◦C. The concentration of oligonucleotides was determined 
by UV adsorption measurements at 90 ◦C using molar extinction coefficient values 
ε(260 nm) of 57800 and 110700M−1 cm−1 for d(TGGGGT) and d(CGCGAATTCGCG), 
respectively. The molar extinction coefficients were calculated by the nearest 
neighbour model13. Compound 1 has been synthesized as reported in the 
literature14, while netropsin has been purchased from Sigma-Aldrich (St. Louis, MO). 
Drug solutions have been prepared in the same buffer used for the 
oligonucleotides, and the concentration has been estimated by UV spectroscopy 
using the calculated extinction coefficient value ε(297 nm) of 30000M−1 cm−1 for 
compound 1 and the reported extinction coefficient value ε(296 nm) of 21500M−1 cm−1 
for netropsin15.  
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Nuclear Magnetic Resonance Experiments. [d(TGGGGT)]4 and 
d(CGCGAATTCGCG)2 NMR samples were prepared at a concentration of 2 mM and 1 
mM respectively, in 0.2 ml (H2O/D2O 9:1) buffer solution having 10 mM 
KH2PO4/K2HPO4, 70 mM KCl, 0.1 mM EDTA, and pH 7.0. NMR spectra were recorded 
with Varian UnityINOVA 700 MHz spectrometer. 1H chemical shifts were referenced 
relative to external sodium 2,2-dimethyl-2-silapentane-5- sulfonate (DSS). 1D 
proton spectra of samples were recorded using pulsed-field gradient DPFGSE for 
H2O suppression16,17. 
 
Isothermal Titration Calorimetry Experiments. ITC experiments were carried 
out at 298 K using a highsensitivity CSC-5300 Nano-ITC microcalorimeter from 
Calorimetry Science Corporation (Lindon, Utah) with a cell volume of 1 ml. Before 
each ITC experiment, the pH of each solution was checked, the reference cell was 
filled with deionised water, and the DNA solutions were degassed for 5 minutes to 
eliminate air bubbles. Care was taken to start the first addition after baseline 
stability had been achieved. In each titration, volumes of 5–10 μL of a solution 
containing compound 1 or netropsin at a concentration of 600–700 μM were 
injected into a solution of quadruplex or duplex DNA (30 μM) in the same buffer, 
using a computer-controlled 250 μL microsyringe. In order to allow the system to 
reach the equilibrium, we applied a spacing of 300 or 400 s between each ligand 
injection. Heat produced by ligands dilution was evaluated by performing a control 
experiment, titrating each ligand into the buffer alone. The interaction heat for each 
injection was calculated after correction for the heat of ligand dilution. The 
corrected heat values were plotted as a function of the molar ratio, to give the 
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corresponding binding isotherms. The resulting isotherms were fitted to a single set 
of identical sites model employing a nonlinear least-squares minimisation algorithm 
to a theoretical titration curve, using the program Bindwork from Calorimetry 
Science Inc. ΔH◦ (reaction enthalpy change in kJmol−1), Kb (binding constant in M−1), 
and n (number of binding sites) were the fitting parameters. The Gibbs energy and 
the entropic contribution were calculated using the relationships ΔbG◦ = −RT ln Kb, (R 
= 8.314 Jmol−1 K−1, T = 298  K) and −TΔbS◦ =  ΔbG◦ − ΔbH◦. 
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4) Structural and conformational requisites in DNA quadruplex groove 
binding: another piece to the puzzle 
 
4.1 Introduction 
 
Here, we report a distamycin A (3) analogue (Figure 4.1), where the major 
change into the structure is the replacement of amidinium group by an uncharged 
N-methyl amide moiety, to probe the real importance of the unique Coulombic 
interaction in the distamycin A/[d(TGGGGT)]4 complex formation. Particularly, the 
synthesis, the NMR titration profile, and the three-dimensional structure of 
3/[d(TGGGGT)]4 complex are reported. To thoroughly characterize the binding of 
the distamycin A derivative with the G-quadruplex DNA motif, a calorimetric study 
was also performed. 
 
 
Figure 4.1: Chemical structure of derivative 3. 
 
4.2 Results and Discussion 
 
Synthesis of Derivative 3. The novel derivative 3 was obtained following the 
procedure reported in the Scheme 1. Starting from derivative 1, prepared by a 
methodology previously reported1, it was condensed with 3-amino-N-
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methylpropanamide hydrochloride2 using an excess (2 equiv.) of 1-ethyl-3-[3-
(dimethylamino) propyl]carbodiimide hydrochloride (EDCI) as coupling agent, in 
DMF and in presence of Hunig’s base at room temperature for 18 h, to obtain the N-
methyl carbamoyl derivative 2 in good yield after purification by silica gel 
flashchromatography.  
The amido modified distamycin A derivative 2 was then transformed in the 
corresponding desformyl derivative 3 by treatment of HCl in a mixture of ethanol 
and water. The reason for this last synthetic step was to obtain the hydrochloride 
derivative 3, that turned out to be more soluble in pure H2O than derivative 2 at the 
concentration used for the preparation of the NMR samples. 
 
Nuclear Magnetic Resonance Experiments. To evaluate the binding 
properties of derivative 3, and to perform a direct comparison with the binding 
behavior of distamycin A, [d(TGGGGT)]4 has been titrated with 3 at the same 
experimental conditions (buffer, temperature, DNA concentration) used for 
distamycin A3. As far as distamycin A is concerned, below 2:1 ligand/quadruplex 
stoichiometry, the addition of distamycin A to [d(TGGGGT)]4 caused gradual 
changing in chemical shift of the signal of the quadruplex, whereas further addition 
of drug caused the appearance of a new set of proton signals, whose intensities 
rose by increasing the amount of drug with the concomitant falling off of the 
original signals which completely disappeared at a ratio of 4:1 drug-DNA.  
On the other hand, the NMR titration profile with 3 turned out to be clearly 
different from that observed in the case of distamycin A (Figure 4.2).  
 
 CHAPTER III 
58 
 
 
 
Figure 4.2: NMR titration of [d(TGGGGT)]4 with derivative 3 (700 MHz, T = 25 °C). 2 mM (8 mM single 
strand concentration), in 0.6 ml (H2O/D2O 9:1) buffer solution having 10 mM KH2PO4, 70 mM KCl, 0.2 
mM EDTA, pH 7.0. Equivalents of the drug are reported on the left of each spectrum. 
 
In fact, the addition of 3 to [d(TGGGGT)]4 caused only gradual changes in the 
chemical shift of DNA proton resonances. At ligand/DNA ratio of 4:1, the titration 
was virtually completed. The four strands resulted to be magnetically equivalent 
throughout the titration, and no splitting of resonances was observed at any stage. 
Moreover, it is noteworthy that, throughout the whole NMR titration, a single set of 
signals was present for derivative 3 protons, which only grew in intensity and did 
not show any significant change in chemical shift values by increasing ligand 
concentration. These observations suggest that derivative 3 bind the quadruplex in 
a fast process on the NMR time scale.  
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To preliminarily evaluate the binding site of derivative 3, a comparison of 
resonances of some protons of the uncomplexed DNA and the complexed one has 
been done. In particular, we report the Δδ values (chemical shifts of the complex 
minus free DNA) of aromatic, methyl and imino protons in Figure 4.3A. 
Interestingly, all the analyzed resonances shifted. Nevertheless, the signal of the 
protons of T1 residue shifted the least, whereas the ones of residue T6 the more. In 
any case, a general shift of the aromatic and imino signals was observed also for the 
G2, G3, G4, and G5. This means that, basically, derivative 3 is able to recognize most 
of the molecule, even if it recognizes preferentially the 3′ edge of the quadruplex.  
 
 
 
Figure 4.3: Difference in chemical shifts (Δδ) of DNA upon binding of 3 (complex 3:DNA minus DNA 
alone) to [d(TGGGGT)]4 (A) and [d(TGGBrGGT)]4 (B). Δδ values are reported for imino (light gray), 
aromatic (dark gray) and methyl (black) protons. No aromatic hydrogens are present for brominated 
residues. 
 
An almost complete assignment of the nonexchangeable/exchangeable 
protons of the complex has been accomplished by means of a combination of the 
analysis of 2D NOESY and TOCSY spectra (700 MHz, T = 25 °C). In particular, as far as 
DNA is concerned, 1H resonances within each deoxyribose were identified by 2D 
TOCSY experiment, while the analysis of NOEs among base protons and H1′, H2′, 
and H2′′ protons allowed us to assign all base protons. The direct comparison of the 
intensities of the NOESY crosspeaks (700 MHz, T = 25 °C, mixing time 100 ms) 
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between the H8 proton bases and sugar H1′ resonances, and among H8 proton 
bases and sugar H2′/H2′′ resonances, indicates that all Gs residues of the complexed 
DNA adopt an anti glycosidic conformation. Then, all bases have classical H8/H2′-
H2′′ sequential connectivities to 5′ neighboring, indicating that the four strands are 
involved in the formation of a helical structure. Moreover, the entire pattern of 
NOEs observed indicates that the backbone conformation resembles closely that of 
the uncomplexed [d(TGGGGT)]4 possessing a right-handed B-form helix structure.  
Each exchangeable proton signal was then assigned to the pertinent 
hydrogen by an in-depth analysis of the NOESY spectra. In particular, the NOE 
contact between H1 proton of DNA at δH 11.34 and the methyl protons at δH 1.34 
of the T1 residue led us to identify the imino protons belonging to the tetrad that is 
in proximity of the 5′ edge of the quadruplex. Similarly, the identification of the 
imino protons belonging to the tetrad in proximity of the 3′ edge was confirmed by 
the NOE between H1 proton at δH 10.64 and the methyl group at δH 1.66 ppm of 
the thymine T6. The other four H1 resonances of the remaining two central tetrads 
were identified by analyzing the NOE connections with the adjacent tetrads.  
The resonances of derivative 3 were assigned, first, identifying the 
resonances belonging to the hydrogen on the convex side of the molecule. 
Particularly, the H5 pyrrole protons (δH 6.70, 6.66, and 6.57 ppm for H5-1, H5-2 and 
H5-3, respectively) have been assigned taking into account that they both exhibit 
scalar and dipolar coupling with methyls that are linked to the same pyrrole ring (δH 
3.52, 3.40, and 3.37 ppm for CH3-1, CH3-2, CH3-3, respectively). As for the protons 
on the concave side of derivative 3, the H3 pyrrole protons (δH 6.42, 6.37, and 6.22 
for H3-1, H3-2 and H3-3, respectively) have been assigned by virtue of very small 
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scalar coupling with H5 protons of the same pyrrole ring. Unfortunately, we were 
not able to unequivocally assign NH-1, NH-2 and NH-3 protons due to the presence 
of ambiguous NOEs with the adjacent H3s.  
The NOESY spectrum of the complex contains a number of intermolecular 
ligand-ligand and ligand-DNA NOEs, in addition to intramolecular ones. Particularly, 
as for ligand ligand contacts, 12 head to tail NOEs (for each molecule of 3, 24 for 
each dimer) were clearly discernible in the NOESY spectra (Table 4.1), that 
unambiguously indicates that the ligand molecules bind to the quadruplex, two by 
two, with each term of the dimeric pairs with an antiparallel orientation and in close 
contact to its partner (as observed for the binding of distamycin A to both duplex 
and quadruplex DNA)3,4. In addition, 14 NOEs were observed between each 
molecule of derivative 3 and [d(TGGGGT)]4. In particular, derivative 3 displayed NOE 
contacts predominantly with residues G4, G5, and T6 of DNA. Analogously to that 
observed for distamycin A, also in this case, there are no contacts between 
derivative 3 and the imino protons of the quadruplex (since these point inside the 
quadruplex core) (Table 4.2). All this suggests that derivative 3 actually does not 
stack on the edges of the quadruplex, even if it prefers to interact with the 3′ edge 
of the quadruplex. 
  
Ligand Proton Ligand Proton 
H3-1 CH3-4, CH3-3, H5-3 
H5-1 CH2-1, CH3-4, CH3-3 
H3-2 CH3-3, H3-3, H5-3  
H5-2 CH3-4 
H3-3 CH3-1 
H5-3 CH3-1 
Table 4.1: Intermolecular head to tail 
ligand ligand NOE contacts 
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Ligand Proton DNA Proton 
H3-1 T6:H2’, T6:H1’,G5:H2’, G3:NH2 
H5-1 G5:H1’, G5:H2’, G4:H2’ 
CH3-1 T6:H1’ 
H3-2 T6:H1’ 
H5-2 G5:H2’ 
H3-3 T6:H6, G5:H1’, G4:H2’ 
H5-3 G4:H2’, G5:H1’ 
Table 4.2: Intermolecular ligand-DNA NOE contacts 
 
Synthesis and NMR Titration of the Quadruplexes Containing Bromine 
Atoms. To further confirm that 3 is able to bind the grooves of the quadruplex, as 
its analogue distamycin A, we have designed and synthesized a modified 
oligonucleotide, namely, d(TGGBrGGT), where dGBr is 8-bromo-2′-deoxyguanosine, 
potentially capable to form quadruplex structure and possessing a bulky group 
(bromine) at the very center of the grooves.  
Our intention was to titrate d(TGGBrGGT) with 3 and to analyze the titration 
profile. As a result, if 3 interacts with the portion of the grooves of the quadruplex 
where the bromine is present, this should prevent (or at least should limit) the 
insertion of molecules of 3 into the grooves. However, we first tested the capability 
of d(TGGBrGGT) to form a quadruplex structure. NMR sample of d(TGGBrGGT) was 
prepared at a concentration of 2 mM, in 0.6 mL (H2O/D2O 9:1) buffer solution 
having 10 mM KH2PO4, 70 mM KCl, 0.2 mM EDTA, pH 7.0. The sample was annealed 
for 5-10 min at 80 ◦C and slowly cooled down to room temperature, then 1H-NMR 
spectra were recorded using DPFGSE pulse sequence for H2O suppression5,6.  
The 1H-NMR spectrum (700 MHz, T = 25 ◦C) of d(TGGBrGGT) shows the 
presence of four well-defined singlets in the region 11-12 ppm (data not shown), 
attributable to imino protons involved in Hoogsteen hydrogen bonds of G-quartets, 
and the presence of five signals (Figure 4.4), belonging to three guanine H8 and two 
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thymine H6 protons in the aromatic region. These indicate that a single well defined 
quadruplex species is present in solution, consisting of four G-tetrads and 
possessing a 4-fold symmetry with all strands parallel to each other. In a quadruplex 
like this, each Br group of the quadruplex faces right into the grooves, pointing 
outward the quadruplex. Thus, the quadruplex [d(TGGBrGGT)]4 has been titrated 
with 3 and the results are reported in Figure 4.4.  
 
 
 
Figure 4.4: Expanded regions of NMR titration of [d(TGGBrGGT)]4 with derivative 3 (700 MHz, T =      
25 °C). 2 mM (8 mM single strand concentration), in 0.6 ml (H2O/D2O 9:1) buffer solution having 10 
mM KH2PO4, 70 mM KCl, 0.2 mM EDTA, pH 7.0. Equivalents of the drug are reported on the left. 
 
The progressive increase of concentration of 3 up to 4 mol equiv caused only 
a slight drift of DNA signals and drug resonances to gradually grow in intensity 
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(between 6 and 7 ppm). Further additions of drug did not lead to significant 
changes. As suggested also by the Δδ values of DNA signals (Figure 4.3B), the extent 
of chemical shift perturbation is lighter in comparison to the unmodified 
quadruplex. This strongly indicates that, actually, the presence of the bromines at 
the very center of the grooves does affect the recognition process, and that 3 binds 
the grooves of [d(TGGGGT)]4. This also suggests that, in spite of 3 which does not 
show any NOE contacts with the 5′ edge of the groove, 3 is actually able to span the 
entire groove. 
 
Structure Calculations. To obtain the three-dimensional structure of the 4:1 
complex at atomic level, an estimation of proton-proton distances has been 
retrieved from cross-peak intensities in 2D NOESY experiments (700 MHz, T = 25 ◦C). 
A total of 278 experimental distance restraints were used for the calculations, and 
as suggested by the presence of eight guanine imino protons in the 1D 1H-NMR 
spectrum, 32 supplementary distance restraints (HN1-O6, HN2-N7) for 32 hydrogen 
bonds corresponding to the four G-quartets were also incorporated during the 
computations (Table 4.3).  
Restraints for a number of backbone torsion angles were also used in the 
calculations. In particular, the combined analysis of the PE-COSY and zTOCSY 
experiments revealed that all measurable JH1′,H2′ and JH1′,H2′′ ranged from 7 to 9 Hz 
and from 5 to 6.5 Hz, respectively, and that a number of crosspeaks for H3′/H4′ 
correlations were missing. Furthermore, the measurable JH3′,H4′ values were very 
low. All this indicates a predominant S-type nature of sugar ring conformations. 
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Total no. of experimental NOE restraints 278 
Quadruplex intraresidual restraints 96 
Quadruplex interresidual restraints 68 
Intermolecular ligand-quadruplex restraints 62 
Intermolecular ligand-ligand restraints 52 
Dihedral angles (α, β, γ, δ, ε and χ) restraints 96 
Quadruplex H-bonds restraints 32 
Planarity restraints for G bases 56 
Average rmsd (all atoms excluding terminal T bases) 0.84 Å 
Energy (kcal/mol)  
Mean amber energy -1610.42 ± 62.29 
     NOE distance restraints violation energy 84.34 ± 4.82 
     Torsion angle restraints violation energy 184.10 ± 18.29 
Restraint violations  
     Distance (> 0.3 Å) 7 
     Experimental dihedral angles (> 10 Å) 2 
Table 4.3: Structural Data for the NMR Restraints and statistics for the 10 best structures 
 
Therefore, the relative δ angles constraints have been consistently 
constrained into the range 95◦/175◦7. Very interesting information could be also 
retrieved from the analysis of the sum of H4′ couplings constant (ΣJH4′ = JH4′,H3′ + 
JH4′,H5′ + JH4′,H5′′). All measured JH4′ turned out to be 10 Hz. This, along with the lack 
of intense NOEs between H8 and any H5′/H5′′protons, suggested that γ angles could 
be constrained in the range 20◦/100◦7. As far as β and ε angles are concerned, their 
estimation have been performed measuring the scalar coupling in the 2D proton-
detected heteronuclear 1H-31P COSY and by using the semiempirical Karplus 
equation7. Thus, since for all JP,H5′ and JP,H5” were 8 Hz, β backbone torsion angles 
were restricted to -230◦/-110◦7. On the contrary, JP,H3′ for residues 2, 3, 4, and 5 
were larger than 8 Hz, and the corresponding ε angles were restricted to -230◦/-
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110◦7. Furthermore, since α (O3′-P-O5′-C5′) and ζ (C3′-O3′-P-O5′) dihedral angles do 
not involve any protons, it has been impossible to directly retrieve structural 
information for these angles. Nevertheless, since in a structured DNA α and ζ angles 
cannot be considered independent from β, γ, δ and ε, we thought opportune to 
restraint at least one of these angles; thus, α angles have been constrained in the 
wide range -150◦/-30◦. Finally, due to the presence of very weak NOEs between H8 
and H1′ hydrogens, glycosidic torsion angles χ were fixed in the anti-domain (-155◦/-
75◦).  
Therefore, 3D structures which satisfy NOEs and dihedral angles were 
constructed by simulated annealing (SA) calculations. A total of 100 structures was 
generated, and among them, the 10 best models were selected based on the value 
of the overall potential energy and NMR restraint violations for further simulations. 
To probe the thermodynamic stability of these structures and to further refine the 
models, these were all subjected to a 5 ns MD simulation in explicit solvent. All the 
10 MD runs demonstrated a good stability of the whole structure. Moreover, the 
aforementioned simulations converged toward a well-defined ligand/DNA 
conformation as depicted in Figure 4.5 reporting the representative conformations 
(namely, the ones with the lowest rmsd value with respect to the average structure 
calculated over the whole production run).  
As expected, differently from what demonstrated for distamycin A, 
compound 3 dimers are shifted toward the 3′ end of the quadruplex. The two 
staggered antiparallel 3 molecules overlap for their total length with each N-
methylpyrrole ring of one molecule contacting the terminal amide bond of the 
other, thus, making synchronized twisting to easily fit the curvature of the DNA 
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quadruplex grooves. Moreover, one molecule of the dimer of 3 is more solvent 
exposed, while the other is sandwiched between the first one and the quadruplex 
structure (herein referred as 3ex and 3in, respectively). The preference for such an 
orientation with respect to the G-quadruplex could be ascribable to the absence of 
a positively charged anchoring point that in distamicyn A stabilizes each monomer 
so as to project the methyl groups toward the solvent and the opposite amide 
protons toward the crevice of the groove.  
 
 
Figure 4.5: Side view (A) and bottom view (B) of the superimposition of the 10 best structures of the 
4:1 3/[d(TGGGGT)]4 complex. Derivative 3 is reported in green, DNA is colored in yellow. 
 
As aforementioned, the two molecules of compound 3 interact with the 
quadruplex in an antiparallel fashion, as its analogue distamycin A. This is a very 
interesting result; in fact, in theory, two possible orientations could be predicted for 
a dimer of 3: parallel and antiparallel. This behavior could be imputed to the charge-
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transfer π-π interactions and to the energetically favorable dipole-dipole 
interactions established between the monomers as demonstrated by the dipole 
moments of the two staggered structures which are pointing in opposite directions.  
The crescent shape of the ligand allows the formation of favorable 
interactions with the quadruplex by following the curvature of the grooves in the 
G4-G5 region and taking contact with T6 at the 3′ end. A comparison with the 
experimental distamycin A/[d(TGGGGT)]4 complex reveals that in both cases a 
crescent shape is adopted by the ligand. Nevertheless, such a conformation alone 
does not seem to guarantee a pure groove binding mode in the [d(TGGGGT)]4. This 
indicates that the concurrence of the crucial anchoring positively charged point 
(amidinium group) and the crescent shape conformation in distamycin A are both 
responsible for a pure groove binding mode.  
Calculation of the Delphi electrostatic potential surface reveals that the 
terminal methylcarboxamide groups of the 3 dimer are hosted in rather polar 
regions of the quadruplex while the terminal pyrrole ring is exposed to the solvent 
in the G4 region in 3ex or embedded in a less hydrophilic environment in the T6 
region in 3in.  
A close-up view of the best binding pose resulting from NMR constrained SA 
experiments reveals that the aforementioned terminal groups of 3 are involved in a 
network of H-bonds with the quadruplex (Figure 4.6).  
Most precisely, the flexible carboxamide terminal group of the 3in molecule 
is kept in place by an intramolecular H-bond between its NH-4 proton and the 
carbonyl oxygen attached to the third pyrrole ring and by an intermolecular one 
established between the terminal carbonyl oxygen of 3in and the terminal NH2 
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group of 3ex. Moreover, the G5 base is contacted by the dimer through two H-
bonds between its O4′ and its N3 atoms with the 3ex NH2 and 3in NH-4 groups, 
respectively. While polar contacts mainly govern the recognition between the 3 
dimer and the center of the quadruplex groove, rather hydrophobic interactions are 
established with the 3′ end of the [d(TGGGGT)]4 structure. Notably, the terminal 
pyrrole ring of the 3in molecule is embedded in a sort of aromatic cage formed by 
the two T6 bases of the grooveand the third pyrrole of the 3ex molecule. 
 
 
Figure 4.6: Side view representation of the 4:1 complex 3/[d(TGGGGT)]4. 3in, 3ex and [d(TGGGGT)]4 
are depicted in magenta, green and yellow sticks, respectively. 
 
 
Isothermal Titration Calorimetry Measurements. Thanks to the great 
advances in the sensitivity and reliability of the calorimeter, ITC has become an 
important tool for the direct measurement of thermodynamic parameters in several 
biological interactions. Moreover, it has been proven to be useful to study the 
energetic aspects of interactions between G-quadruplexes and other molecules, 
including small ligands8.  
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Therefore, we have utilized ITC to characterize the thermodynamics of 
binding of derivative 3 to [d(TGGGGT)]4 quadruplex. Figure 4.7 shows the binding 
isotherm resulting from the integration of raw data after correction for the heat of 
ligand dilution.  
 
 
 
Figure 4.7: Normalized heat of interaction between compound 3 and [d(TGGGGT)]4. The squares 
represent the experimental data obtained by integrating the raw data and subtracting the heat of 
ligand dilution into the buffer. The line represent the best fit obtained by a nonlinear least-squares 
procedure based on a single set of identical sites model. 
 
The calorimetric data indicate an endothermic interaction. After a number of 
injections of ligand, increasingly less heat uptake was observed until constant values 
were obtained (corresponding to the heat of dilution), reflecting a saturable 
process. The values of Kb and ΔH◦ derived by ITC enable us to complete the 
thermodynamic binding profiles by calculating corresponding values of TΔS◦ and 
ΔG◦. The resulting thermodynamic parameters are showed in Table 4.4.  
 
Drug n Kb (M-1) ΔH° (kJ mol-1) TΔS° (kJ mol-1) ΔG°298K (kJ mol-1) 
3 4 9 x105 6 40 -34 
Table 4.4: Thermodynamic parameters for the interaction of compound 3 with [d(TGGGGT)]4 
determined by ITC at 25 °C 
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The binding affinity measured from ITC is 9 × 105 M-1 at 25 °C. The binding 
enthalpy was found to be positive (ΔH◦ = 6 kJ mol-1) and the stoichiometry of 
interaction was found to be 4:1 ligand-quadruplex. Inspection of the data reveals 
that the entropic contribution (TΔS◦ = 40 kJ mol-1) to the binding of derivative 3 to 
the quadruplex provides the driving force for the ligand-quadruplex binding 
reaction, while the positive heat of formation of the complex indicates that this 
interaction is an enthalpically unfavorable process.  
The results from the calorimetric titration data alone do not allow us to 
demonstrate with certainty the binding mode of this ligand. Usually, small 
molecules bind to duplex DNA by two predominant binding modes, intercalation 
and groove binding. Calorimetric studies have determined the enthalpic and 
entropic contributions to the DNA binding of representative DNA binding 
compounds. Generally, the binding of an intercalator to DNA is driven by a large 
favorable enthalpy change and by an unfavorable entropy decrease, while the 
binding of a groove binder to DNA is characterized by a large favorable increase of 
entropy and a small favorable or unfavorable enthalpy change9. In this case, the 
thermodynamic data determined by ITC for the binding of derivative 3 to 
[d(TGGGGT)]4 (large favorable increase of entropy and small unfavorable enthalpy 
change) are in agreement with the groove binding profile and are confirmed by the 
structure of the complex.  
The thermodynamic parameters for the interaction of derivative 3 are 
slightly different from the ones determined by ITC for the binding of distamycin A to 
the same quadruplex molecule. In both cases, the driving force for the binding 
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reaction is the entropy change. However, the binding of derivative 3 shows a small 
unfavorable enthalpy change, while in the case of distamycin A, a small favorable 
enthalpy change was observed. This interesting difference is probably due to 
structural features of the two ligands. Indeed, the positively charged amidinium 
moiety of distamycin A interacts with the phosphate groups of the quadruplex, 
providing a favourable (although small) enthalpy contribution, while in the 
derivative 3, the amidinium group is replaced by the uncharged N-methyl amide 
moiety that cannot give this contribution.  
 
4.3 Conclusions 
 
In summary, the structural data herein reported unveil the role of the 
Coulombic interaction engaged by distamicyn A and the quadruplex. Such an 
interaction not only influences the strength of ligand/quadruplex formation, but 
surprisingly governs the orientation of the ligand with respect to the DNA. In fact, 
the removal of the positively charged terminal group results in an unprecedented 
ligand binding position in which both the groove and the 3′ end of the DNA are 
occupied. Furthermore, the lack of charge in the ligand does not affect the relative 
orientation of two molecules of 3 forming a dimer. All this opens up the tempting 
opportunity for a fine-tuning of the drug-quadruplex interaction mode. Moreover, 
with this further contribution, we provided the scientific community with an 
enhanced knowledge of the structural and conformational demands of the 
quadruplex groove that will serve as a platform for a rational design of novel groove 
binding agents. 
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4.4 Materials and Methods 
 
Oligonucleotide synthesis. The oligonucleotide d(TGGGGT) was synthesized 
on a Millipore Cyclone Plus DNA synthesizer using solid phase β-cyanoethyl 
phosphoramidite chemistry at 15 μmol scale. Commercially available 5’-DMT-
aminoprotected-8-bromodeoxyguanosine-3’-phosphoramidite was used for the 
preparation of the modified oligonucleotide d(TGGBrGGT). The latter was assembled 
using the standard solid phase β-cyanoethylphosphoramidite chemistry. The 
oligomers were detached from the support and deprotected by treatment with 
concentrated aqueous ammonia at 55 °C for 12 h. The combined filtrates and 
washings were concentrated under reduced pressure, redissolved in H2O, analyzed 
and purified by high-performance liquid chromatography (HPLC) on a Nucleogel SAX 
column (Macherey–Nagel, 1000-8/46); using buffer A: 20 mM KH2PO4/K2HPO4 
aqueous solution (pH 7.0), containing 20% (v/v) CH3CN; buffer B: 1 M KCl, 20 mM 
KH2PO4/K2HPO4 aqueous solution (pH 7.0), containing 20% (v/v) CH3CN; a linear 
gradient from 0 to 100% B for 30 min and flow rate 1 ml/min were used. The 
fractions of the oligomer were collected and successively desalted by Sep-pak 
cartridges (C-18). The isolated oligomers proved to be > 98% pure NMR. 
 
Synthesis of N-[5-({[5-({[(3-amino-3-(N-methylcarbamoyl) ethyl] 
amino}carbonyl)-1-methyl-1H-pyrrol-3-yl]amino}carbonyl)-1-methyl-1H-pyrrol-3-
yl]-4-(formylamino)-1-methyl-1H-pyrrole-2-carboxamide (2). A solution of               
3-amino-N-methylpropanamide hydrochloride (123 mg, 1.2 mmol) in dry DMF (8 
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ml) was cooled to 5 °C and N, N’-diisopropylethylamine (206 ml, 1.2 mmol) was 
added. After 10 min, the acid 1 (412 mg, 1 mmol) and then EDCI (384 mg, 2 mmol) 
were added. The reaction mixture was stirred at room temperature for 18 hours, 
the solvent evaporated in vacuo and the crude residue purified by flash 
chromatography. The crude product purified by chromatography on a silica gel 
column, using DCM: MeOH (8:2) as eluent, furnished the compound 2 as a white 
solid (367 mg, 74% yield).    Mp = 156-158 °C; IR (KBr): 3420, 3310, 1665, 1554, 1312 
and 1212 cm-1; 1H-NMR (DMSO-d6) δ: 2.42 (m, 2H), 2.77 (m, 3H)3.34 (m, 2H), 3.78 
(s, 3H), 3.82 (s, 3H), 3.83 (s, 3H), 6.65 (d, J = 1.6 Hz, 1H), 6.83 (d, J = 1.6 Hz, 1H), 6.82 
(d, J = 1.6 Hz, 1H), 7.01 (d, J = 1.6 Hz, 1H), 7.17 (d, J = 1.6 Hz, 1H), 7.22 (d, J = 1.6 Hz, 
1H), 7.89 (bs, 1H), 8.08 (s, 1H), 8.13 (s, 1H), 8.18 (s, 1H); 9.91 (s, 1H), 9.94 (s, 1H). 
FAB-MS (MALDI-TOF): 497.8 [M+1]+. 
 
Synthesis of 4-Amino-N-[5-({[5-({[(3-amino-3-(N-methylcarbamoyl) ethyl] 
amino} carbonyl)-1-methyl-1H-pyrrol-3-yl]amino}carbonyl)-1-methyl-1H-pyrrol-3-
yl]-1-methyl-1H-pyrrole-2-carboxamide (3). To 5 ml of a solution obtained by the 
addition of 24 ml of ethanol (95%) to 1 ml of 36% HCl in water was added 
compound 2 (248 mg, 0.5 mmol), and the mixture stirred at room temperature for 
24 hours. After this time, the reaction was filtered, the residue washed with dry 
ethyl ether (5 ml) and then dried on P2O5, to furnish compound 3 as brown solid, 
m.p. = 262-264 °C; 1H-NMR (DMSO-d6) δ: 2.41 (m, 2H), 2.56 (m, 3H), 3.24 (m, 2H), 
3.78 (s, 3H), 3.80 (s, 3H), 3.81 (s, 3H), 6.75 (d, J = 1.6 Hz, 1H), 6.82 (d, J = 1.6 Hz, 1H), 
6.84 (d, J = 1.6 Hz, 1H), 6.96 (d, J = 1.6 Hz, 1H), 7.04 (d, J = 1.6 Hz, 1H), 7.20 (d, J = 1.6 
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Hz, 1H), 7.88 (bs, 1H), 8.12 (s, 1H), 9.92 (s, 1H), 9.96 (s, 1H), 10.20 (bs, 3H). FAB-MS 
(MALDI-TOF): 469.4 [M+1]+. 
 
 
 
Figure 4.8: Chemical synthesis of derivative 3. 
 
Nuclear magnetic resonance experiments. The quadruplex NMR sample was 
prepared at a concentration of 2 mM (8 mM single strand concentration), in 0.6 ml 
(H2O/D2O 9:1) buffer solution having 10 mM KH2PO4, 70 mM KCl, 0.2 mM EDTA, pH 
7.0. For D2O experiments, the H2O was replaced with D2O by drying down the 
sample, followed by lyophilization and redissolution in D2O alone. NMR spectra 
were recorded with Varian UnityINOVA 700 MHz spectrometer. 1H chemical shifts 
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were referenced relative to external sodium 2,2-dimethyl-2-silapentane-5-sulfonate 
(DSS). 1D proton spectra of the sample in H2O were recorded using pulsed-field 
gradient DPFGSE5,6 for H2O suppression. Phase-sensitive NOESY spectra10 were 
recorded with mixing times of 100 and 200 ms (T = 25 °C). Pulsed-field gradient 
DPFGSE5,6 sequence was used for NOESY experiments in H2O. TOCSY11 and zTOCSY12 
spectra with mixing times of 100 ms were recorded with D2O solution. 
All experiments were recorded using STATES-TPPI13 procedure for 
quadrature detection. In all 2D experiments, the time domain data consisted of 
2048 complex points in t2 (16K in the zTOCSY) and 400–512 fids in t1 dimension. 
The relaxation delay was kept at 3s for NOESY experiments used in the structure 
determination. A relaxation delay of 1.2 s was used for all other experiments. The 
NMR data were processed on a SGI Octane workstation using FELIX 98 software 
(Accelrys, San Diego, CA) and on iMAC running iNMR software (www.inmr.net). 
 
Isothermal Titration Calorimetry. ITC measurements were conducted at    
25 °C on a CSC 4200 Calorimeter from Calorimetry Science Corporation (Lindon, 
Utah). In these experiments, 10 µL aliquots of a 1250 µM ligand solution were 
injected into a sample cell containing 1300 ml of 40 µM quadruplex solution, with 
stirring at 297 rpm, for a total of 25 injections. The delay between injections was 
400 seconds. Each ligand injection produced a heat burst curve. The areas under 
these heat burst curves were determined by integration to yield the associated 
injection heats. The heats of dilution were determined in parallel experiments by 
injecting a ligand solution of the same concentration in the same buffer. The heat of 
dilution was subtracted from the interaction heats prior to curve fitting. The 
 CHAPTER III 
77 
 
corrected heat values are plotted as a function of the molar ratio, to give the 
corresponding binding isotherms. The resulting isotherms were then fitted to a 
single set of identical sites model using the Bindwork program supplied with the 
instrument, to give the binding enthalpy (ΔH°), equilibrium binding constant (Kb), 
and stoichiometry (n). The remaining thermodynamic parameters, ΔG° and TΔS°, 
were derived using the standard relationships ΔG° = -RT ln Kb and TΔS° = ΔH° - ΔG°. 
The buffer conditions used for ITC measurements were the same of NMR 
experiments.  
 
Structure calculations. Restrained Simulated Annealing (SA) calculations 
were performed using the AMBER 10.0 package14, with DNA described by the latest 
AMBER force field for nucleic acids (ff99bsc0)15,16 while compound 3 was 
parameterized using the General AMBER Force Field17. The Jaguar software package 
(Schrodinger) was used to calculated atomic charges using DFT with an HF/6-31G** 
basis set at the B3LYP level. 
For the initial AMBER model, compound 3 was manually docked into two 
opposite grooves of the [d(TGGGGT)]4 using as a reference structure the distamycin 
A/[d(TGGGGT)]4 solution structure (PDB code 2JT7)3. In fact, given the presence of 
many head to tail ligand-ligand NOEs, as happened for distamycin A, also 3 is 
expected to bind the quadruplex structure in a dimeric antiparallel form. Each 3 
dimer was then placed into the quadruplex groove consistently with what recorded 
in NMR experiments.  
For annealing simulations the General Born solvation (igb = 2) with 
monovalent salt concentration corresponding to 0.1 M was used. The complex was 
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heated to 900 K in the first 5 ps, cooled to 100 K for the next 13 ps and then cooled 
to 0 K for the last 2 ps. The temperature of the system was maintained with a 
varying time constant: 0.4 ps during heating, 4 ps during cooling to 100 K, 1 ps for 
the final cooling stage, and then reduced from 0.1 to 0.05 for the last picosecond. 
The force constants for NOE constraints were increased from 3 to 30 kcal mol-1 Å-2 
during the first 5 ps and then maintained constant for the rest of the simulation. 
These force constants were applied in the form of a parabolic, flat-well energy term 
where r is the model distance or torsion angle and k is the respective force 
constant. 
Econstraint = k(r2- r)2 r1 ≤ r <r2 
Econstraint = 0 r2 ≤ r ≤ r3 
Econstraint = k(r3- r)2 r3 ≤ r < r4 
 
The values for r1 and r4 represent upper and lower distance bounds, 
defining the linear energetic penalty before and after the flat-well energy term. The 
applied distance NOE constraints were retrieved by cross-peak volume integrations 
performed with the program FELIX 98 (Accelrys, San Diego, USA), using the NOESY 
experiment collected at mixing time of 100 ms. The NOE volumes were then 
converted to distance restraints after they were calibrated using known fixed 
distances. The NOE restraints were generated with three distance classifications as 
follows: strong NOEs (r2 = 1.0 Å; r3 = 3.5 Å), medium NOEs (r2 = 3.0 Å; r3 = 4.5 Å) 
and weak NOEs (r2 = 4.0 Å; r3 = 6.0 Å). Distance constraints between base pairs, set 
at half the NOE distance constraint strength, were applied to maintain hydrogen 
bonding (as indicated by the observation of imino proton resonances). Hydrogen 
bonds constraints were used in the range of 1.7 Å (r2)/ 2.3 Å (r3). Planarity force 
 CHAPTER III 
79 
 
constraints of 200 kcal mol-1 rad-2 were applied to G bases throughout the 
simulations. In agreement with NMR data (see Results and Discussion section), the 
backbone torsion angles α, β, γ, δ and ε were restrained in the range -150°/-30°,       
-230°/-110°, 20°/100°, 95°/175° and -230°/-110°, respectively7. Further, glycosidic 
torsion angles χ were fixed in the anti domain (-155°/-75°). Interactions within the 
system were calculated. An unrestrained energy minimization step completed the 
simulated annealing run. This simulated annealing/energy minimization procedure 
was repeated 100 times. Ten best models were selected based on the value of the 
overall potential energy and NMR restraint violations for further analysis. After 
charge neutralization by the addition of 20 K+ ions, the complexes were solvated 
with 16758 water molecules in a TIP3P pre-equilibrated box18. Several equilibration 
steps were performed comprising minimization of the solvent molecules with the 
DNA and ligand fixed, minimization of the whole system, and slow heating to 300 K 
with weak positional restraints on DNA and drug atoms under constant-volume 
conditions. The following 5 ns production runs were applied in the NPT ensemble. 
The particle mesh Ewald method19 was used to evaluate the electrostatic 
interactions with a direct space sum cutoff of 10 Å. With the bond lengths involving 
hydrogen atoms kept fixed with the SHAKE algorithm, a time step of 2 fs was 
employed20. 
Related conformational substates populated during the molecular dynamics 
simulation were analyzed with the AMBERS’s PTRAJ module21. For the 10 
trajectories the average configuration was taken as a reference for subsequent 
mass-weighted rmsd calculations considering all atoms excluding terminal T bases. 
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The single snapshot of each trajectory with the lowest rmsd was taken as the 
representative dynamic structure of that simulation.  
The final set of coordinates has been deposited in the Protein Data Bank 
(accession code: 2KVY).   
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5) Tandem application of virtual screening and NMR experiments in 
the discovery of brand new DNA quadruplex groove binders 
 
Recently, our research group has unambiguously demonstrated a groove 
binding mode between distamycin A and the quadruplex [d(TGGGGT)]41 (Section 2). 
So far, this compound remains the only comprehensively documented groove 
binder for DNA quadruplex. Classical intercalation, as observed in the duplex DNA 
structures, have not been demonstrated to date, most probably due to the 
presence of cations like K+ or Na+ in the very center cavity of the quadruplex 
structures, that prevents such a binding mode.  
Generally, stacking interaction and groove-binding modes are characterized 
by very different specificities. Groove-binding recognition generally offers a higher 
extent of selectivity, since it can more easily recognize different DNA sequences 
and, in the case of quadruplex structures, it can also discriminate among several 
quadruplex topologies, taking advantage of their different groove widths. However, 
in order to find new quadruplex groove binding agents, a consideration must be 
made about the chemical nature of the quadruplex grooves. Interestingly, all known 
quadruplex structures are characterized by grooves that are chemically and 
conformationally very different from the minor groove of the duplex DNA. This 
means that searching for new quadruplex groove binding agents among duplex 
minor groove binders may not be the most successful strategy. For this reason, a 
number of research groups have recently focused their attention in finding 
alternative molecular scaffolds able to recognize the groove of the quadruplex2,3. 
Here, we attempted to search for brand new molecular scaffolds able to interact 
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with the groove of quadruplex structures by means of a structure-based virtual 
screening (VS) approach4. Actually, whereas there are numerous studies using these 
screening methods for targeting proteins, only few VS campaigns have been 
undertaken targeting nucleic acids, and, to the best of our knowledge, none 
targeting the groove of the quadruplex. In a recent review, Trent and co-workers5 
have outlined that the software Autodock optimally balances docking accuracy and 
ranking. Thus, as a starting point, this program was used in VS experiments aimed at 
targeting a very simple quadruplex, namely [d(TGGGGT)]4 (PDB code 1S45)6. This 
quadruplex possesses a fourfold symmetry with all strands parallel to each other, 
which afford four grooves of identical medium width, and all nucleosides in an anti 
glycosidic conformation. Thus, the docking software Autodock4 (AD4) was used to 
dock a diversity set of the commercially available Life Chemicals database (6000 
compounds). In order to avoid finding redundant information, a search area large 
enough to enclose only one of the four identical grooves was used (Figure 5.1). The 
VS results were sorted on the basis of their predicted binding free energies (∆GAD4) 
which ranged from -0.95 to -9.55 kcal/mol. Solutions with a predicted binding free 
energy greater than -6.0 kcal/mol and a cluster size lower than 10 out of 100 
individuals were discarded. Based on these criteria only 137 individuals were 
retained for further considerations. The binding poses calculated for these 
compounds were then visually inspected to discard all the individuals which were 
not predicted to establish tight interactions with the groove of the quadruplex 
structure. More precisely, compounds that were not able to form H-bond with any 
of the guanine bases and/or to establish electrostatic interaction with the backbone 
phosphate groups were not considered. After this final step, 30 compounds 
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corresponding to 0.5% of the original Life Chemicals database were selected and 
purchased for further analysis. 
 
 
Figure 5.1: Groove of the quadruplex [d(TGGGGT)]4 used as VS search area 
The experimental test of the top computational “hits” for binding has been 
performed by NMR, which has the significant advantages that it can detect weak 
binders and readily identify the ligand binding sites, consequently verifying the 
binding specificity7. Thus, we prepared 30 identical DNA samples containing 6.8 mM 
of d(TGGGGT) (meaning 1.7 mM concentration of quadruplex), in 0.2 ml (H2O/D2O 
9:1) buffer solution having 10 mM KH2PO4, 70 mM KCl, 0.2 mM EDTA, at pH 7.0. The 
first problem that we encountered in testing the selected compounds was solubility 
(most of them were not soluble in water). Nevertheless, all samples turned out to 
be soluble in DMSO. Therefore, we tested the stability of the quadruplex 
[d(TGGGGT)]4 in buffers containing different % of DMSO. The quadruplex turned out 
to be perfectly structured even in buffer solutions containing 30% of DMSO. 
Therefore, we dissolved each equivalent of the selected compounds in 5 µL of 
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DMSO, in such a way to get an overall percentage of DMSO at the end of the 
titration not higher than 15%.  
The NMR titrations (700 MHz, T = 25 °C) were carried out monitoring 
resonance chemical shift changes of DNA, which were used to estimate whether a 
given compound is able to interact with the quadruplex and to determine the 
binding site.  
In line with the expected results of a VS campaign, a number of false positive 
were found: i) 8 molecules do not significantly interact with the quadruplex, ii) 11 
molecules caused shift of the signal of Ts (T1 and T6), iii) 3 molecules caused shift of 
the resonances belonging to external bases (T1 and G2, T6 and G5), most probably 
due to an end-stacking interaction.  
Outstandingly, six molecules (1-6, Figure 5.2) were found to cause an 
appreciable shift, among the others, of the G3 and G4 resonances signals, thus 
suggesting, as expected, a groove binding interaction. 
Particularly, compounds 1-5 provided NMR titration profiles very similar to 
each other, causing mainly drifting of the signals of G3, G4, G5 and T6, and so 
indicating that the recognition process involves mostly the 3’ side of the grooves. 
This is a very interesting result, since it is surprisingly consistent with the mode of 
binding calculated by the VS. On the other hand, 6 seems to entirely span the 
grooves, perturbing more uniformly all the residues of the quadruplex. In addition, 
6 causes a major change of the resonances of the quadruplex, suggesting a higher 
affinity. Interestingly, while 1-4 and 6 are positively charged as most of the already 
known groove binders, 5 does not possess any charge, so that the binding might be 
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more driven by the presence of a number of H-bond acceptor heteroatoms. The 
titration of all 6 molecules turned out to be virtually completed at 4 equivalents. 
 
 
Figure 5.2: Structures of the newly identified groove binders. The Life Chemicals codes are reported 
in plain text. Numerals used in this paper are reported below in bold. 
 
In summary, the application of VS calculations together with NMR 
experiments proved to be a successful strategy in the identification of new 
molecular chemotypes able to bind the grooves of DNA quadruplex structures. The 
structural diversity of these inhibitors has provided valuable alternative series for 
ongoing lead-optimization aimed at the identification of brand new 
pharmacological tools, endowed of a better affinity and pharmacokinetic profile, 
useful in the clarification of the mechanism, targeting, and therapeutic potential of 
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G-quadruplexes. In the future we plan to apply this lead discovery approach 
targeting different and more complex G-quadruplex structures.  
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6) A more detailed picture of the interactions between virtual 
screening-derived hits and the DNA G-quadruplex: NMR, molecular 
modelling and ITC studies 
 
6.1 Introduction 
 
The first evidence that the grooves of a quadruplex structure can be 
recognised by an organic molecule came approximately three years ago from our 
own NMR work revealing that, distamycin A can bind in a dimeric form to the two 
opposite grooves of the quadruplex1. Whereas the end-stacker ligands are the 
major part of all known quadruplex binders and their number is growing each day, 
quadruplex groove binders represent a quite unexplored and valuable field. In fact, 
grooves in duplex and quadruplex DNA are chemically  and conformationally 
different, and since groove dimensions differ according to the type of quadruplex, 
groove binders can in principle be selective for a particular quadruplex topology. 
Thus, with the aim of finding brand new molecular scaffolds able to interact with 
the groove, starting from the quadruplex structure found in complex with 
distamycin A, we recently performed an extensive structure based virtual screening 
(VS) campaign2. As a result, six molecules (1-6, Figure 5.2, section 5) were found to 
be somehow groove binding agents. Herein, we have performed additional NMR 
titrations of the six compounds with modified quadruplexes, namely [d(TGGBrGGT)]4 
and [d(TGGGGBrT)]4. These NMR spectroscopy experiments combined with 
molecular modelling studies, provided a more detailed picture of the interactions 
between each binder and the quadruplex DNA. Noteworthy, isothermal titration 
calorimetry (ITC) measurements on the above-mentioned compounds revealed that 
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2, 4, and 6 despite their relatively small dimensions, are more effective in groove 
binding with respect to distamycin A, to the best of our knowledge, the most potent 
groove binder identified thus far. 
 
6.2 Results and Discussion 
 
NMR and molecular modeling studies.Using NMR, six molecules (1-6, Figure 
5.2, section 5) were found to be potential groove binders: they cause an 
appreciable shift, amongst others, of the signals of G3, G4, G5 and T6 of the parallel 
quadruplex [d(TGGGGT)]4, indicating that the recognition process involves mostly 
the 3’ side of the grooves, as also computed by the Virtual Screening calculations2. 
In order to get further insights into the binding mode of compounds 1-6, we 
have acquired a number of NOESY experiments of the complexes of the six 
compounds with the quadruplex [d(TGGGGT)]4. Unfortunately, as no diagnostic NOE 
cross-peak could be retrieved for any complex, none of the three-dimensional 
structures at atomic level could be determined. 
Thus, we decided to get a more detailed picture of the interactions from the 
NMR titration of modified quadruplexes and from molecular docking calculations. 
As a result, we designed and synthesized modified oligonucleotides, namely 
d(TGGBrGGT), d(TGGGBrGT) and d(TGGGGBrT), where dGBr is 8-bromo-2’-
deoxyguanosine, potentially capable of forming quadruplex structures and 
possessing a bulky group (bromine) at different positions of the grooves (G3, G4 and 
G5), as this portion of the DNA should be involved in 1-6 recognition2. These 
modified quadruplexes would then be titrated with the six molecules 1-6 and the 
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results of the NMR titration profile analyzed. The rationale behind these 
experiments derived from the assumption that if these compounds interacted with 
the quadruplex groove region, the presence of the bromine group should now 
prevent (or at least limit) the ligand/DNA interactions.  
Prior to these experiments, we tested the capability of d(TGGBrGGT), 
d(TGGGBrGT) and d(TGGGGBrT), to form a quadruplex structure. Their NMR samples 
were prepared at a concentration of 2 mM, in 0.6 ml (H2O/D2O 9:1) buffer solution 
having 10 mM KH2PO4, 70 mM KCl, 0.2 mM EDTA, pH 7.0. These samples were then 
annealed for 5-10 minutes at 80 °C and slowly cooled down to room temperature, 
then 1H-NMR spectra were recorded by using DPFGSE pulse sequence for H2O 
suppression3,4. The 1H-NMR spectra (700 MHz, T = 25 °C) of d(TGGBrGGT) and 
d(TGGGGBrT) show the presence of four well defined singlets in the region 11-12 
ppm, ascribable to imino protons involved in Hoogsteen hydrogen bonds of G-
quartets, as well as the presence of five signals belonging to three guanine H8 and 
to two thymine H6 protons in the aromatic region. This indicates that a single well 
defined quadruplex species is present in solution for both molecules, consisting of 
four G-tetrads and possessing a fourfold symmetry with all strands parallel to each 
other. In such a quadruplex, each Br group faces the grooves and points outward. 
On the other hand, the 1D 1H-NMR spectrum of d(TGGGBrGT) shows the presence of 
a great number of signals in the regions of imino and aromatic protons, suggesting 
that d(TGGGBrGT) is affected by structural heterogeneity, thus preventing its use in 
our experiments. Hence, only the quadruplexes [d(TGGBrGGT)]4 and [d(TGGGGBrT)]4 
were titrated with compounds 1-6 and the titrations monitored by NMR. A 
comparison of resonances of protons of the uncomplexed quadruplex and the 
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complexed one has been performed. In particular, we report the Δδ values 
(chemical shifts of the complex minus free DNA) of aromatic, methyl and imino 
protons. As far as compound 1 is concerned, the titration with unmodified 
quadruplex [d(TGGGGT)]4 led to a general shift of the monitored signals (white bars 
in Figure 6.1). On the other hand, the titration of [d(TGGBrGGT)]4 causes a slight shift 
(light-gray bars in Figure 6.1) of the residues at the 3’ edge of the quadruplex, 
namely G5-H8, T6-H6/Me, and only of T1-H6/Me at 5’ edge, whilst no appreciable 
shift can be measured for the other signals. This means that the bromine atom at 
the very centre of the groove did affect the binding of compound 1, and that 1 can 
be confidently considered a groove binder. Furthermore, the titration of 
[d(TGGGGBrT)]4 led to a severe line broadening of all signals, making impossible to 
retrieve any information from the spectra. This NMR phenomenon can be 
interpreted assuming that the ligand is changing its binding pose on the NMR time 
scale. It is noteworthy that compounds 1-6 have been discovered from a previous 
Virtual Screening campaign and in that study Autodock4 program was used with a 
search area large enough to enclose only one of the four identical grooves to avoid 
redundant information2. However, this couldn’t cast out the possibility that one or 
more of the selected molecules can also be able to bind to other part of the target. 
Thus, herein, we present results of new docking calculations where the search area 
has been enlarged to comprise the entire surface of the quadruplex [d(TGGGGT)]4 
with the purpose of checking for the capability of the ligands to extend their binding 
out of the groove. 
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Figure 6.1: Δδ values of aromatic (H6/H8), methyl (Me) and imino protons (NH) for [d(TGGGGT)]4 
(white bars), [d(TGGBrGGT)]4 (light-gray bars) and [d(TGGGGBrT)]4 (dark-gray bars). Shadowed 
columns gather resonance variation belonging to the same residue. Asterisks indicate a severe line-
broadening of the monitored signals. Arrows indicate the lack of bars due to the presence of 
bromine atoms. 
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Regarding 1, docking calculations showed that all solutions in the lowest 
energy families (ΔG = -6,2 kcal/mol), were found to be anchored to the 3’ side of the 
groove in line with the above mentioned NMR data (1 was predicted in a groove 
binding mode 75 out of 100 time. As shown in Figure 6.2a, the amine group of 1 
engages a H-bond with the 4’O of the T6 nucleoside, while the ligand carbonyl 
group together with the ortho-hydroxyl group of the phenyl moiety forms H-bonds 
with G5 base. Three H-bonds have been also detected between 1 and the 
phosphate backbone. The above-described binding pose has been found 25 out of 
100 times.  
Surprisingly, compound 2 generates almost identical Δδ values in the 
titration with [d(TGGGGT)]4 and [d(TGGBrGGT)]4 (white and light-gray bars, 
respectively, in Figure 6.1), having a general perturbation of the signals belonging to 
the 3’ side of the groove. This can be interpreted by assuming that the bromine 
atom does not affect the binding of 2 suggesting that this compound should not 
preferentially bind the very centre of the groove. On the other hand, the titration of 
[d(TGGGGBrT)]4 (dark-gray bars in Figure 6.1) led to a marked shift of T6-H6/Me 
signals whereas only a slight shift of all the other monitored signals can be 
observed. This indicates that 2 prefers to interact with the 3’ edge of the 
quadruplex.  
A clearer picture of the ligand-quadruplex interaction could be obtained 
from docking calculations using again the unmodified quadruplex [d(TGGGGT)]4 as 
target. The calculations highly converged toward one family of conformations      
(ΔG = -7.4) (Figure 6.2b) in which the benzoisoquinolinedione ring stacks on the 
surface of the 3’ terminal quartet, particularly between the T6 and G5 rings, and the 
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rest of the molecule inserts into the groove, where the main anchor point is 
represented by the protonated nitrogen of the piperazine ring, which establishes a 
charge reinforced H-bond with the phosphate backbone. This binding mode is in 
agreement with the new NMR titrations performed in this investigation indicating 
that 2 is actually characterized by a mixed binding mode, providing both stacking 
and groove binding interactions.  
 
 
Figure 6.2: Binding poses calculated by AD4 for compounds 1 (a), 2 (b) and 3 (c) in the quadruplex 
structure. DNA backbone is represented as white stick bonds. Ligands are depicted as green sticks. H-
bonds are represented as dashed blue lines. 
 
Differently from 1 and 2, titration of compound 3 with [d(TGGGGT)]4, 
[d(TGGBrGGT)]4 and [d(TGGGGBrT)]4 led to a general shift of almost all signal (Figure 
6.1). However, the resonances of [d(TGGGGT)]4 (white bars) shifted more and those 
of [d(TGGBrGGT)]4 and [d(TGGGGBrT)]4 less (light- and dark-gray bars, respectively). 
This indicates that 3 does not possess a well defined binding mode, so that, when 
the groove is unavailable by the presence of the bromine atoms, 3 slides toward the 
3’ edge groove of the quadruplex; vice versa, in the case of [d(TGGGGBrT)]4, the 
molecule is able to interact only weakly with the available part of the groove. 
Docking calculations on [d(TGGGGT)]4 suggest that the ligand binds the 3’ end of the 
groove (ΔG = -8.2) (3 was predicted in a groove binding mode 87 out of 100 time). 
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As shown in Figure 6.2c, two H-bonds were found, the first between the pyridine 
nitrogen of 3 and the T6 3’-OH group and the second between the hydroxyl group 
of the chromenone core and the G3 NH2. Hydrophobic contacts between the 
pyridine and the T6 rings were also detected together with a charge reinforced H 
bond established by the protonated nitrogen of the piperazine ring with the 
phosphate backbone. The above-described binding mode has been found by 
Autodock program 27 out of 100 times. 
Interestingly, compound 4 displayed different behaviours for the three 
quadruplexes tested. With the quadruplex [d(TGGBrGGT)]4 (light-gray bars in Figure 
6.1), the titration provided higher Δδ values for the residues at the edges of the 
quadruplex with the respect of unmodified [d(TGGGGT)]4 (white bars in Figure 6.1). 
On the contrary, titration of [d(TGGGGBrT)]4 caused major shift for the residue 
sitting in the very centre of the groove (dark-gray bars). This means that compound 
4 can interact with the grooves, and, accordingly, when the very centre of the 
groove is hindered, 4 binds the end sides of the grooves, but it is able to bind the 
very centre of the grooves when their 3’ edges are unavailable. Docking calculations 
suggest two binding poses especially in line with NMR data (Figures 6.3a and 6.3b), 
where the molecule can either interact with 5’ residues (binding mode A, ΔG = -8.2) 
or with the 3’ end (binding mode B, ΔG = -7.9). Specifically, in A, the benzoquinone 
ring establishes a π-π interaction with the T1 ring, while an H-bond between the G2 
NH2 group and the carbonyl moiety is detected. In B, the two carbonyl moieties of 
the ligand are engaged in H-bonds with G4 NH2 and T6 NH respectively. In both 
binding modes a charge reinforced H-bond is observed between the protonated 
nitrogen of 4 and the phosphate backbone. Based on this finding and on the shift of 
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NMR signals observed for all residues forming the groove, a sliding motion of 4 
inside the groove can be proposed. Noteworthy, 100 out of 100 runs propose 4 as 
groove binder.  
 
 
Figure 6.3: Two binding poses calculated by AD4 for compound 4 (a and b), and one for compound 5 
(c) in the quadruplex structure. DNA backbone is represented as white stick bonds. Ligands are 
depicted as green sticks. H-bonds are represented as dashed blue lines. 
 
As far as compound 5 is concerned, the titration of [d(TGGGGT)]4 (Figure 6.1, white 
bars) clearly indicates that 5, like the other selected compounds, prefers to bind the 
3’ edge of the groove. The titration of [d(TGGBrGGT)]4 displays significant lower Δδ 
values for the imino protons (Figure 6.1, light-gray bars), while the shifts of the 
signal of G4, G5 and T6 remain substantially unchanged. On the other hand, the 
titration of [d(TGGGGBrT)]4 indicates that 5 is still able to interact with the 3’ edge of 
the quadruplex probably via end-stacking interaction. A mixed binding mode is 
therefore expected for compound 5. In line with these data, docking calculations 
suggested that in 5 the quinolone ring is adapted on the top of the 3’ end 
sandwiched between the T6 and G5 bases (Figure 6.3c), with the imidazo-
pyrimidine moiety extending towards the groove incipience and H-bonding with the 
G5 NH2 group (ΔG = -6.7). The above-described binding mode has been proposed by 
the docking program 60 out of 100 times. 
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Finally, compound 6 displays peculiar titration behaviours. While the 
titration of the unmodified [d(TGGGGT)]4 showed marked shifts of the G2, G3, G4 
and G5 residues (Figure 6.1, white bars), the titration of [d(TGGBrGGT)]4 is instead 
characterized by very low Δδ values for all residues (light-gray bars). Furthermore, 
the titration of [d(TGGGGBrT)]4 mainly caused shifts of the residues G2, G3 and T6, 
along with a severe line broadening of the imino proton signals (dark-gray bars, 
Figure 6.1). This means that 6 does bind the grooves of the quadruplex, and, as in 4, 
the uniform perturbation of all groove residues of the quadruplex [d(TGGGGT)]4, 
with respect to the limited ligand size, suggests that a fast sliding motion of 6 inside 
the groove is also possible. Molecular docking calculations also revealed that two 
molecules of 6 could in principle simultaneously anchor the two opposite ends of 
the groove although the 5’ end is preferred (42 times out of 100) (Figures 6.4a and 
6.4b). Notably, in perfect line with the changes experimentally observed for G2 and 
G5 aromatic protons signals, the ligand alternatively forms H-bonds with G2         
(ΔG = -7.5) or G5 (ΔG = -6.1) bases in the two reported binding modes (Figure 6.4).  
 
 
Figure 6.4: Two binding poses calculated by AD4 for compound 6. DNA backbone is represented as 
white stick bonds. Ligands are depicted as green sticks. H-bonds are represented as dashed blue 
lines. 
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Finally, the two poses suggested by the docking program, in which a π-π 
interaction is formed with T1 or T6 ring, could somehow account for the T6-H6 
proton and T1-methyl signals shift.  
 
Isothermal Titration Calorimetry Measurements. In order to determine the 
binding affinity of the compounds 1-6 with the quadruplex [d(TGGGGT)]4, ITC 
titration experiments were carried out5.  
Previously, we characterised the interaction of distamycin A with the same 
quadruplex and revealed that four molecules of the drug were accommodated in 
two opposite grooves of the quadruplex; moreover, the thermodynamic signature 
of the binding event suggested that the entropic contribution was the one driving 
the complex formation1. An analogous study however was not possible for the six 
new ligands identified with the virtual screening, because their poor solubility in 
water prevented us from performing canonical ITC experiments5, in which a 
solution of the quadruplex is titrated with a concentrated drug solution in the 
identical aqueous buffer. As an alternative approach to investigate the affinity of 
the new drugs for the DNA quadruplex, we carried out competition/displacement 
experiments, by analysing the ability of distamycin A to bind to the quadruplex in 
the presence of another compound6,7. Despite the solubility concerns, mixtures of 
the quadruplex and each of the six new drugs were successfully prepared by 
solubilising the molecules in DMSO and diluting them in a phosphate solution 
containing the quadruplex (as described in the Methods); these complexes were 
then titrated with distamycin A, and the outcome followed by ITC. 
In Figure 6.5 three representative ITC experiments are reported. First, the 
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interaction of distamycin A with [d(TGGGGT)]4 was repeated in the new buffer used 
in this study in absence of any other ligand, clearly showing that in the new 
experimental conditions this binding event is identical to what was previously 
observed (Figure 6.5, Panels A and B and Table 6.1).  
 
 
Figure 6.5: Calorimetric analysis of the interactions of the quadruplex [d(TGGGGT)]4 and its 
complexes with the drugs 5 and 6, with distamycin A. Raw titration data showing the thermal effect 
of injecting distamycin A into a calorimetric cell containing the quadruplex alone (A), quadruplex 
with 5 (C) and quadruplex with 6 (E). The normalised heat for the titrations, shown in B, D and F 
respectively, was obtained by integrating the raw data and subtracting the heat of the ligand 
dilution. The heat effect reveals the typical double step binding curve of the distamycin A interaction 
to the quadruplex in B and C, null interaction in F. The red lines in B and D represent the best fit 
derived by a non-linear least-squares procedure based on an independent binding sites model. 
 
Table 6.1: Thermodynamic parameters for the interaction of distamycin A with [d(TGGGGT)]4 and its 
complexes formed with 1, 3 and 5. 2, 4 and 6 are not reported since they abolishthe binding of 
distamycin A 
 
The binding occurs in two separate steps, the first one centred on a 
stoichiometry of 1:2 in which two molecules of distamycin A interact with the 
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quadruplex and then a second event in which two more molecules bind, leading to 
a final stoichiometry of 4 molecules of distamycin A per quadruplex. Panels C and E 
report two displacement experiments carried out titrating with distamycin A the 
complexes obtained with the drugs 5 and 6 respectively. The two experiments are 
quite different and indicative of two distinct phenomena. In the first case, a binding 
curve similar to the control experiment is obtained (compare Figures 6.5D and 
6.5B), indicating that the presence of the drug 5 in the mixture did not have an 
effect on the association of distamycin A with the [d(TGGGGT)]4. Distamycin A still 
binds in two distinct events, with stoichiometry and binding constants not 
significantly affected by the presence of 5 (Table 6.1). Conversely, the ITC titration 
of distamycin A into the quadruplex/6 complex (Figures 6.5E and 6.5F) gives a 
completely different outcome. In this case, distamycin A appears no longer able to 
interact with the DNA, suggesting that 6 binds to the quadruplex tightly than 
distamycin A.  
It is important to highlight that the competition/displacement experiments 
do not give any information about the stoichiometry of the complex formed 
between the quadruplex and the compound competing with the distamycin A. A 
summary of the results for all six compounds is reported in Table 6.1: 1 and 3 
behave as 5, whereas the presence of 2 or 4 or 6 abolishes the binding of distamycin 
A.  
In conclusion the competition ITC experiments represent a possible strategy 
to evaluate whether an insoluble groove binder is stronger or weaker than a soluble 
drug that could be used as reference point. In our case, using the distamycin A as 
reference drug, we were able to group the six drugs identified with virtual screening 
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in two extreme classes. The first class contains compounds that bind rather weakly 
to the quadruplex (1, 3 and 5), whereas in the second class the drugs that bind 
substantially stronger than distamycin A (2, 4 and 6) are clustered. 
 
6.3 Conclusions 
 
A successful structure-based virtual screening (VS) campaign was recently 
undertaken by our research group and it resulted in the identification of six small 
molecules able to interact with the groove of the quadruplex [d(TGGGGT)]4. Herein, 
we report NMR spectroscopy experiments which, combined with extensive 
molecular docking studies, allow for a more detailed picture of the interaction 
between each VS-derived binder and the quadruplex DNA. Noteworthy, isothermal 
titration calorimetry (ITC) measurements revealed that 2, 4, and 6, despite their 
relatively small dimensions, bind substantially stronger than distamycin A, which is, 
to the best of our knowledge, the most potent groove binder identified so far. As it 
is widely accepted that specificity among the various DNA G-quadruplexes, that 
might be simultaneously present in the human genome, is a fundamental 
requirement for the quadruplex binder to become a drug, extensive binding tests 
towards DNA duplex and different DNA quadruplex topologies will be the next step 
in our research program. The future results combined with structural studies will 
provide a source of inspiration for the design of next generation of potent and 
selective quadruplex DNA drug-like binders. 
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6.4 Material and methods 
 
Oligonucleotide synthesis. The oligonucleotide d(TGGGGT) was synthesized 
on a Millipore Cyclone Plus DNA synthesizer using solid phase β-cyanoethyl 
phosphoramidite chemistry at 15 μmol scale. Commercially available 5’-DMT-
aminoprotected-8-bromodeoxyguanosine-3’-phosphoramidite was used for the 
preparation of the modified oligonucleotides. The oligomers were detached from 
the support and deprotected by treatment with concentrated aqueous ammonia at 
55 °C for 12 h. The combined filtrates and washings were concentrated under 
reduced pressure, redissolved in H2O, analyzed and purified by high-performance 
liquid chromatography (HPLC) on a Nucleogel SAX column (Macherey–Nagel, 1000-
8/46); using buffer A: 20 mM KH2PO4/K2HPO4 aqueous solution (pH 7.0), containing 
20% (v/v) CH3CN; buffer B: 1 M KCl, 20 mM KH2PO4/K2HPO4 aqueous solution (pH 
7.0), containing 20% (v/v) CH3CN; a linear gradient from 0 to 100% B for 30 min and 
flow rate 1 ml/min were used. The fractions of the oligomer were collected and 
successively desalted by Sep-pak cartridges (C-18). The isolated oligomers proved to 
be > 98% pure by NMR. 
 
Nuclear magnetic resonance experiments. The quadruplex NMR samples 
were prepared at a concentration of 2 mM (8 mM single strand concentration), in 
0.6 ml (H2O/D2O 9:1) buffer solution having 10 mM KH2PO4, 70 mM KCl, 0.2 mM 
EDTA, pH 7.0. NMR spectra were recorded with Varian UnityINOVA 700 MHz 
spectrometer. 1H chemical shifts were referenced relative to external sodium 2,2-
dimethyl-2-silapentane-5-sulfonate (DSS). 1D proton spectra of the sample in H2O 
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were recorded using pulsed-field gradient DPFGSE3,4 for H2O suppression. Phase-
sensitive NOESY spectra8 were recorded with mixing times of 100 and 200 ms (T = 
25 °C). Pulsed-field gradient DPFGSE3,4 sequence was used for NOESY experiments 
in H2O. NOESY experiments were recorded using STATES-TPPI9 procedure for 
quadrature detection. The time domain data consisted of 2048 complex points in t2 
and 400 fids in t1 dimension. A relaxation delay of 1.2 s was used. The NMR data 
were processed on iMAC running iNMR software (www.inmr.net). 
 
Molecular Modeling. The binding modes of compounds 1-6 were studied by 
means of docking experiments with the aid of Autodock4 (AD4)10 and using the 
[d(TGGGGT)]4 G-Quadruplex DNA structure as deposited in the Protein Data Bank 
(PDB code 1S45) as macromolecules. The 3D structures of all the compounds were 
generated with the Maestro Build Panel11. For the purpose of docking each 
molecule has been constructed in the protonation state suggested by the 
MarvinSketch 5.2.5.1 package (http://www.chemaxon.com) using a pH 7.0 
accordingly with the NMR titrations. The target DNA structures were prepared 
through the Protein Preparation Wizard of the graphical user interface Maestro 
9.0.21111 and the OPLS-2001 force field. Water molecules were removed, hydrogen 
atoms were added and minimization was performed until the RMSD of all heavy 
atoms was within 0.3 Å of the crystallographically determined positions. Then the 
constructed compounds and DNA structures were converted to AD4 format files 
using ADT generating automatically all other atom values. In order to allow the 
ligands to explore all the possible search space, the docking area has been centred 
on the mass centre of the quadruplex structure and defined by a box large enough 
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to comprise the entire macromolecule. Accordingly, grids points of 84 × 84 × 84 
with 0.375 Å spacing were calculated around the docking area for all the ligands 
atom types using AutoGrid4. 100 separate docking calculations were performed for 
each binder. Each docking calculation consisted of 25 × 106 energy evaluations using 
the Lamarckian genetic algorithm local search (GALS) method. A low-frequency local 
search according to the method of Solis and Wets was applied to docking trials to 
ensure that the final solution represents a local minimum. Each docking run was 
performed with a population size of 150, and 300 rounds of Solis and Wets local 
search were applied with a probability of 0.06. A mutation rate of 0.02 and a 
crossover rate of 0.8 were used to generate new docking trials for subsequent 
generations. The docking results from each of the 100 calculations were clustered 
on the basis of root-mean square deviation (rmsd 2.0 Å) between the Cartesian 
coordinates of the ligand atoms and were ranked on the basis of the free energy of 
binding. All docking solutions were analyzed for the coherency with NMR data and 
for each compound, the lowest energy solution more in line with the experimental 
data was further considered and subjected to energy minimization through the 
OPLS-2001 force field. All Figures were rendered using Chimera software package12. 
 
Isothermal Titration Calorimetry. The [d(TGGGGT)]4 stock solution was 
prepared by dissolving the lyophilised compound in 10 mM phosphate buffer with 
70 mM KCl, 0.2 mM EDTA, pH 7. The solution was annealed by heating at 95 °C for 5 
min and slowly cooling to room temperature. The concentration of the dissolved 
oligonucleotide was evaluated by UV measurement at 95 °C, using as molar 
extinction coefficient the value calculated by the nearest-neighbour model13 for the 
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sequence d(TGGGGT). Stock solutions of the six drugs were prepared by solubilising 
weighted amounts in DMSO to a final concentration of 8 mM. The complexes 
between the quadruplex and the drugs were prepared diluting the drug stock 
solution into the quadruplex solution to get a final DNA:drug molar ratio of 1:4 and 
a final DMSO concentration of 7%. Distamycin A was solubilised in the same buffer 
used for the oligonucleotide containing 7% of DMSO. 
The titrations were carried out in 10 mM phosphate buffer, 70 mM, KCl, 0.2 
mM EDTA, 7% DMSO, pH 7, at 293 K, using a high-sensitivity ITC-200 
microcalorimeter from Microcal (GE Healthcare). In each experiment, volumes of 2 
µL of a 1.2 mM distamycin A solution were added into a 50 µM solution of 
quadruplex-DNA complex, using a computer-controlled 40-µL microsyringe, with a 
spacing of 180 s between each injection. Each titration was corrected for heat of 
dilution by subtracting the measured enthalpies of the injections following 
saturation. Integrated heat data obtained for the titrations were fitted using a 
nonlinear least-squares minimisation algorithm to a theoretical titration curve, 
using the MicroCal-Origin 7.0 software package from which the binding parameters 
∆H° (reaction enthalpy change in kcal·mol-1), Kb (binding constant in M-1), and n 
(stoichiometry) were derived. The entropic contribution was calculated using the 
relationships ∆G° = -RT·lnKb (R 1.987 cal·mol-1·K-1, T 293 K) and ∆G° = ∆H°-T∆S°. 
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7) Shooting for selective drug-like G-quadruplex binders: evidence 
for telomeric DNA damage and tumor cell death. 
 
7.1 Introduction 
 
Recently, our pursuit of new G-quadruplex ligands succeeded in the 
discovery of six lead-like chemotypes which were proven to effectively interact with 
the [d(TGGGGT)]4 G-quadruplex structure1. Among them, compound 6 renamed  1a 
in the current work (Table 7.1), appeared to be the most promising hit. So far, 
ligands that selectively recognize G-quadruplex grooves are few2, even though 
quadruplex groove recognition is likely to provide much more quadruplex-selective 
ligands. Interestingly, 1a was proven to span the entire quadruplex grooves and was 
demonstrated to interact more tightly than distamycin A3, which was described as 
the most affine G-quadruplex groove binder4. More general considerations need to 
be done on the drug-like properties of the 1a coumarin core. This is a naturally 
occurring structure (mainly in plants) which is present in a plethora of compounds 
endowed with different biologically activities (anti-HIV, CNS-active, anti-coagulant, 
anti-inflammatory, antitumor)5. Thanks to the number of documented biological 
activities as well as its amenability to combinatorial chemistry, the coumarin 
scaffold represents a well-known example of privileged structure5. 
In the present study, the promising derivative 1a was used as a seed for 
searching similar entities in several commercially available databases and NMR 
experiments allowed to identify a small focused library of structural analogues with 
G-quadruplex binding properties. By a back and forth approach, the structural 
features responsible for G-quadruplex groove recognition were delineated, while 
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isothermal titration calorimetry (ITC) measurements allowed for the identification 
of chemotypes featuring a tighter binding than distamycin A. Differently from 
distamycin A, the best binders were also proved to be G-quadruplex selective over 
duplex. These results propelled the biological characterization of the new ligands 
demonstrating their ability to induce selective DNA damage at telomeric level and 
induction of apoptosis and senescence on tumor cells. 
 
7.2 Results and Discussion 
 
Compound selection and G-quadruplex NMR binding assays. Given the 
relative synthetic accessibility of coumarin compounds we first decided to search in 
commercial molecular databases if analogues of compound 1a were available. This 
approach has the advantage to rapidly provide a library of structural analogues of 
the lead compound being also highly economically efficient. Therefore, the 
simplistic pairwise Tanimoto similarity score was computed between 1a and the 
compounds present in the full ZINC database collection of purchasable compounds 
(ca. 7 million compounds) using a 70% similarity threshold. This resulted in 272 
compounds that were visually analyzed revealing that, as expected, coumarin 
derivatives were selected (Table 7.1) as well as several analogues featuring the 
regioisomeric chromone scaffold (Table 7.2). With the aim of exploring the 
influence of the pendant amine moiety on the quadruplex binding, five of the 
available coumarin derivatives deriving from the filtered database were first 
purchased (1b-f). These were all tested for their ability to interact with the DNA 
quadruplex through Nuclear Magnetic Resonance (NMR) spectroscopy, that is a 
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valuable tool to study molecular interactions in solution6. A number of DNA 
quadruplex folding topologies is known and the kind of folding is strongly affected 
by the sequence, buffer and molecular crowding conditions. This is particularly true 
for the human telomeric sequence. In fact, several structures have been reported 
having different strand orientations and loop distributions. Unfortunately, the 
topology of quadruplex structure adopted by the human telomeric sequence in vivo 
is unknown, so that, in analogy to what was done in our previous investigations1,4, 
we have decided to use the highly symmetric tetramolecular quadruplex 
[d(TGGGGT)]4. In particular, we employed the chemical shift perturbation method7 
to detect interaction between a molecular candidate and the G-quadruplex 
structure. The signals that can be most easily monitored are the imino and aromatic 
protons of all bases and the methyl protons of thymines as they all are in the less 
crowded region of the NMR spectrum of [d(TGGGGT)]4.  
 
 
Cpd R1 Cpd R1 
1a 
 
1d 
 
1b 
 
1e 
 
1c 
 
1f 
 
Table 7.1: Structures of the selected coumarin derivatives 
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Cpd R1 R2 R3 Cpd R1 R2 R3 
2a -H -H -H 2k -H -H 
 
2b -H -H 
 
2l -NH2 -H 
 
2c -H -H 
 
2m -NH2 -H 
 
2d -H -H 
 
2n -NH2 -H 
 
2e -H -H 
 
2o -NH2 -H 
 
2f -H -H 
 
2p -NH2 -H 
 
2g -H -H 
 
2q -H -CH2CH3 
N
 
2h -H -H 
 
2r -H -CH2CH3 
 
2i -H -H 
 
2s -CH3 -H 
 
2j -H -H 
 
2t -CH3 -H 
 
Table 7.2: Structures of the selected chromone derivatives 
Since we were mainly interested in potential groove binder analogues, in our 
inspection we considered quadruplex ligands all the compounds providing a shift of 
the G3 and G4 signals of at least 0.05 ppm. Following this criterion, among the five 
 CHAPTER III 
113 
 
tested coumarins, compounds 1b-d demonstrated appreciable G-quadruplex 
binding while 1e and 1f displayed no DNA interaction. This indicates that the 
presence a H-bond donor (1b) and/or a positively charged group at a distal position 
(1c-d) with respect to the coumarin scaffold is critical for DNA binding. 
More structural variability was present when considering the regioisomeric 
chromone derivatives (2a-k, Table 7.2). This moiety is also regarded as a privileged 
structure being present in different biologically active compounds and prone to 
combinatorial synthesis8. In this case, we first tested the G-quadruplex binding 
properties of 2a through NMR titration. This experiment did not indicate 
appreciable shift of any signal of [d(TGGGGT)]4 suggesting that the soul chromone 
scaffold is unable to provide efficient binding for the quadruplex. On the other 
hand, the positively charged group in position 8 (R3 substituent) should provide this 
moiety with a critical interaction point with the quadruplex (most probably, with 
the phosphate backbone atoms), as confirmed by the presence of detectable 
interactions of compound 2b and 2c with the target. Furthermore, bulky tertiary 
amines are not tolerated (2d), while cyclic amines (2e-k) are able to cause 
substantial shift of the G3, G4, G5 and T6 signals. In order to probe the influence of 
a substituent in position 2 on the chromone scaffold (R1 in Table 7.2), 2l-2p, 
featuring H-bond donor groups, were also tested. Interestingly, while 2l-2o still 
provide appreciable quadruplex binding, 2p does not interact with the DNA, 
suggesting that bulkier amines are detrimental for the binding regardless the 
presence of a H-bond donor in position 2. Indeed, the latter position seems to 
directly influence the G-quadruplex recognition considering that the simple 
substitution with a methyl group (2s-t) abolishes the ligand binding as 
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demonstrated by NMR experiments. The same holds true for position 6 (R2) of the 
chromone ring that when substituted with a ethyl chain results in compounds (2q-
r), which are incapable of [d(TGGGGT)]4 binding. 
 
Isothermal titration calorimetry (ITC) experiments. For compounds 
demonstrating appreciable interaction with the DNA G-quadruplex (1a-b, 2b-c, 2e-
o) displacement isothermal titration calorimetry (ITC) experiments9 were performed 
to investigate their quadruplex binding affinity. Since it is well known that multiple 
conformations of the human telomeric sequences may coexist in solution and that 
such polymorphism could invalidate the data obtained by ITC measurements, we 
have decide to use, in analogy to NMR, the [d(TGGGGT)]4 quadruplex.  
Unfortunately, efforts to obtain direct thermodynamic information from 
canonical ITC experiments failed due to solubility issues regarding the ligands at the 
rather high concentrations required for such measurements10. Displacement 
experiments were then effectively carried out by analyzing the binding of 
distamycin A to the G-quadruplex previously saturated with each ligand (see 
Experimental Section). Although the displacement ITC experiments don’t allow to 
directly measuring the thermodynamic parameters involved in the binding 
processes, this strategy represents a valid approach to evaluate the efficiency of a 
G-quadruplex (or duplex) binder compared to distamycin A. Indeed, when the DNA-
ligand complex is formed, the ligand will inhibit the binding of distamycin A if its 
affinity for the G-quadruplex is higher than the latter; conversely, it will be displaced 
by a stronger binder. 
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Figures 7.1a and 7.1b show two representative ITC displacement 
experiments carried out by titrating with distamycin A the [d(TGGGGT)]4 saturated 
with compounds 2o and 2l, respectively.  
 
 
Figure 7.1: Raw ITC data (top panels) and integrated heat (bottom panels) for titration of 
[d(TGGGGT)]4/2o (a), [d(TGGGGT)]4/2l (b), and d(CGCGAATTCGCG)2/2l (c) mixtures with distamycin A 
(Dst) at 25 °C. The integrated heat for the titrations (squares) was obtained by integrating the raw 
data and subtracting the heat of the ligand dilution. The lines represent nonlinear least squares ﬁt of 
the data to the appropriate binding model. 
 
The results obtained in the two experiments clearly show two different 
phenomena. In the first case, the ITC profile for the titration of ligand-saturated G-
quadruplex is essentially identical to the one obtained for the binding of distamycin 
A to the G-quadruplex alone3, thus indicating that the presence of 2o does not 
affect significantly the interaction. On the contrary, the titration of [d(TGGGGT)]4/2l 
mixture with distamycin A (Figure 7.1b) gives completely different results. In this 
case, ITC data show constant heat release at each injection of distamycin A, only 
due to ligand dilution, proving that it is no longer able to interact with the G-
quadruplex.  
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Overall, ITC experiments showed that four out of fifteen compounds (1a, 2c, 
2l and 2m) have the ability to bind the G-quadruplex more tightly than distamycin 
A, inhibiting its interaction. To evaluate a possible selectivity of the best ligands for 
G-quadruplex over duplex, we performed identical ITC displacement experiments by 
titrating d(CGCGAATTCGCG)2 duplex/ligand mixtures with distamycin A. This self-
complementary DNA dodecamer was chosen because it contains the central AATT 
core, considered being one of the specific binding sites for distamycin A11. 
Figure 7.1c shows an example of raw ITC data and binding isotherm for the 
titration of d(CGCGAATTCGCG)2/2l mixture with distamycin A. As shown, at each 
injection of distamycin A solution, less and less heat release was measured until 
constant values were obtained, implying a saturable process. The binding isotherm 
shows a typical sigmoidal binding curve and clearly suggests that the presence of 
the compound in the mixture has no effect on the interaction of distamycin A with 
the duplex. Similar results were obtained for 2c and 2m, suggesting G-quadruplex 
selectivity of these three compounds. On the other hand, 1a showed to affect 
distamycin A-duplex interaction, thus suggesting a poor selectivity. 
 
The newly identified G-quadruplex ligands induce DNA damage and cell-
cycle arrest. These encouraging results propelled the full biological characterization 
of the new ligands to investigate the ability of the new ligands to cause telomere 
uncapping (Figure 7.2). To this aim, a two-steps analysis was performed to establish, 
in a first one, if the compounds were able to induce DNA damage and, in a second 
one, if the DNA damage was localized to the telomeres.  
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By using human transformed BJ fibroblasts (BJ-HELT), we found that, 
differently from distamycin A, all the ligands were able to induce DNA damage (at 
least at the higher drug dose; Figure 7.2a) and deconvolution microscopy analysis 
showed that some of the damaged foci co-localized with TRF1, a good marker for 
interphase telomeres12 forming the so-called TIFs (Telomere-dysfunction Induced 
Foci)13 (Figure 7.2d). Of note, quantitative analysis identified compounds 2c, 2l and 
2m as the most potent in inducing telomere damage: the percentage of cells with 
more than four γH2AX/TRF1 colocalizations reached about 50% (Figure 7.2b), with a 
mean of about eight TIFs per nucleus (Figure 7.2c). Such a biological evaluation also 
confirmed that the sole chromone structure (2a) did not prove to cause substantial 
DNA damage.  
Interestingly, the whole data are in perfect consonance with ITC experiments 
that indicated 2c, 2l and 2m are strong selective G-quadruplex binders. A further 
correlation can also be done for compound 1a that, by promiscuously binding the 
DNA (see ITC data), is able to induce high levels of DNA damage but few TIFs. 
The above results raised the interesting possibility that telomere damages 
induced by the ligands in transformed fibroblasts may rapidly and efficiently 
promote growth inhibition in tumor cells. Treatment of Hela cells with one of the 
most promising selected ligands (2l), triggered a dose-dependent inhibition of cell 
survival, (Figure 7.3a) associated with an early accumulation of cells in the G2/M 
phase of the cell cycle, and at 96 hrs. of treatment a fraction of cell population 
resided to the sub-G1 compartment, indicative of apoptosis (Figure 7.2b).  
Apoptosis induction triggered by 2l has been confirmed by Annexin staining 
(Figure 7.3c; at 96 hrs. of treatment about 30% of cells are annexin V-positive/PI 
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negative) and it was also accompanied by the induction of a senescence phenotype: 
large cell size, vacuolated cytoplasm and β-galactosidase activity (Figure 7.3d). 
 
Figure 7.2: DNA damage activation at telomeres. BJ-EHLT fibroblasts were treated for 24 hrs. with 
distamycin A and the indicated ligands at the doses 0.1 (light-grey bars) and 0.5 µM (dark-grey bars). 
Cells were processed for immunofluorescence (IF) using antibodies against γH2AX and TRF1 to mark 
DNA damage and telomeres respectively. Percentages of γH2AX- (a) and TIF-positive (b) treated vs 
untreated cells are reported in the histograms. (c) Mean number of TIFs in the indicated samples. 
Cells with four or more γH2AX /TRF1 foci were scored as TIF positive. The red bars highlight the most 
effective ligands. Error bars indicate the standard deviation. (d) Representative images of IF of 
untreated and distamycin A, 2c, 2l and 2m-treated BJ-EHLT cells. Enlarged views of TIFs are reported 
below the merged images. The images were acquired with a Leica Deconvolution microscope 
(magnification 100x). 
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Figure 7.3: Biological effects of 2l ligand. (a) Survival curve of the HeLa cells exposed to different 
doses of 2l ranging from 0.5 to 5 µM. (b) Cell cycle analysis and (c) apoptosis evaluation of HeLa cells 
processed at the indicated times after exposure with 3.5 µM 2l. (c) Bi-parametric dot plots showing 
PI vs annexin V staining in the indicated samples. (d) SA-β-gal staining of Hela cells untreated and 
treated with 5 µM 2l for 5 days. 
 
The newly identified G-quadruplex ligands feature enhanced drug-likeness. 
In our inspection, the most interesting ligands (1a, 2c, 2l and 2m) were also 
compared for their predicted absorption, distribution, metabolism and excretion 
(ADME) properties with respect to other compounds previously described as G-
quadruplex binders. These calculations were performed employing the QikProp 
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software (QikProp, version 3.4, Schrödinger, LLC, New York, NY, 2011). In addition 
to predicting molecular properties, QikProp provides ranges for comparing each 
compound’s property with those of 95% of known drugs. This software was also 
used because it allows for flagging reactive functional groups that may cause false 
positives in biological assays. According to these calculations, only seven out of 32 
inspected compounds display no violations of the ranges recommended for each 
descriptor or property. Strikingly, compounds 1a, 2c, 2l and 2m are among these 
most promising ligands.  
 
7.3 Conclusions 
 
Targeting of DNA secondary structures such as G-quadruplexes is now 
considered an appealing opportunity for drug intervention in anticancer therapy14. 
So far, efforts made in the discovery of chemotypes able to target G-quadruplexes 
mainly succeeded in the identification of a number of polyaromatic compounds 
featuring end-stacking binding properties. Unfortunately, the poor drug-like 
properties of these compounds turned out to be a main limitation during the in vivo 
verification of their anti-tumor properties. Herein, with the aim of discovering        
G-quadruplex groove binders with enhanced drug-like properties, a lead 
optimization campaign was undertaken starting from a promising virtual screening 
hit. Thus, the physico-chemical characterization (NMR and ITC) of the binding of a 
set of closely related analogues allowed to identify novel ligands of the 
[d(TGGGGT)]4 quadruplex. Interestingly, their biological characterization 
demonstrated the ability to induce selective DNA damage at telomeric level and 
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induction of apoptosis and senescence on tumor cells. These results substantiate 
our choice of using the [d(TGGGGT)]4 structure as working model to design new 
molecular entities endowed with G-quadruplex binding properties. Furthermore, for 
the first time, we demonstrate that selective G-quadruplex binding and telomeric 
DNA-damage can be both elicited by more drug-like chemotypes. These findings 
pave the way to the design of new potential drugs and shed new insights onto the 
emerging field of DNA quadruplex. 
 
7.4 Materials and Methods 
 
Oligonucleotide synthesis. The oligonucleotide d(TGGGGT) was synthesized 
using standard protocol15. The oligomer was detached from the support and 
deprotected by treatment with concentrated aqueous ammonia at 55 °C for 12 h. 
The combined filtrates and washings were concentrated under reduced pressure, 
redissolved in H2O, analyzed and purified by high-performance liquid 
chromatography (HPLC) on a Nucleogel SAX column (Macherey–Nagel, 1000-8/46); 
using buffer A: 20 mM KH2PO4/K2HPO4 aqueous solution (pH 7.0), containing 20% 
(v/v) CH3CN; buffer B: 1 M KCl, 20 mM KH2PO4/K2HPO4 aqueous solution (pH 7.0), 
containing 20% (v/v) CH3CN; a linear gradient from 0 to 100% B for 30 min and flow 
rate 1 ml/min were used. The fractions of the oligomer were collected and 
successively desalted by Sep-pak cartridges (C-18). The isolated oligomer proved to 
be > 99% pure NMR. 
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Selected compounds. The selected compounds were purchased by supplier. 
The purity of compounds 1a-f and 2a-t was assessed using reversed-phase high-
performance liquid chromatography (HPLC) analyses using Shimadzu C18, 5 μm 
(150 mm × 4.6 mm) column. The elution was performed with a 1.0 ml/min flow rate 
using a linear gradient from 0 to 100% methanol in water over 30 min. The 
detection was performed at 210 nm. The purity was also tested with high-
performance liquid chromatography–mass spectrometry (HPLC–MS) analyses 
performed on an Agilent 1200 series (Agilent  Technologies, Santa Clara, CA, USA) 
equipped with an Agilent 6110 Series LC/MS Quadrupole, using a Phenomenex 
Luna® C18, 5 μm (150 mm × 4.6 mm). The elution was performed with a 1.0 ml/min 
flow rate using a linear gradient from 0 to 90% acetonitrile in water over 20 min. 
Detection was performed at 210 nm. The relative purity of compounds 1a, 1c–e, 
2a–d, 2f, 2h, 2i, 2l-n and 2p–r was higher than 98.0%. Purity of compounds 1b, 1f, 
2e, 2g, 2j, 2k, 2o, 2s and 2t ranged between 95 and 98%. 
 
Nuclear magnetic resonance experiments. The quadruplex NMR samples 
were prepared at a concentration of 0.1 mM (0.4 mM single strand concentration), 
in 0.2 ml (H2O/D2O 9:1) buffer solution having 10 mM KH2PO4, 70 mM KCl, 0.2 mM 
EDTA, pH 7.0. NMR spectra were recorded with Varian UnityINOVA 700 MHz 
spectrometer. 1H chemical shifts were referenced relative to external sodium 2,2-
dimethyl-2-silapentane-5-sulfonate (DSS). 1D proton spectra of the sample in H2O 
were recorded using pulsed-field gradient DPFGSE16,17 for H2O suppression. The 
NMR data were processed on iMAC running iNMR software (www.inmr.net). 
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Chemical Shift Perturbation experiments. The quadruplex [d(TGGGGT)]4 has 
been titrated with each of the selected compound. The samples 1e-1f, 2a, 2d, 2p-2t 
were not able to cause any significant shift of the DNA signals. On the other hand, 
the compounds 1b-1d, 2b, 2c, 2e-2k, 2l-2o turned out to be able to bind the 
quadruplex. Particularly, for all the titrations of 1b-1d, 2b, 2c, 2e-2k, 2l-2o, the four 
DNA strands turned to be magnetically equivalent throughout the titration, and no 
splitting of resonances was observed at any stage. In order to preliminarily evaluate 
the binding site of each analogue, a comparison of resonances of some protons of 
the uncomplexed DNA and the complexed one has been done. In particular, we 
report the Δδ values (chemical shifts of the complex minus free DNA) of aromatic, 
methyl and imino protons. Generally, the signal of the protons of T1 residue shifted 
the least, whereas the ones of residue T6 the more. In any case, a general shift of 
the aromatic and imino signals was observed also for the G2, G3, G4 and G5. 
 
Isothermal titration calorimetry. The d(TGGGGT) and d(CGCGAATTCGCG) 
oligonucleotide sequences were prepared by dissolving the lyophilized compound in 
10 mM phosphate buffer with 70 mM KCl, 0.2 mM EDTA, pH 7. The solutions were 
annealed by heating at 90 °C for 5 min and slowly cooling to room temperature, and 
then equilibrated at 4 °C for 24 h. The concentration of oligonucleotides was 
determined by UV adsorption measurements at 90 °C using molar extinction 
coefficient values ε(260 nm) of 57800 and 110700 M−1 cm−1 for d(TGGGGT) and 
d(CGCGAATTCGCG), respectively. The molar extinction coefficients were calculated 
by the nearest neighbor model18. Stock solutions of the investigated compounds 
were prepared by solubilizing weighted amounts in DMSO to a final concentration 
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of 8 mM. The mixtures of the DNA molecules and the compounds were prepared 
diluting the ligand stock solution into the DNA solution to get a final ligand/DNA 
molar ratio of 4:1 and a final DMSO concentration of 7%. Distamycin A was 
solubilized in the same buffer used for the mixtures. ITC experiments were 
performed at 298 K using a CSC 5300 Nano-ITC microcalorimeter from Calorimetry 
Science Inc. (Lindon, Utah) with a cell volume of 1 ml. The titrations were carried 
out in 10 mM phosphate buffer, 70 mM KCl, 0.2 mM EDTA, 7% DMSO, pH 7. In each 
experiment, volumes of 5-10 µL of distamycin A solution (360-720 µM) were added 
into a 30 µM solution of DNA or DNA/ligand mixture, using a computer-controlled 
250 µL microsyringe, with a spacing of 200-400 s between each injection. Each 
titration was corrected by subtracting the heat of distamycin A dilution. Where 
possible, integrated heat data obtained for the titrations were fitted employing a 
nonlinear least-squares minimization algorithm to a theoretical titration curve, 
using the Bindwork software from Calorimetry Science Inc. 
 
Cells and culture conditions. Transformed human BJ fibroblasts expressing 
hTERT and SV40 early region (BJ-HELT), and human epithelial carcinoma cell line 
(HeLa) were obtained as previously reported8 and grown in Dulbecco Modified 
Eagle Medium (D-MEM, Invitrogen Carlsbad, CA, USA) supplemented with 10% fetal 
calf serum, 2 mM L-glutamin and antibiotics. 
 
Immunofluorescence. Immunofluorescence was performed as previously 
reported20. Cells were fixed in 2% formaldehyde and permeabilized in 0.25% Triton 
X100 in PBS for 5 min at room temperature. For immunolabeling experiments, cells 
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were incubated with primary antibody, then washed in PBS and incubated with the 
secondary antibodies. The following primary antibody were used: pAb anti-TRF1 
(Abcam Ltd.; Cambridge UK);mAb anti-γH2AX (Upstate, Lake Placid, NY). The 
following secondary antibody were used: TRITC conjugated Goat anti Rabbit, FITC 
conjugated Goat anti Mouse (Jackson Lab.). Fluorescence signals were recorded by 
using a Leica DMIRE2 microscope equipped with a Leica DFC 350FX camera and 
elaborated by a Leica FW4000 deconvolution software (Leica, Solms, Germany). 
 
Clonogenic assay. HeLa cells were seeded in 60-mm Petri dishes (Nunc, 
MasciaBrunelli, Milan, Italy) at a density of 5 x 102 cells per dish and 24 hrs later 
exposed to different doses (ranging from 0.5 to 5 mM) of 2m. Cell colony-forming 
ability was determined as previously described20. All the experiments were 
repeated four times in triplicate. 
 
Flow cytometric analysis. The cell cycle analysis was performed by flow 
cytometry. Cells were washed in PBS and fixed in 70% ethanol in PBS. 1x 106 cells 
were centrifuged and resuspended in a staining solution (50 µg/ml PI, 75 KU/ml 
RNase A in PBS) for 30 min at room temperature in the dark and analyzed by flow 
cytometry using FACScalibur (Becton-Dickinson, San Jose, CA, USA). For each 
analysis 20.000 events were collected. Cell cycle distribution and percentage of 
apoptotic cells was analyzed using Cell Quest (BDIS) and ModFit LT (Verity Software 
House, Topsham , ME). 
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Evaluation of apoptosis. Apoptosis was detected by flow cytometric analysis 
of annexin V staining. Annexin V–FITC vs PI assay (Vibrant apoptosis assay, V-13242, 
Molecular Probes, Eugene, OR, USA) was performed as previously described21. 
Briefly, adherent cells were harvested and suspended in the annexin-binding buffer 
(1x106 cells/ml). Thereafter, cells were incubated with annexin V–FITC and PI for 15 
min at room temperature in the dark and immediately analyzed by flow-cytometry. 
The data are presented as bi-parametric dot plots showing PI red fluorescence vs 
annexin V–FITC green fluorescence. 
 
Senescence Analysis. Senescence-associated β-galactosidase (SA-β-gal) 
staining on HeLa cells was performed as described by Dimri et al.22 Briefly, after 
exposure with 3.5 µM 2 m for 5 days of cell culture, the cells were fixed with 2% 
glutaraldehyde in PBS for 5 min at room temperature, washed in PBS, and 
incubated at 37 °C for 24 hrs in staining solution: 1 mg/ml 5-bromo-4-chloro-3-
indolyl-β-d-galactoside (X-gal), 5 mm potassium ferrocyanide, 5 mm potassium 
ferricyanide, 2 mm MgCl2 in PBS, pH 6.0. Then cells were analyzed using an optical 
microscope. 
 
Statistical analysis. The experiments have been repeated from three to five 
times and the results obtained are presented as means ± SD. Significant changes 
were assessed by using Student’s t test for unpaired data, and P values < 0.05 were 
considered significant. 
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1. The G-Triplex DNA 
 
1.1 Introduction 
 
Nucleic acids represent the alphabet of the cellular language generating 
through their sequencing encrypted messages that regulate functions vital for the 
cell. In 1953, the discovery that DNA could adopt a double helix conformation1 
(Figure 1.1), represented a milestone in biology, showing that important genetic 
information could be delivered by specific DNA topology.  
 
 
 
Figure 1.1: DNA structural motifs. (Top panel) Schematic illustration of duplex, triplex, G-triplex and 
G-quadruplex. (Bottom panel) Examples of base pairing: T-A for duplex, T-A:A and C-G:C+ for triplex 
(where G-C and A-T indicates the regular Watson-Crick pairing, whereas the colon signs indicate the 
pairing with the third strand), G-triad for G-triplex, and G-tetrad for G-Quadruplex. 
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The specificity and the complexity of the genetic language were further 
increased in recent years, since variations from the Watson-Crick duplex structure 
have been found to play key roles in many cellular processes. Examples are higher-
order architectures of DNA, such as hairpins2, cruciforms3, parallel-stranded 
duplexes4, triplexes5, G-quadruplexes6 and the i-motif7, that are involved in several 
important processes like DNA packaging, replication, transcription and 
recombination. These structures can be formed by nucleotides sequences 
distributed throughout the whole human genome and their location in the genome 
is not random but associated with human diseases8. From a structural point of view, 
all these complexes are formed by one up to four DNA strands, stabilized by base 
stacking and base pairing interactions with a wider variety of base pairing motifs 
than the standard Watson-Crick ones (Figure 1.1). For instance, DNA triplexes can 
present G:G-C, A:A-T, C+:G-C and T:A-T base pairings with two strands in the 
standard Watson-Crick duplex structure (i.e. G-C and A-T) and the third one lying in 
the major groove of the duplex (Figure 1.1). Another example are G-quadruplexes, 
that are four stranded structures and have a core of two or more guanine tetrads 
stacked one upon the other. A G-tetrad consists of a planar arrangement of four 
guanine bases associated through a cyclic array of Hoogsteen-like hydrogen-bonds 
in which each guanine accepts and donates two hydrogen-bonds (Figure 1.1). 
Nucleotide sequences able to adopt structures like triplexes and G-quadruplexes, 
are very abundant in the human genome and play key roles in the regulation of 
many genes functions vital for the cell9. 
These findings have highlighted the high polymorphism of the genetic 
language suggesting that there might exist other DNA structures with specific 
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cellular functions that are to date unknown. In this scenario, the discovery of novel 
DNA structural motifs is more than ever an important breakthrough that provides 
new molecular bases to elucidate functional mechanisms of cell otherwise 
unexplained and unveil the way to interact with them. 
Here, combining advanced state-of-the-art computations and experiments, 
we have identified a new DNA structural motif. This structure is named “G-triplex” 
and at variance with the known triplexes, it is formed by G:G:G triad planes 
stabilized by an array of Hoogsteen-like hydrogen-bonds (Figure 1.1). This is the first 
time that DNA is found to assume this kind of topology and unveiling its biological 
role, which is to date unknown, represents a major research goal in the near future. 
 
1.2 Results and Discussion 
 
Metadynamics study. The biological relevance of DNA structures like 
triplexes and G-quadruplexes, makes imperative to elucidate their functional 
mechanism and new insight in this sense can be obtained by the study at molecular 
level of their folding mechanism. Unfortunately, this kind of processes takes from 
microseconds to hundreds of seconds, thus is impossible to simulate in the time-
scale of standard computational techniques such as molecular dynamics (MD). 
However, advances in the study of large time-scale processes, have been recently 
reported with the aid of enhanced sampling techniques such as metadynamics10-12. 
In fact, metadynamics has been successfully used even in complex ligand docking 
studies, such as the cyclooxygenases case13, being able to predict the binding 
conformation of a potent inhibitor, SC-558, in COX-1, prediction that was 
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subsequently validated by X-ray experiments14. This technique enhances sampling 
by adding a bias on few degrees of freedom of the system, called collective 
variables (CVs), allowing to investigate large time-scale processes in affordable 
computational time15. Furthermore, metadynamics allows to reconstruct the free 
energy profile, thus identifying different conformations of the system and the 
energetic cost of converting one into the other. This is of fundamental importance 
in the present case study, since ordered DNA structures may form transiently at 
specific times during the cell cycle with a specific role and regulatory mechanism. 
While many studies on protein folding are reported in literature, DNA/RNA 
folding studies are still in their infancy thus representing a cutting edge topic of 
research. We decided to tackle this challange and using well-tempered 
metadynamics simulations16, we have investigated the folding/unfolding process of 
one of the simplest G-quadruplex structure: the Thrombin Binding Aptamer (TBA)17. 
TBA is formed by 15 nucleotides (5’-dGTTGGTGTGGTTGG-3’) organized in an anti-
parallel monomolecular G-quadruplex, characterized by a chair-like structure 
consisting of two G-tetrads connected by two TT loops and a single TGT loop (Figure 
1.1). We have used as CV the radius of gyration formed by the oxygen atoms of the 
guanine bases of the G-quadruplex planes (see Methods for details). This CV is able 
to describe the formation and the disruption of the G-tetrad planes and has been 
already used in other metadynamics studies of protein folding18,19. Although this CV 
can well describe the global motion of the system, it is not able to distinguish the 
multiple conformations assumed by the system during the folding process. In order 
to overcome this limitation and have a clearer representation of the free energy 
profile associated with the TBA folding process, we have computed the Free Energy 
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Surface (FES) as a function of a second CV, namely the number of hydrogen-bonds 
formed by the guanine bases of the G-tetrads (see Methods for details). This can be 
done using the reweighting algorithm20 recently developed in our lab (see Methods 
for details). Looking at the FES obtained after around 80 ns of metadynamics 
simulation, three main energy minima can be identified (Figure 1.2).  
 
 
 
Figure 1.2: Representation of the Free Energy Surface (FES) of the 3’ end opening of TBA. a, 
Representation of the NMR structure of TBA (PDB ID code 1qdf). b. In the FES three main energy 
minima are shown: one deep and narrow, basin A, which represents TBA in the G-quadruplex 
structure; the second one, basin B, which represents an intermediate state; and the last one, basin C, 
which shows the G-triplex structure formed by the triads G1:G6:G10 and G2:G5:G11. c, Plots 
showing the phase space represented as the Hcore and Rcore CV, explored during the metadynamics 
simulation. It can be observed that the 3’ end of TBA opens and closes several times, passing from 
basin A to basin B and basin C, and then folded again in the G-quadruplex stucture, basin A. Thanks 
to the recrossing events between different basins, the calculated FES is accurate and quantitatively 
well characterized. 
 
The deepest one, basin A, is at the gyration radius CV (CV1) value of 2.5 Å 
and at high values of the Hydrogen-bonds CV (CV2). This pose corresponds to the 
experimental G-quadruplex structure of TBA21 with two G-tetrad planes and eight 
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guanines involved in standard Hoogsteen hydrogen-bonds. Interestingly, during the 
metadynamics simulation the three loops have a different behavior. While the GTG 
loop is rather stable, the two TT loops show higher flexibility with T3 and T12 
changing their orientation several times during the simulation. At variance with T3 
and T12, T4 and T13 conserve their original position showing a good conformational 
stability. This is in line with the NMR data, to be described below, that indicate that 
these bases are involved in hydrogen-bond interactions. In our case, T4 and T13, 
albeit very close, do not form hydrogen-bond interactions, while stacking 
interactions with the guanines placed above, G5 and G14 for T4 and T13, 
respectively, are engaged and contribute to the energy stability of this 
conformation. Looking at the FES two further minima, basin B and basin C, can be 
detected at higher energy values. In basin B, TBA shows a partial opening of the 3’ 
end with G15 oriented towards the solvent. Interestingly, in this basin G14 moves 
slightly from its original position pointing the oxygen of the nucleobase towards the 
center of the planes formed by G1:G6:G10 and G2:G5:G11 (Figure 1.2). In such a 
way, G14 conserves the hydrogen-bond interactions with G2 and G11 and at the 
same time it partially fills the vacancy in the coordination shell of the metal present 
at the core of the structure. This step can be considered the very first event in the 
unfolding process of TBA. 
 
G-triplex structure. After the partial opening of the 3’ end, TBA folded again 
into its original G-quadruplex structure (Figure 1.2). Subsequently, the 3’ end opens 
completely with G14 and G15 leaving the G-tetrad planes and pointing towards the 
solvent. This state is represented by the broad energy minimum C in Figure 1.2. This 
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minimum is approximately 6.5 kcal/mol higher in energy than basin A and here TBA 
assumes a number of different conformations due to the conformational flexibility 
of the 3’ overhang formed by T13-G14-G15. These bases rearrange to form a single 
helix that assumes a number of conformations, all of these stabilised by stacking 
interactions between the bases. While the 3’ overhang is flexible, the rest of the 
TBA molecule is rather stable forming two G:G:G planes, namely G-triads, composed 
by G1:G6:G10 and G2:G5:G11, that engage an array of Hoogsteen-like hydrogen-
bonds (Figure 1.1). In this conformation the metal is coordinated at the center of 
the two triads in a way similar to that of the G-quadruplex structure. This is the first 
time that DNA is found in a triplex conformation with G:G:G base pairs. This 
structure is named “G-triplex” to distinguish it from the known triplex structures 
that present G:G-C, A:A-T, C+:G-C and T:A-T base pairings with two strands in the 
standard Watson-Crick duplex structure and the third one lying in the major groove 
of the duplex (Figure 1.1). At variance with the other two minima A and B, in basin 
C, T12 does not point out towards the solvent, on the contrary it is rotated towards 
the core of TBA engaging stacking interactions with T4 of the TT loop at the 5’ end 
(basin C in Figure 1.2). This position favors the formation of hydrogen-bond 
interactions between the imide hydrogens of T13 and G14 and the backbone 
phosphates of G11. These interactions further contribute to the energy stability of 
this pose. The stability of the TBA conformation in the three energy minima A, B and 
C, has been further assessed through standard molecular dynamics calculations. 
 
Molecular dynamics simulations on TBA in the conformations representing 
the energy basins A, B and C, and on the oligonucleotide 4. We assessed the 
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stability of the conformations representing the energy basins A, B and C using 50 ns 
long molecular dynamics simulations. Different behaviors have been observed for 
the different poses considered. As expected, basin A resulted very stable 
throughout the whole simulation with the two G-tetrads planes formed by 
G1:G6:G10:G15 and G2:G5:G11:G14, constantly formed (Figure 1.3).  
 
 
Figure 1.3: Plots regarding the MD simulations on basin A, B and C conformation. (Top graph) Plot of 
the rmsd of the heavy atoms of guanines foming the G-tetrad planes, G1:G6:G10:G15 and 
G2:G5:G11:G14, during over 50 ns of MD simulation. The very low rmsd values reflect the good 
stability of this pose. (Middle graph) Plot of the rmsd of the heavy atoms of guanines foming the G-
tetrad planes, G1:G6:G10:G15 and G2:G5:G11:G14, during over 50 ns of MD simulation using the 
basin B pose as starting conformation. The rmsd are calculated relatively to the basin B (black lines) 
and basin A (red lines) conformation. The red plots clearly show that the basin B conformation 
changes in the basin A one after approximately 17 ns. This change is possible thanks to the relatively 
low energy barrier that separates basin B from basin A. (Lower graph) Plot of the rmsd of the heavy 
atoms of guanines foming the G-triad planes, G1:G6:G10 and G2:G5:G11, during over 50 ns of MD. 
The very low average rmsd value of 0.63 Å reflects the high stability of the G-triplex structure. 
 
As seen in the metadynamics calculation, even in the MD simulation the T7-
G8-T9 loop is rather stable while T12 in the T12-T13 loop, is very flexible and points 
away towards the solvent. Furthermore, T3, T4 and T13 present a good 
conformational stability favored by the engagement of stacking interactions with 
the above placed nucleobases. 
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At variance with basin A, basin B is rather unstable. At this basin the partial 
opening of the 3’ end of TBA has been observed during the metadynamics 
simulation, with the G15 base pointing towards the solvent (Figure 1.2). As can be 
seen in Figure 1.3, after approximately 18 ns of MD simulation TBA leaves its 
starting conformation, basin B, transforming in that of basin A. In particular, G15 
slowly moves towards the center of the G-tetrads forming again the G-tetrads 
planes and the Hoogsteen hydrogen-bonds first with G1 and then with G10. This 
finding is not totally surprising since, looking at the FES of the metadynamics 
simulation (Figure 1.2), the energy barrier that separates basin B from basin A, is 
rather small, approximately 2 kcal/mol, and thus it can be overcome in the standard 
MD time-scale. This motion can be better appreciated looking at Figure 1.3 where 
the r.m.s.d. of the guanine bases with respect to their position in the G-quadruplex 
conformation has been calculated. 
A different behavior has been instead observed for basin C. In fact, during 
the MD simulation the energy minimum TBA conformation is stable conserving all 
the interactions previously found in the metadynamics calculation. In particular, at 
this pose, the 3’ end of TBA is completely open with T13, G14 and G15 forming a 
single helix overhang that points away from the core of the TBA structure (Figure 
1.2). The other nucleobases are arranged to form a well-organized structure where 
G1:G6:G11 and G2:G5:G10 form two G-triad planes stabilized by an array of 
Hoogsteen-like hydrogen-bonds. This structure, namely G-triplex, is very stable 
along the whole MD simulation with a low average r.m.s.d. of 0.63 Å for the guanine 
bases forming the G-triad planes (Figure 1.3).  
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Furthermore, we have carried out a very long MD simulation, more than 100 
ns, on the oligonucleotide 4 in its G-triplex conformation as found by the NMR 
experiments. This calculation has been performed simulating the experimental 
buffer condition of 70 mM KCl. During this simulation the G-triplex structure is very 
stable with a low average r.m.s.d. of 0.88 Å for the guanines forming the triad 
planes. In fact, the triads formed by G1:G6:G11 and G2:G5:G10 are stabilized by 
Hoogsteen-like hydrogen-bonds as previously described in the other simulations 
(Figure 1.4).  
 
 
Figure 1.4: Plots regarding the MD simulation of the oligonucleotide 4 represented as average 
structure. (Left graph) Plot of the rmsd of the heavy atoms of guanines foming the G-triad planes, 
G1:G6:G10 and G2:G5:G11, in the 11-bases oligonucluotide (4). The very low average rmsd value of 
0.88 Å reflects the high stability of the G-triplex structure that is rapresented in the inset picture. 
(Right graph) Representation as histograms of the mean values of the distances between the 
hydrogen-bond acceptor and hydrogen-bond donor groups in guanines forming G-triplex. The error 
bars show the SEM (standard error of the mean). Data for both the graphs are obtained from the 
over 100 ns MD simulation reproducing the experimental ion concentration. 
 
At the center of the two triad planes the potassium ion is coordinated by six 
oxygen atoms of the guanines. Analogously to the metadynamics results, T4 has a 
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good conformational stability thanks to the stacking interactions engaged with G5, 
while T3 is more flexible. However, during the simulation this base often occupies a 
position under G2 where favorable stacking interactions can be formed. On the 
other hand, the T7-G8-T9 loop is stable with G8 stacked above the plane formed by 
the G1:G6:G10 triad engaging favorable interactions with G6. 
All the simulations have shown a great stability of the G-triplex structure in 
both TBA and oligonucleotide 4, suggesting to investigate the presence of G-triplex 
structures even in other poliguanine sequences of DNA and RNA.  
 
Nuclear Magnetic Resonance. In order to provide experimental evidence of 
the formation of the G-triplex structure, four oligodeoxynucleotides formed by the 
gradual truncation of the 3’ end of the TBA sequence (5’-GGTTGGTGTGGTTGG-3’) 
have been investigated in solution by NMR: 5’-GGTTGGTGTGGTTG-3’ (1), 5’-
GGTTGGTGTGGTT-3’ (2), 5’-GGTTGGTGTGGT-3’ (3) and 5’-GGTTGGTGTGG-3’ (4). 
Samples 1-4 were analyzed by 1H-NMR at 25 °C in 80 mM K+-containing buffer (see 
experimental section). The spectra of samples 1, 2 and 3 exhibited conformational 
heterogeneity (data not shown). This does not depend on the nature of the buffer 
solution, be it a potassium or sodium containing buffer, or on its concentration and 
temperature. At variance with these previous results, the analysis of the 
oligodeoxynucleotide 5’-GGTTGGTGTGG-3’ (4) clearly indicates the presence of a 
predominant well-defined hydrogen-bonded structure in solution, proven by the 
presence of four well defined exchangeable proton signals in the 11.0 - 12.5 ppm 
region of the 1D 1H-NMR spectrum (Figure 1.5a).  
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Figure 1.5: 1D 1H-NMR and 2D NOESY spetra of 5’-GGTTGGTGTGG-3’ (4). Imino, amino and aromatic 
regions of the 1D 1H-NMR spectra of 4 acquired at 25 °C (a) and 1 °C (b). (c) Two expanded regions of 
the NOESY spectrum (900 MHz, T = 1 °C, mixing time 100 ms). H8 protons of the syn residues G1, G5 
and G10 show intense cross-peaks with H1’ proton and weak connectivities with H2’ and H2” 
protons of their own sugar. On the contrary, anti residues G2, G6, G8 have opposite relative 
intensity. (d) Distances of the correlated protons in the NOESY spectrum. 
 
It is worth noting that signals that resonate in this region, are typical 
diagnostic of the formation of DNA structures presenting Hoogsteen Hydrogen-
bonds network22. On the other hand, the region of aromatic protons (6,5 - 8,5 ppm) 
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of 4 is characterized by the presence of eleven intense signals that can be attributed 
to the seven guanine H8 and four thymine H6 protons, and by a number of minor 
signals (Figure 1.5a). The presence of these minor signals in the aromatic region 
could be attributed to the unstructured DNA that is in equilibrium with the 
structured one. The equilibrium between folded (structured) and unfolded 
(unstructured) forms turns out to be very sensitive to temperature. In fact, the 
intensity of the signals of the two species can be changed by varying the 
temperature, as clearly demonstrated by the spectrum acquired at   1 °C, in which 
the intensities of the minor signals are <10% of the major species (Figure 1.5b). 
Interestingly, in the latter spectrum the signal at 7.63 ppm, attributed to G10-H8 
(see later), is broad, suggesting that its conformation varies on the NMR timescale. 
 
 
Thermodynamic characterization. Circular Dichroism (CD) spectroscopy has 
been exploited to further investigate the structure adopted by 4 in solution. CD 
spectra were recorded at 1 °C, a temperature at which the folded-unfolded 
equilibrium of 4 is strongly shifted towards the folded form, as shown by NMR, CD 
melting and DSC experiments. For DNA, a CD spectrum is generated by a chiral 
disposal of the chromophores, i.e. the nucleobases, and it is strictly related to the 
base-stacking pattern. Since the two faces of a base are heterotopic, when two 
bases are stacked together, they can interact through the same (head-to-head or 
tail-to-tail) or the opposite (head-to-tail) faces, leading to a heteropolar or 
homopolar stacking, respectively. When the glycosyl bonds of the guanines 
alternate in syn and anti conformations along the strand, head-to-head and/or tail-
to-tail interactions are realized, leading to a CD signal characterized by two positive 
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bands at approx. 295 and 245 nm and two negative bands at approx. 230 and 265 
nm17,18. The experimental CD spectrum of 4 is characterized by two positive CD 
bands at 289 and 253 nm, and two negative bands at 235 and 265 nm (Figure 1.6a), 
values that are consistent with the structure proposed by metadynamics 
calculations and NMR23,24. Such spectrum closely resembles that of TBA. However, 
both positive and negative bands are slightly shifted, thus suggesting a similar, but 
obviously not identical, stacking of the bases. Rationalizing the differences is 
difficult at this stage, although they may be ascribable to the fact that in 4 G1-G2 
and G10-G11 strands are closer than in TBA, resulting therefore in a different 
stacking of the bases. 
In order to investigate the thermodynamic stability and to further 
characterize the molecularity of the structure formed by 4, we acquired CD spectra 
and performed CD melting and Differential Scanning Calorimetry (DSC) 
experiments.  
Figure 1.6b shows the CD melting profile of 4 recorded at the wavelength of 
maximum absorbance variation upon folding (λ = 289 nm). As shown by almost 
superimposable heating and cooling curves, the melting profile was reversible, with 
no significant hysteresis observed, indicating a quasi-equilibrium process. Analysis 
of CD melting curves yielded a melting temperature, Tm, of 33.5 (± 1.0) °C. The 
model-dependent van’t Hoff analysis of melting curves gave an enthalpy change, 
ΔH°vH, of 145 (± 15) kJ mol-1. 
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Figure 1.6: Biophysical characterization of 5’-GGTTGGTGTGG-3’ (4). (a) CD spectra of 4 (solid line) 
and TBA (dashed line) at 1 °C. (b) Normalized CD melting curves of 4 recorded at 289 nm at a scan 
rate of 0.5 °C min-1. Heating and cooling curves are shown with solid and dashed line, respectively. 
(c) DSC profiles for 4 at 0.5 (solid line) and 1.0 (dashed line) °C min-1 heating rate. All the experiments 
were performed in a buffer solution containing 10 mM potassium phosphate, 70 mM KCl, 0.2 mM 
EDTA (pH 7.0). 
 
DSC measurements were then carried out under the same solution 
conditions as the CD experiments, in an effort to characterize the denaturation 
thermodynamics of 4 with a model-independent analysis method25.  
Typical DSC thermograms for denaturation of 4 are shown in Figure 1.6c. The 
unfolding of 4 is a highly reversible process, as demonstrated by the recovery of the 
original signal by rescanning the same sample.  
Furthermore, the change of the heating rate from 0.5 to 1.0 °C min-1 does 
not alter the thermodynamic parameters significantly, thereby demonstrating that 
the investigated process is not kinetically controlled26. The DSC curves show a 
symmetric shape with a maximum centered at Tm of 34.0 (± 0.5) °C, in good 
agreement with that obtained by CD melting. The melting temperature was almost 
concentration-independent, consistent with a structure resulting from unimolecular 
folding. The initial and final states of the investigated transition have similar heat 
capacity values and indicate that the unfolding of 4 is accompanied by a negligible 
heat capacity change. The integration of the denaturation peak gives a ΔH°cal of 135 
(± 5) kJ mol-1. Interestingly, the change in enthalpy as obtained from the area under 
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the DSC curve is almost identical to the van’t Hoff enthalpy calculated from DSC 
curves and very close to the one calculated from CD curves. This indicates that the 
transition of 4 takes place in a two-state manner, i.e., no intermediate states are 
present. Finally, the Gibbs energy value, which rigorously measures the 
thermodynamic stability, was calculated by the experimental thermodynamic 
parameters. The calculated ΔG°(298 K) value is 4 (± 1) kJ mol-1, and results from the 
characteristic compensation of the favorable enthalpy term with an unfavorable 
entropy contribution (ΔS° = 0.44 ± 0.02 kJ mol-1K-1). The whole set of 
thermodynamic parameters shows that, as expected, 4 is less stable than TBA27. 
Particularly, the favorable enthalpy term is lower than the one derived for TBA, 
probably due to the greater contribution from stronger base stacking and more 
Hoogsteen hydrogen-bonds involved in the TBA quadruplex structure. This is 
consistent with the lack of G-tetrads in the structure adopted by 4. 
 
Structural characterization. The non-exchangeable base and sugar protons 
of 4 were assigned through a combination of the analysis of 2D NOESY (900 MHz,    
T = 1 °C), 2D TOCSY (700 MHz, T = 1 °C) and 2D COSY (700 MHz, T = 1 °C) NMR 
spectra (see Table 1.1).  
Interestingly, the presence of three intense cross-peaks between the H8 
proton bases and sugar H1’ resonances for residues G1, G5 and G10 in the NOESY 
spectrum (900 MHz, T = 1 °C, mixing time 100 ms), along with the presence of weak 
cross-peaks between the same aromatic protons and the H2’ and H2” protons of 
their own ribose moiety, indicated that these three residues adopt a syn glycosidic 
angle conformation (Figure 1.5c). On the contrary, residues G2, G6, G8 and G11 
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turned out to assume an anti glycosidic conformation, having opposite relative 
intensity with respect to the cross-peaks mentioned above (Figure 1.5c). The three 
H8 resonances of syn G residues are downfield shifted with respect to those of the 
anti ones, exactly as reported for TBA28.  
 
 H8/H6 CH3 H1' H2' H2'' H3' H4' H5'/H5'' H1/H3 H2 
(H-bonded) 
H2 
(non H-bonded) 
G1 7.40 -- 5.62 2.68 1.81 4.67 3.60 3.40, 2.86 12.00 9.72 6.15 
G2 8.04 -- 6.16 2.44 2.75 4.92 4.41 4.80, 4.02 12.42 6.90 6.90 
T3 7.09 1.65 5.04 1.30 2.04 4.41 4.29 4.23, 3.83 -- -- -- 
T4 7.41 1.61 6.05 2.23 2.29 4.45 3.01 2.81, 2.59 10.34 -- -- 
G5 7.44 6.12 6.12 3.64 2.84 4.87 4.51 4.37, 3.96 12.23 7.17 7.17 
G6 8.26 -- 6.13 2.66 3.00 5.02 4.57 4.25 12.51 6.91 6.91 
T7 6.86 1.92 5.50 0.50 1.79 4.65 4.17 4.00, 3.99 11.76 -- -- 
G8 8.11 -- 6.03 2.54 2.98 5.01 4.18 4.06, 4.00 10.65 -- 5.90 
T9 7.25 1.54 5.91 1.72 2.22 4.52 3.62 3.44, 2.54 12.42 -- -- 
G10 7.63 -- 5.98 2.84 2.53 4.72 4.31 3.95 11.55 6.48 6.48 
G11 8.02 -- 5.74 2.38 2.65 4.78 4.15 4.10, 3.60 12.08 10.12 6.91 
Table 1.1: 1H-NMR assignment of 4 at 1 °C (900 MHz) 
 
Furthermore, the NOESY spectrum showed that the three anti-Gs (G2, G6 
and G11) have classical H8/H2’–H2’’ sequential connectivities to 5’ neighboring syn-
Gs (G1, G5, G10, respectively). This suggests the presence of the subunits G1–G2, 
G5–G6, G10–G11 (where underlined residues adopt a syn glycosidic conformation), 
and indicated that these subunits are involved in the formation of a helical 
structure. Notably, unusual NOE connectivities were observed between a number 
of Gs and Ts, indicating that 5’-TG-3’ and 5’-GT-3’ tracts do not adopt a helical 
winding, and that the TT and TGT tracts form loops. Furthermore, the alternation of 
syn and anti G residues implies that our sequence, as in TBA, folds back into a 
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unimolecular structure, as also demonstrated by CD and DSC experiments (see 
thermodynamic characterization). Since the number of imino protons is four, 
presumably sample 4 adopts the folding proposed by metadynamics calculations, 
where the presence of two G-triads is consistent with four imino protons in slow 
exchange with the solvent. 
The assignment of the exchangeable imino protons was instead obtained by 
the study of the JR-HMBC correlation experiment. The jump-return version of 
HMBC29 allowed us to assign the imino protons from the assigned H8 protons of 
individual guanine residues (Figure 1.7a). Thus, H8 signals at δH 7.40 (G1), 8.02 
(G11), 7.44 (G5) and 8.26 (G6) turned out to be correlated to the NH protons of 
their own base resonating at δH 12.00, 12.08, 12.23, 12.51, respectively. 
Furthermore, G8-H8 (δH 8.11) turned out to be correlated with the imino proton at 
δH 10.65. This low value for an imino proton suggests that G8 is not involved in 
classical Hoogsteen hydrogen-bonds.  
Once the imino protons has been assigned, it is easy to determine the 
folding topology of sample 4. In fact, by using the jump-return version of the 2D 
NOESY experiment, it was possible to detect a number of intense NOEs between the 
imino proton of a given base and the H8 proton of another base. Generally, this kind 
of NOE is very diagnostic in case the two bases adopt the Hoogsteen base pairing. In 
our case, we observed NOEs between G11-NH (12.08 ppm)/ G5-H8 (7.44 ppm) and 
G5-NH (12.23 ppm)/G2-H8 (8.04 ppm). These two correlations indicate that, as in 
TBA, G5 is involved in the formation of Hoogsteen hydrogen-bonds with both G11 
and G2 and this is in agreement with the calculated structure (Figure 1.7b-c). We 
have also observed a NOE between G1-NH (12.00 ppm) and G6-H8 (8.26 ppm), 
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indicating that G1 and G6 are also paired. All of this indicates that the structure of 4 
could be characterized also by a second G-triad formed by G10, G6 and G1. 
Unfortunately, due to unfavorable T1 noise, no NOE between G6-NH and G10-H8 
could be unambiguously detected. Nevertheless, the fact that the subunit G10-G11 
adopts a helical winding strongly supports the idea that actually also G10 does take 
part in the second G-triad.  
 
 
Figure 1.7: JR-HMBC and JR-NOESY spectra of 5’-GGTTGGTGTGG-3’ (4). (a) Expanded regions of the 
JR-HMBC (600 MHz, T = 1 °C) showing correlations between H8 and H1 guanine protons with C5 
carbons. (b) Expanded region of the 2D JR-NOESY (900 MHz, T = 1 °C) showing diagnostic correlations 
between H8 and H1 protons of paired bases.  (c) Tridimensional representation of the G-triplex 
structure adopted by 5’-GGTTGGTGTGG-3’ (4) as found in the MD calculations. (d) G-triads involved 
in the formation of the G-triplex. Red arrows show NOE correlations between H8 and H1 protons of 
paired bases. 
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In addition, the formation of the G-triplex is also inferred by the presence of 
a number of NOEs between NH protons and by the identification of other 
exchangeable protons. Particularly, in the 1D 1H-NMR spectrum, along with the 
intense and narrow signals of the assigned imino protons (δH 12.00, 12.08, 12.23, 
12.51) a number of other exchangeable protons could be observed. In order to 
clarify whether these signals could be attributable to other imino or amino protons, 
a 2D 1H-15N HSQC experiment was acquired at 25 °C. At this temperature, the 
already assigned signals with δH (T = 1 °C) of 12.00, 12.08, 12.23, 12.51 and 10.65, 
were shifted respectively at δH 11.92, 11.99, 12.14, 12.37 and 10.45. These signals 
turned out to be correlated to nitrogens resonating at δN 143.37, 144.36, 144.66, 
145.74 and 144.67 respectively. All these values are characteristic of N1 guanine 
bases. It is interesting to note that also the broad signal at δH 11.52 (25 °C) turned 
out to be correlated to similar frequencies (143.72 ppm), indicating that also this 
resonance is attributable to an imino proton of guanine. Unfortunately, no 
correlation could be observed in the JR-HMBC spectrum for this signal and it could 
not be unambiguously assigned to the pertinent base. Nevertheless, this signal is 
correlated with T9-H6,H1’,H2”,Me; T7-Me; G10-H2” and G8-H4’. All of this can be 
interpreted assuming that the imino proton resonating at δH 11.52 is assigned to 
G10. Probably, the signals of this NH proton is observable because involved in 
hydrogen bond. In fact, taking into account that the strand G14-G15 originally 
present in TBA is now missing, it is reasonable to assume that the strands G1-G2 
and G10-G11 tend to bring themselves closer to each other, so that the formation 
of hydrogen bonds between G1 and G2 and G10 and G11, respectively, can not be 
ruled out. Furthermore, the formation of the G-triplex is also inferred by the 
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presence of a number of NOEs between NH protons. In particular, we observed 
strong NOEs between G1-NH/G5-NH and G6-NH/G11-NH; medium intensity NOEs 
between G1-NH/G6-NH and G5-NH/G11-NH; and weak NOEs between G5-NH/G6-
NH, that once again support the formation of the G-triplex, having two G-triplets: 
G1-G6-G10 and G2-G5-G11 characterized by syn-anti-syn and anti-syn-anti 
arrangement of the residues, respectively. 
Finally, a number of other NOEs definitely confirmed the structure of the G-
triplex. Particularly, T7-Me shows correlations with G1-NH, G6-NH and G10-NH, 
confirming that the loop TGT is spatially very close to the G-triplet G1-G6-G10. 
Then, G11-NH shows correlations with T4-H2’,H2”,H4’,H5’,H6 and T3-
H4’,H5’,H5”,H6. Furthermore, G5-NH is also correlated with T3-H3’, indicating that 
the TT loop is very close to the G-triplet G2-G5-G11.  
 
MD simulation on the 11-mer oligonucleotide (4). The 11-mer 
oligonucleotide, 4, in the G-triplex conformation has also been studied through an 
extensive MD calculation, in which we have reproduced the ionic concentration of 
70 mM KCl used in the experiments. The G-triplex structure is very stable 
throughout the whole simulation (Figure 1.4) and fully agrees with the distances 
between atoms measured by the NMR experiments.  
 
1.3 Conclusions 
 
During the folding process of the G-quadruplex DNA aptamer TBA, we have 
observed the formation of a new DNA structural motif, the G-triplex. The existence 
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of this structure has been inferred in a 11 mer oligonucleotide, whose structural 
and thermodynamics properties were characterized by advanced computations, 
NMR, CD and DSC experiments. At variance with the already known triplex 
structures characterized by triads having standard Watson-Crick base pairings, G-
triplex presents G:G:G triad planes stabilized by array of Hoogsteen-like hydrogen-
bonds (Figure 1.1). This is the first time that DNA is found in the G-triplex 
conformation and this finding definitely supports the hypothesis of the existence of 
G-triplex structures during the G-quadruplex folding process30,31. 
This discovery is an important breakthrough that paves the way to new 
horizons in biology. In fact, guanine-rich regions, potentially able to form G-triplex 
structures, are very abundant in the genome and our study provides the molecular 
bases and the tools to investigate the presence of these structures in the genome, 
their biological role and the way to interact with them. Furthermore, our study 
raises new questions: are G-triplex structures present in the folding process of other 
DNA or RNA structures? Are there small molecules able to bind and interact with G-
triplex? Are G-triplex structures useful for the design of new aptamers? These are 
only some of the issues that are to be addressed in the near future. 
 
1.4 Materials and Methods 
Metadynamics simulations. The starting conformation coordinates for TBA 
were obtained in its G-quadruplex conformation (PDB ID code 1qdf)21. The system 
was solvated using the TIP3P water model32 and neutralized adding Na+ ions with 
one of these ions placed at the center of the G-tetrad planes. All the simulations 
were carried out using periodic boundary conditions and Particle Mesh Ewald to 
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treat long range electrostatic. Before doing metadynamics simulations the system 
was equilibrated through 25 ns MD under NPT conditions at 1 atm and 300 K using 
the parmbsc0 parameters, which is a modified version of the Amber force field 
adapted for nucleic acids33-35. The Amber charges were applied to the DNA and 
waters atoms. The PLUMED plugin36 was used to carry out metadynamics 
calculations with the NAMD code37. 
The estimation F(s,t) at time t of the free-energy surfaces F(s) as a function 
of the CVs was determined by metadynamics10 in its new well-tempered variant15, 
using the following formula: 
 
 
 
where V(s,t) is the bias potential added to the system and T is the temperature of 
the simulation. ΔT is the difference between the fictitious temperature of the CV 
and the temperature of the simulation. The bias potential is made up by the sum of 
the Gaussians deposited along the trajectories of the CVs. Thanks to this new 
formalism, one can increase barrier crossing and facilitate the exploration in the CVs 
space by tuning ΔT. A Gaussians deposition rate of 0.2 kcal/mol per picosecond was 
initially used and gradually decreased on the basis of the adaptive bias with a ΔT of 
2,700 K. Given the good results previously published18,19, we used the same CVs of 
their work. In particular, the first CV is the radius of gyration (Rcore) calculated on the 
oxygen atoms of the guanines forming the G-tetrad planes. This collective variable is 
calculated using the following formula: 
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where the sums are over the n atoms and the center of mass is defined by 
 
 
 
The gyration radius is a common descriptor in protein folding studies 
because it is able to discriminate between completely unfolded and globule states. 
A Gaussian width of 0.02 Å was used for this CV. In order to distinguish between 
globule and folded states, we used as second CV the number of intramolecular 
hydrogen-bonds engaged by the guanine bases forming the G-tetrad planes (Hcore). 
The number of hydrogen-bonds is evaluated using the switching function 
 
 
 
where r0 is set to 2.0 Å, n and m are set to 6 and 12, respectively, i and j are the 
donor and acceptor hydrogen-bond atoms of the guanines used to calculate the 
number of hydrogen-bonds (Table 1.2). 
On the latter CV we have used the reweighting algorithm20 to compute the 
FES. In fact, this algorithm is able to reconstruct the Boltzmann distribution of CVs 
different from those used originally in the metadynamics run. Once the free energy 
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of the metadynamics simulation is converged, using the newly computed 
probability distribution, the reweighting method allows to build the FES on these 
CVs. 
 
CV type Atoms 
Rcore O6 (G1); O6 (G2); O6 (G5); O6 (G6); O6 (10); O6 (G11); O6 (G14); O6 (G15) 
Hcore 
H-bond acceptor H-bond donor 
O6 (G1) H1 (G15) 
N7 (G1) H21 (G15) 
O6 (G2) H1 (G5) 
N7 (G2) H21 (G5) 
O6 (G5) H1 (G11) 
N7 (G5) H21 (G11) 
O6 (G6) H1 (G1) 
N7 (G6) H21 (G1) 
O6 (G10) H1 (G6) 
N7 (G10) H21 (G6) 
O6 (G11) H1 (G14) 
N7 (G11) H21 (G14) 
O6 (G14) H1 (G2) 
N7 (G14) H21 (G2) 
O6 (G15) H1 (G10) 
N7 (G15) H21 (G10) 
Table 1.2: List of the atoms used to define the Rcore and Hcore CV 
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NMR spectroscopy. All the experiments were collected on samples of the 
thrombin binding aptamer (TBA) and of its truncated constructs 1, 2, 3 and 4 at 
concentrations ranging from 0.7 mM up to 1.5 mM in potassium phosphate buffer 
(70 mM KCl, 10 mM KH2PO4, 0.2 mM EDTA, pH 7). NMR spectra were performed at 
1 °C and 25 °C on Bruker spectrometers operating at 900, 700 and 600 MHz, 
equipped with triple resonance cryo-probes. Different pulse sequence schemes 
(presaturation, excitation sculpting38,39 and watergate40) were used to suppress the 
water signal. 2D 1H-1H TOCSY and 2D 1H-1H COSY experiments were acquired at 700 
MHz for the assignment of the spin systems. Proton–proton distance restraints 
were derived from the analysis of 2D 1H-1H NOESY and 2D 1H-1H ROESY acquired in 
H2O at 900 and 800 MHz. 2D 1H-1H NOESY was acquired using several mixing times 
ranging between 50 and 300 ms. 2D 1H-15N HSQC spectrum was acquired at 800 
MHz to identify imino protons. Intranucleotide connectivities between imino and 
aromatic protons were obtained by a jump-and-return HMBC29 spectrum acquired 
at 600 MHz and 950 MHz on an isotopically natural-abundance sample using 5120 
transients. All spectra were processed with the Bruker TOPSPIN software packages 
and analyzed by the program CARA (Computer Aided Resonance Assignment, ETH 
Zurich)41. 
 
CD and DSC experiments. Oligonucleotide samples were prepared by using 
the same buffer solution used for NMR experiments. CD spectra and CD melting 
curves of oligonucleotide samples were recorded by using a Jasco J-715 
spectropolarimeter equipped with a Jasco JPT-423-S temperature controller using 1 
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mm path-length cuvettes. CD spectral scans were accumulated over the wavelength 
range 200−360 nm at 1 °C. The spectra were recorded at a scan rate of 100 nm/min 
with a response of 1 s, at 2.0 nm bandwidth and were averaged over 5 scans. Buffer 
baseline was subtracted from each spectrum. CD melting and annealing curves 
were recorded as a function of temperature in the range 0-90 °C at 289 nm with a 
scan rate of 0.5 °C/min. The CD melting curve of 4 was analyzed with a two-state 
model, using a theoretical equation for an intramolecular association, according to 
the van’t Hoff analysis42. The Tm and ΔH°vH values provide the best fit of the 
experimental melting data. 
Differential scanning calorimetry (DSC) measurements were carried out 
using a Nano DSC III (TA Instruments, New Castle, DE). The experiments were 
performed at oligonucleotide concentration of 0.2 mM. Scans were carried out at 
0.5 and 1.0 °C/min scan rate in the temperature range 0-90 °C. Reversibility and 
repeatability were proven by multiple scans. A buffer-buffer scan was subtracted 
from the sample-buffer scans and linear-polynomial baselines were drawn for each 
scan. Baseline corrected thermograms were then normalized with respect to the 
oligonucleotide concentration to obtain the corresponding molar heat capacity 
curves. The model-independent transition enthalpies were obtained by integrating 
the area under the heat capacity versus temperature curves42. The melting 
temperatures were estimated as the temperatures corresponding to the maximum 
of each thermogram peak. Entropy values were obtained by integrating the ΔCp/T 
versus T curves (where ΔCp is the molar heat capacity and T is the temperature in 
kelvin) and the Gibbs energy values were computed by the equation ΔG° = ΔH° - 
TΔS°. The thermodynamic parameters reported are the averages of at least three 
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different heating experiments. The reported errors are the standard deviations of 
the mean from the multiple determinations. 
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1) La protein 
 
1.1 La protein: an RNA-binding protein 
 
The La protein is a highly abundant nuclear phosphoprotein that often acts 
as an autoantigen in systemic lupus erythematosus and Sjogren's syndrome 
patients., Interestingly, La has been exhibited key roles in the processing and use of 
coding and noncoding RNAs1,2. In the nucleus, La facilitates the production of tRNAs, 
acting as a RNA polymerase III (RNAP III) transcription factor by binding to the U-rich 
3'UTR of nascent transcripts, assisting in their folding and maturation (e.g., pre-
tRNA, 5S rRNA, and U6 and RNase P snRNAs)1,2,3. It has been shown that the binding 
of La prevents degradation by 3′ exonucleases4,5 but can even promote the nuclear 
retention of certain RNA precursors6,7, and assist the pre-tRNA maturation8,9 and 
facilitate the proper assembly of other pol III transcripts, such as U6 RNA, into 
functional RNA:protein complexes5. 
In yeast, La confirmed its function of stabilizing and protecting RNAs against 
exonucleolitic nibbling, binding to the 3′ poly(U) ends that become exposed during 
endonucleolytic processing of pol II transcripts (e.g., snRNAs)5,10. 
Furthermore, La can directly facilitate translation of specific cellular11,12,13 
and viral mRNAs14,15,16 usually by binding internal RNA sequences within the 
untranslated regions of target mRNAs. Thus, La exhibits remarkable versatility in its 
modes of binding to RNA. 
Human La (HsLa) is a 408 amino acid monomeric modular protein containing 
three structured domains: a La motif and two RNA recognition motifs (RRMs 1 and 
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2); these are followed by a largely unstructured C-terminal tail that possesses a 
short basic motif (SBM) and a nuclear localization signal (NLS)1,2  (Figure 1.1). 
Recently , in order to shed light on the the molecular basis of La:RNA 
interactions, several studies have focused on the N-terminal domain (NTD), the 
most strongly conserved region of the protein between all eukaryotic species. The 
LaNTD is characterized by the presence of two domains contains the La motif and 
RRM1, the domains required for high-affinity binding of 3′ oligo(U) RNA17,18; indeed, 
it has been shown that the two domains must act synergistically to bind 3′ oligo(U) 
tails18,19,20. 
 
 
Figure 1.1: a) Domain organization of human La. Conventionally1, 2 human La is divided in two 
halves, N-terminal domain, comprising the La motif (b) and the adjacent RRM (c), and C-terminal 
domain, encompassing the RRM (d), the SBM and the NLS. 
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Structural studies on La have so far revealed several surprising aspects of the 
molecule. Although initially predicted to adopt an RRM fold, the controversial 
nature of the La motif domain1,2 was finally settled when it was shown to be an 
elaborated version of the winged-helix domain18,20. Strikingly, chemical shift 
mapping experiments revealed that the recognition helix and wing loop of the La 
motif, which are normally used by this type of module to bind DNA21 or RNA22, are 
not involved in recognition of 3′ oligo(U) sequences, indicating that La adopts a 
novel mode of interaction with RNA ligands18. 
 
1.2 HsLa-RNA interaction 
 
Previously it has been shown studies have established that both domains, 
the La motif and RRM1, were required for the interaction of 3′-UUUOH with 
La17,23,24,25; A detailed crystallographic study revelaled that the recognition of a 
short RNA ending in 3’-UUUOH by La domain from HsLa, involves other than to the 
expected surfaces26, but nonetheless confirming the requirement for both motifs 
for RNA binding (Figure 1.2). Particularly, the structural analysis of this co-crystal 
has shown that  the interaction of the protein with RNA induce the folding of the 
linker polypeptide connecting the two domains into an α helix. This appears to be 
an indirect effect since there are no contacts between the RNA and this portion of 
the polypeptide26.  
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Figure 1.2: A co-crystal structure of binding modes of the La motif and RRM1 of the human La 
protein (NTD) with UUU RNA bound. La motif is in light blue, interdomain linker in pink and RRM1 in 
cyan. 
 
To explain the binding mode of La protein Kotik-Kogan et al.26 have 
performed NMR and crystal studies with different RNA oligomers ended with         
3’-UUUOH; in particular they studied the following oligos: AUUUU, AUAAUUU, 
AUAUUUU,UUUUUUUU for the crystal structures, whilst for the NMR study they 
used UU, UUU, UUUU, UCUU, AUUUU, UUUUUUUU RNA oligomers. 
The crystal structure of the complex LaNTD: AUUUU revealed a number of 
important structural details of the recognition of the 3′ end of the RNA oligomer 
that help to explain the specificity of the LaNTD for sequences terminating in          
3’-UUUOH. The major interactions are made by the terminal pair of nucleotides 
(U−1/U−2), which consistently make the closest contacts with the protein and 
appear to provide the majority of the binding energy for the interaction (Figure 1.3). 
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Figure 1.3: Structure of the LaNTD:AUUUU complex showing just the last two nucleotides, U−1 and 
U−2. The RNA is shown as a s?ck model. The protein is colored by domain: La mo?f orange and 
RRM1 brown; selected side chains are shown as sticks with their carbon atoms colored by domain. 
Hydrogen bonds are shown as dashed lines. (Taken from Kotik-Kogan et al. 200826) 
 
The NMR studies have highlighted that the chemical shift perturbation result 
to be similar among all classes, revealing a common mode of 3’ end recognition that 
involves both the La motif and RRM1 domains. In particular, all crystal structures 
revealed that the binding to RNAs appears largely based on the interactions 
established by the last two nucleotides in the sequence, U-1 and U-2. U−1 interacts 
exclusively with the La motif (Figure 1.3), interacting with specific H-bonds that 
involve only backbone features of the nucleotide: the 2’ and 3’-OH groups from the 
ribose ring of U−1 are speciﬁcally recognized by hydrogen bonds to the O atoms of 
the side-chain carboxylate moiety of D33 (Figure 1.3), additionally, the O1 atom of 
the U−1 phosphate group makes hydrogen bonds with both the backbone NH 
groups of N56 and R57 and with the side-chain OH of Y24. Consistent with the 
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structure, these interactions with the ribose-phosphate backbone have been shown 
by mutagenesis to be important for 3’ end recognition20,27. 
The penultimate nucleotide, U−2, makes in?mate contacts with the protein 
that involve both the La motif and RRM1 (Figure 1.3). In contrast to U−1, it is the 
nucleotide base of U−2 and not its backbone that makes speciﬁc hydrogen bonds to 
the protein. Atoms O2 and O4 from the pyrimidine ring of U−2 hydrogen bond to 
the side-chain amide of Q20 (La motif) and the mainchain amide of I140 (RRM1), 
respectively, a pair of interactions that clearly helps to draw the two domains 
together. The pyrimidine ring of U−2 is also stacked directly on top of Y23, a residue 
from the La motif that is positioned by a hydrogen bond from the tyrosine side 
chain to the side chain of N139 of RRM1, which in turn stacks on top of F28 from 
the La motif (Figure 1.3). The U−2 pyrimidine ring is also packed directly underneath 
L124 from RRM1, a residue that is at least partly secured in place by the salt bridge 
made by its neighbour (D125) with R57 from the La motif. Thus, the recognition of 
U−2 in the complex engages a concerted set of protein:RNA and protein:protein 
interactions involving residues from both domains to form a tightly defined pocket 
that is specific in size, shape, and hydrogen-bonding capacity for a uridylate base; 
NMR analyses confirm that these interdomain interactions only form upon RNA 
binding. This induced fit of the binding pocket around U−2 accounts well for the 
cooperative nature of RNA binding by both domains of LaNTD17,18,19,20. In the 
nucleus, La interacts mainly with 3’-oligoU containing RNAs, while in the cytoplasm 
La is able to recognize different mRNAs characterized by the absence of a 3’-UUUOH 
trailer. An example of the latter is the binding of La to the IRES domain IV of the 
hepatitis C virus (HCV) RNA, which is involved in the stimulation of viral translation. 
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A biophysical investigation performed by Martino et. al, revealed that La binds to 
domain IV using a different binding mode from the one shown for its 3’-UUUOH 
recognition: although the La motif and first RNA recognition motif (RRM1) are 
sufficient for high-affinity binding to 3’-oligoU, recognition of HCV domain IV 
requires not only the presence of the La motif and RRM1, but even the cooperation 
of the atypical RRM2, which to date was not involved in RNA binding. This new 
mode of binding does not depend from the sequence  appear sequence specific, but 
recognizes different conformations of the RNA, in particular a double-stranded stem 
flanked by single stranded extensions. This study is the first step for a better 
understanding of the role of La in viral translation initiation. 
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2) La-Related Proteins 
2.1 LARPs 
 
The presence of the La Module (La motif plus RRM1) was even exhibited by a 
group of proteins otherwise unrelated to genuine La, defined as La-related proteins 
(LARPs) 1-9. Functional and structural studies on LARPs are still in their infancy and so 
far only a few LARPs have been characterized. Through phylogenetic analyses and 
structural motif searches LARPs have been divided into four clearly distinct families 
(LARP1, 4, 6, and 7). The greatest degree of homology from the structural point of 
view between these various LARPs occurs in the La motif and also the RRM1 (Figure 
2.1). 
 
 
Figure 2.1: Schematic alignment indicating the conserved La motif–RRM domain architecture of the 
genuine La proteins followed by LARPs. 
 
Initially, because of their similarity to La genuine protein, the researchers 
thought that LARPs also had same features of binding, in other words that they 
were capable to bind ligand with 3’-UUUOH ended, but this has not always proved 
true. In fact, whereas some LARPs are indeed capable to recognize the RNA ending 
with the 3’-UUUOH like the genuine La protein, LARP4 shows a different mechanism 
of recognition in that instead of binding poly (U) RNA it binds poly (A) RNA. In 
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humans two LARP4 family members are found (HsLARP4a and HsLARP4b, previously 
called HsLARP5)10, which share 37% identity and 53% similarity throughout their 
amino acid sequence. Unlike other LARPs, LARP4 and LARP4b diverge in several of 
the amino acids critical for canonical 3’-UUUOH recognition, suggesting that, as 
already outlined, that the LARP4 family is the most diverged from genuine La 
proteins and other LARPs in the RNA binding pockets of their La Module11. 
 
2.2 Role of LARP4 
 
The La motif-RRM arrangement has been found in La-related proteins 1 
(LARP1), 1b, 4, 4b, 6, and 7, which have been separately conserved during 
evolution10,11,12 (LARP4b is also referred to as LARP5 in multiple databases and here 
will be designated LARP5/4b). LARP1, -6, and -7 have conserved all of the amino 
acids involved in 3’-UUUOH recognition in La- RNA crystals13,14, while LARP4 and -
5/4b have diverged, suggesting alternative RNA binding11. Moreover, an invariant 
divergence in all of the LARP4 and -5/4b sequences available occurs in a most 
critical residue involved in base-specific recognition seen in La-RNA crystals, 
corresponding to human La Q20, suggesting a conserved difference in RNA 
recognition11. A detailed overview of the role and functions of LARP4 occurred in 
2010 with a study conducted by Conte’s group in collaboration with others15. 
According to their results, LARP4 appears to be involved in mRNA metabolism and 
translation. Multiple data indicate that LARP4 is intimately associated with 
translating polyadenylated mRNAs. The conserved RNA binding La motif-RRM of 
LARP4 exhibits a binding preference for poly(A), as well as other unexpected 
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properties of a La motif-RRM-containing protein. The interaction of LARP4 with RNA 
has been investigated by EMSA assays, where the binding properties of the La 
modules of human La(1-235) and LARP4(1-286) have been compared. Among the 
homopolymers tested, A(20) exhibited the best affinity for LARP4-NTD, as reflected 
by the ratio of free to bound RNA, whereas U(20) showed less binding and C(20) 
and G(20) showed no binding (Figure 2.2 A to D). 
 
 
Figure 2.2: EMSA of homopolymeric 20-mer RNAs for binding to the RNA binding domain of LARP4 
protein. (Taken from Yang R. et al.15) 
 
LARP4 binding to RNA was not affected by addition of 3’ phosphate; this is a 
difference with La protein that is capable to bind only ssRNA ending with 3’ hydroxyl 
(Figure 2.3). 
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Figure 2.3: Comparison of LARP4(1-286) binding to otherwise identical 36-mer RNAs that end with a 
3’-OH or a 3’ phosphate. (Taken from Yang R. et al.15) 
 
ITC (Figure 2.4) was employed to investigate in more detail the RNA binding 
properties of the La module of LARP4. The interaction of LARP4(111-303) with three 
different RNAs was tested.  
 
 
Figure 2.4: (A to C) Isothermal titration calorimetric analysis of LARP4(111-303) interactions with 
A(15), U(15), and A(10). The Kd and other thermodynamic parameters derived from this analysis are 
reported in Table 2.1. (Taken from Yang R. et al.15) 
 
Figure 2.4 A to C shows the interactions of a LARP4(111-303) fragment with 
three RNAs. The titration analysis of LARP4(111-303) with A(15), has shown that 
binding occurs as one event centred on a molar ratio of 1. LARP4(111-303) interacts 
with A(15) with a Kd of 714 nM, with entropically driven binding (Table 2.1). 
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Table 2.1: Thermodynamic parameters of the interaction of La(1-194) and LARP4(111-303) with 
single-stranded RNA sequence. The values represent the averages and the standard deviations over 
three independent measurements 
 
In contrast, LARP4(111-303) displayed very weak association with U(15) and 
A(10) with a Kd beyond the threshold that could be rigorously measured by ITC, i.e., 
≥0.1 mM. Therefore, LARP4 binds to A(15) at least 200-fold more tightly than U(15) 
and A(10). 
The LARP4 La motif-RRM is flanked on both sides by PABP interacting 
regions. The region N-terminal to the La motif-RRM contains a conserved PAM2w 
sequence that we showed is important for PABP interaction. PAM2 sequences 
mediate direct contacts with the MLLE domain of PABP16,17. Direct binding as 
monitored by ITC, as well as NMR and crystallography, showed that the LARP4 
PAM2w makes contacts with the MLLE domain of PABP. 
Notably, it has been shown evidence that is consistent with a model in which 
LARP4 and PABP interact in the presence of RNA and that this contributes to the 
stability of their interaction. This characterization represents the first detailed 
mechanism by which a LARP interacts with PABP. 
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3) Study of the interaction between Human La-Related Protein 4 
(HsLARP4) and poly-A15 RNA 
 
3.1 Introduction 
 
Human La-Related Protein 4 (HsLARP4) interacts with high affinity and 
specificity to poly-A15 RNA (see section 2.2). The La module of HsLARP4 is essential 
for the interaction with poly-A15 RNA.  
In this project, five highly conserved residues in the La module of HsLARP4 
were identified through sequence alignment with HsLa, and three of them were 
mutated to Alanine through point mutation (Figure 3.1). The aim of the study was 
to investigate if the highly conserved residues that play a key role in the interaction 
HsLa/3’-UUUOH, result to be important also in the HsLARP4/poly-A15 interaction .  
The mutants were used in Isothermal Titration Calorimetry (ITC) to 
investigate the interaction between HsLARP4 and poly-A15 RNA. Mutation of 
residues 126, 139 and 160 to Alanine in the La module of HsLARP4, decreased its 
binding affinity to poly-A15, hence, indicating that these residues of HsLARP4 play 
key roles in the interaction with RNA. 
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Figure 3.1: Sequence alignment of the conserved La module of HsLa and HsLARP4a. The residues 
that in HsLa are responsible for the 3´ oligoU specific binding are indicated with blue arrowheads. 
The residues that were mutated into Alanine in HsLARP4 La module are indicated with blue stars. 
The secondary structure of HsLARP4 La motif is reported according to the NMR solution structure, 
while the secondary structure of the RRM1 domain has been derived from preliminary NMR data 
obtained with TALOS+. 
 
3.2 Results and Discussion 
 
Generation of plasmids encoding for three point mutations of HsLARP4(111-
287). Contrary to the interaction of HsLa with poly U RNA, HsLARP4’s interaction 
with poly A15 RNA was shown to be to be length-dependent (see section 2.2). In 
order to evaluate if the conserved residues in the La motif of the LARPs play a key 
role in the interaction of LARP4 with poly-A15 RNA, we selected three conserved 
residues (Q126, D139, M160) and mutate them into Alanine residues. This goal was 
achieved through the Polymerase Chain Reaction (PCR) using primers in Figure 3.37 
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(section 3.4). Agarose gel electrophoresis analysis showed bands of about 6 
kilobases and smears for all three PCR products (Figure 3.2), and they are likely to 
be formed by the plasmids (5.1 kilobases) supercoiled in various conformations. 
Further, DNA sequencing results showed that the desired mutation was present in 
all plasmids.  
 
Figure 3.2. Agarose gel electrophoresis of the PCR products generated from the point mutation. First 
lane: 1Kb DNA ladder (Promega, USA), lane Q126A: Plasmid encoding for Q126A mutant, lane 
D139A: Plasmid encoding for D139A mutant, lane M160A: Plasmid encoding for M160A mutant. 
 
Protein expression test in Rosetta2 cells at different temperature. The 
plasmids of section 3.4 were transformed into Rosetta2 cells, and expression test 
was performed at 18 °C and 37 °C. SDS-PAGE analysis in Figures 3.4 and 3.5 showed 
that there were over-expression of proteins around the 23 kDa mark in 
HsLARP4(111-287) wild-type and all mutants. The molecular weight of wild-type 
HsLARP4(111-287), Histidine-Tag (His-Tag) and Tobacco-Etch-Virus (TEV) cleavage 
site (see Figure 3.3) was about 23.1 kDa.  
 
CHAPTER V 
179 
 
 
Figure 3.3: Sequence of HsLARP4(111-287),Histidine-Tag (His-Tag) and Tobacco-Etch-Virus (TEV) 
cleavage site. The His-Tag and TEV site are reported in red, while the point mutations Q126A, D139A 
and M160A are reported in green. 
 
Since in the point mutations only one residue of the wild-type sequence was 
replaced with an Alanine, all the mutants were expected to have similar molecular 
weight. More proteins were present in the soluble fraction when induced at 18 °C 
than 37 °C (data not shown).  
 
 
Figure 3.4. SDS-PAGE analysis of the expression test with induction done at 18oC on Rosetta2 cells 
transformed with plasmid encoding for HsLARP4(111-287). First lane: Protein Ladder 10-250 kDa 
(New England BioLabs, UK), lane Pre: Wild-type pre-induction sample, lane Post: post-induction 
sample, lane Ins.: insoluble fraction, lane Sol.: soluble fraction respectively. 
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Figure 3.5. SDS-PAGE analysis of the expression test with induction done at 18oC on Rosetta2 cells 
transformed with plasmid encoding for HsLARP4(111-287) Q126A, HsLARP4(111-287) D139A a 
HsLARP4(111-287) M160A. First lane: Protein Ladder 10-250 kDa (New England BioLabs, UK), lanes 
Pre, Post, Sol., Ins. (Q126A): HsLARP4(111-287) Q126A pre-induction sample, post-induction sample, 
soluble fraction, insoluble fraction respectively, lanes Pre, Post, Sol., Ins. (Q126A): HsLARP4(111-287) 
D139A pre-induction sample, post-induction sample, soluble fraction, insoluble fraction respectively, 
lanes Pre, Post, Sol., Ins. (M126A): HsLARP4(111-287) M160A pre-induction sample, post-induction 
sample, soluble fraction, insoluble fraction respectively. 
 
Isolation and purification of the HsLARP4(111-287) & the mutants. 
Expression test has shown the over-expression of HsLARP4(111-287) wild-type and 
the three mutants in Rosetta2 cells on induction. Large-scale production, isolation 
and purification were done to produce sufficient proteins for NMR and ITC 
experiments. Purification of HsLARP4(111-287) wild-type, mutant Q126A, D139A 
and M160A were successful as reported in the following session. 
HsLARP4(111-287). Figure 3.6 shows the elution profile of HsLARP4(111-287) 
wild-type from Nickel Column, with the peak occurring from fraction A9 to C1. SDS-
PAGE analysis (Figure 3.7) confirmed the presence of the protein from fraction A12 
to B9.  Manual purification through Nickel column after TEV cleavage removed the 
His-tag, TEV protease and contaminating protein. In Figure 3.8, the size of the 
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protein reduced from about 23.1 kDa to 20.5 kDa after TEV cleavage. Purification 
through Heparin columns removed nucleic acids contaminants. Figure 3.9 shows 
elution profile from Heparin Column, with the peak occurring from fraction C4 to 
D3. SDS-PAGE analysis (Figure 3.10) confirmed the presence of the protein from 
fraction C4 to D3. Finally, in order to eliminate last residues of contaminants, size 
exclusion column (SEC) purification was performed. Figure 3.11 shows the elution 
profile from SEC. Two peaks appear in the chromatogram: one from fraction C9 to 
D5 and the other one from fraction E4 to F2. According to SDS-PAGE analysis (Figure 
3.12), only the fractions from E4 to F2 were collected. 
 
 
 
Figure 3.6: Elution profile HsLARP4(111-287) wild-type from Nickel affinity column using a gradient 
of Nickel buffer B following a wash with Nickel buffer A. Protein elution was monitored by UV 
absorbance at 280nm. Distinct peak of UV absorbance was observed from fraction A9 to C1. Blue 
curve: Ultraviolet Absorbance; Green curve: Nickel Buffer B concentration. 
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Figure 3.7: SDS PAGE analysis of fraction A5 to B9 from the Nickel column, showing that 
HsLARP4(111-287), of about 23.1 kDa, was found predominantly from fraction A12 to B9. First lane: 
Protein Ladder 10-250 kDa (New England BioLabs, UK), lane Ins.: Insoluble cell fraction after 
sonication and centrifugation, lane Sol.: Soluble cell fraction after sonication and centrifugation lane 
FT: Flow-through from Nickel column, lane 5: Fraction collected after washing the column with 
Nickel buffer A, lane A5: Fraction A5, lane A12: Fraction A12, lane B1: Fraction B1, lane B2: Fraction 
B2, lane B3: Fraction B3, lane B4: Fraction B4, lane B5: Fraction B5, lane B7: Fraction B7, lane B9: 
Fraction B9. 
 
 
Figure 3.8: SDS-PAGE analysis of the protein solution after the 2nd round of purification through the 
Nickel affinity column after the removal of His-tag by TEV protease. Prior to TEV cleavage, the 
protein was about 23.1 kDa. After TEV cleavage, the molecular weight of the protein was reduced to 
about 20.5 kDa. First lane: Protein Ladder 10-250 kDa (New England BioLabs, UK), lane Pre-TEV: 
protein solution prior to cleavage, lane Tot.: protein solution after cleavage, but prior to purification 
through the Nickel column, lane FT: protein solution after passing though the Nickel column and 
eluted in the flow-through, lane WA: Elution of the contaminating protein with Nickel Buffer A. 
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Figure 3.9: Elution profile HsLARP4(111-287) from the Heparin columns washed with Heparin Buffer 
A, and eluted with a Heparin Buffer B gradient. Protein elution was monitored by UV absorbance at 
280nm. Distinct peak of UV absorbance was formed from fraction C4 to fraction D3. Blue curve: 
Ultraviolet Absorbance; Green curve: Heparin Buffer B concentration. 
 
 
Figure 3.10: SDS PAGE analysis of fraction B1 to F10 from the Heparin columns, showing that 
HsLARP4(111-287) of about 20.5 kDa after removal of HisTag by TEV protease, was found 
predominantly from fraction E5 to E12. First lane: Protein Ladder 10-250 kDa (New England BioLabs, 
UK), lane FT: Flow-through of protein solution after passing through the double Heparin columns, 
lane B1: Fraction B1, lane B4: Fraction B4, lane B11: Fraction B11, lane C5: Fraction C5, lane C7: 
Fraction C7, lane C11: Fraction C11, lane D3: Fraction D3, lane E5: Fraction E5, lane E10: Fraction E10. 
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Figure 3.11: Elution profile HsLARP4(111-287) from the Size Exclusion column washed with NMR/ITC 
buffer. Protein elution was monitored by UV absorbance at 280nm. Distinct peaks of UV absorbance 
were visible from fraction C9 to fraction D5 and E4 to F2. Blue curve: Ultraviolet Absorbance; Green 
curve: NMR/ITC buffer concentration. 
 
 
Figure 3.12: SDS PAGE analysis of fraction D1 to F2 from the size exclusion column, showing that 
HsLARP4(111-287) of about 20.5 kDa after removal of HisTag by TEV protease, was found 
predominantly from fraction E4 to F9. First lane: Protein Ladder 10-250 kDa (New England BioLabs, 
UK), lane Tot.: Sample prior 3rd round of purification, lane D1: Fraction D1, lane D5: Fraction D5, lane 
D7: Fraction D7, lane D12: Fraction D12, lane E4: Fraction E4, lane E8: Fraction E8, lane E12: Fraction 
E12, lane F2: Fraction F2. 
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HsLARP4(111-287) Q126A. Figure 3.13 shows the elution profile of 
HsLARP4(111-287) Q126A from Nickel Column, with the peak occurring from 
fraction A9 to B12. SDS-PAGE analysis (Figure 3.14) confirmed the presence of the 
protein from fraction A11 to B12.  
Manual purification through Nickel column after TEV cleavage removed the 
His-tag, TEV protease and contaminating protein. In Figure 3.15, the size of the 
protein reduced from about 23.1 kDa to 20.5 kDa after TEV cleavage.  
Purification through Heparin columns removed nucleic acids contaminants. 
Figure 3.16 shows elution profile from Heparin Column, with the peak occurring 
from fraction C1 to D5. SDS-PAGE analysis (Figure 3.17) showed the protein 
presence from fraction C1 to D1.  
Finally, in order to eliminate last residues of contaminants, size exclusion 
column (SEC) purification was performed. Figure 3.18 shows the elution profile from 
SEC, with a peak occurring from fraction E5 to F5. According to SDS-PAGE analysis 
(Figure 3.19), only the fractions from E5 to F5 were collected. 
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Figure 3.13: Elution profile HsLARP4(111-287) Q126A from Nickel affinity column using a gradient of 
Nickel buffer B following a wash with Nickel buffer A. Protein elution was monitored by UV 
absorbance at 280nm. Distinct peak of UV absorbance was observed from fraction A9 to B12. Blue 
curve: Ultraviolet Absorbance; Green curve: Nickel Buffer B concentration. 
 
 
Figure 3.14: SDS PAGE analysis of fraction A1 to B11 from the Nickel column, showing that 
HsLARP4(111-287) Q126A, of about 23.1 kDa, was found predominantly from fraction A9 to B12. 
First lane: Protein Ladder 10-250 kDa (New England BioLabs, UK), lane Ins.: Insoluble cell fraction 
after sonication and centrifugation, lane Sol.: Soluble cell fraction after sonication and centrifugation 
lane FT: Flow-through from Nickel column, lane 5: Fraction collected after washing the column with 
Nickel buffer A, lane A1: Fraction A1, lane A3: Fraction A3, lane A8: Fraction A8, lane A11: Fraction 
A11, lane B2: Fraction B2, lane B5: Fraction B5, lane B8: Fraction B8, lane B11: Fraction B11. 
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Figure 3.15: SDS-PAGE analysis of the protein solution after the 2nd round of purification through 
the Nickel affinity column after the removal of His-tag by TEV protease. Prior to TEV cleavage, the 
protein was about 23.1 kDa. After TEV cleavage, the molecular weight of the protein was reduced to 
about 20.5 kDa. lane 1: Protein Ladder 10-250 kDa (New England BioLabs, UK), lane 2: protein 
solution prior to cleavage, lane 3: protein solution after cleavage, but prior to passing through the 
Nickel column, lane 4: protein solution after passing though the Nickel column and eluted out in the 
flow-through, lane WA: Elution of the contaminating protein by washing the column with Nickel 
Buffer A, lane WB: Elution of the contaminating protein by washing the column with Nickel Buffer B. 
 
 
Figure 3.16: Elution profile HsLARP4(111-287) Q126A from the Heparin columns washed with 
Heparin Buffer A, and eluted with a Heparin Buffer B gradient. Protein elution was monitored by UV 
absorbance at 280nm . Distinct peak of UV absorbance was formed from fraction C1 to fraction D5. 
Blue curve: Ultraviolet Absorbance; Green curve: Heparin Buffer B concentration. 
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Figure 3.17: SDS PAGE analysis of fraction A8 to D1 from the Heparin columns, showing that 
HsLARP4(111-287) Q126A, of about 20.5 kDa was found predominantly from fraction C1 to D1. First 
lane: Protein Ladder 10-250 kDa (New England BioLabs, UK),  lane Tot.: Sample prior to 2nd round of 
purification, lane FT: Flow-through of protein solution after passing through the double Heparin 
columns, lane A8: Fraction A8, lane B3: Fraction B3, lane B9: Fraction B9, lane C2: Fraction C2, lane 
C8: Fraction C8, lane C4: Fraction C4, lane D1: Fraction D1. 
 
 
Figure 3.18: Elution profile HsLARP4(111-287) Q126A from the Size Exclusion column washed with 
NMR/ITC buffer . Protein elution was monitored by UV absorbance at 280nm . Distinct peak of UV 
absorbance was visible from fraction E5 to fraction F5. Blue curve: Ultraviolet Absorbance; Green 
curve: NMR/ITC buffer concentration. 
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Figure 3.19: SDS PAGE analysis of fraction C4 to F11 from the size exclusion column, showing that 
HsLARP4(111-287) Q126A of about 20.5 kDa after removal of HisTag by TEV protease, was found 
predominantly from fraction E4 to F9. First lane: Protein Ladder 10-250 kDa (New England BioLabs, 
UK), lane Tot.: Sample prior 3rd round of purification, lane B12: Fraction B12, lane C4: Fraction C4, 
lane D2: Fraction D2, lane D12: Fraction D12, lane E5: Fraction E5, lane E9: Fraction E9, lane E11: 
Fraction E11, lane F2: Fraction F2, lane F4: Fraction F4, lane F8: Fraction F8, lane F11: Fraction F11. 
 
HsLARP4(111-287) D139A. Figure 3.20 shows the elution profile of 
HsLARP4(111-287) D139A from Nickel Column, with the peak occurring from 
fraction B2 to C2. SDS-PAGE analysis (Figure 3.21) confirmed the presence of the 
protein from fraction B2 to C2.  
Manual purification through Nickel column after TEV cleavage removed the 
His-tag, TEV protease and contaminating protein. In Figure 3.22, the size of the 
protein reduced from about 23.1 kDa to 20.5 kDa after TEV cleavage.  
Purification through Heparin columns removed nucleic acids contaminants. 
Figure 3.23 shows elution profile from Heparin Column, with the peak occurring 
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from fraction C1 to D5. SDS-PAGE analysis (Figure 3.24) confirmed the presence of 
the protein from fraction C3 to D3.  
Finally, in order to eliminate last residues of contaminants, size exclusion 
column (SEC) purification was performed. Figure 3.25 shows the elution profile from 
SEC, with a major peak occurring from fraction E5 to F5. According to SDS-PAGE 
analysis (Figure 3.26), only the fractions from E5 to F5 were collected. 
 
  
Figure 3.20: Elution profile HsLARP4(111-287) D139A from Nickel affinity column using a gradient of 
Nickel buffer B following a wash with Nickel buffer A. Protein elution was monitored by UV 
absorbance at 280nm. Distinct peak of UV absorbance was observed from fraction B2 to C2. Blue 
curve: Ultraviolet Absorbance; Green curve: Nickel Buffer B concentration. 
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Figure 3.21: SDS PAGE analysis of fraction A4 to C11 from the Nickel column, showing that 
HsLARP4(111-287) D139A, of about 23.1 kDa, was found predominantly from fraction B2 to C2. First 
lane: Protein Ladder 10-250 kDa (New England BioLabs, UK), lane Ins.: Insoluble cell fraction after 
sonication and centrifugation, lane Sol.: Soluble cell fraction after sonication and centrifugation lane 
FT: Flow-through from Nickel column, lane 5: Fraction collected after washing the column with 
Nickel buffer A, lane A4: Fraction A4, lane A9: Fraction A9, lane B1: Fraction B1, lane B4: Fraction B4, 
lane B7: Fraction B7, lane B10: Fraction B10, lane C2: Fraction c2, lane C11: Fraction C11. 
 
Figure 3.22: SDS-PAGE analysis of the protein solution after the 2nd round of purification through 
the Nickel affinity column after the removal of His-tag by TEV protease. Prior to TEV cleavage, the 
protein was about 23.1 kDa. After TEV cleavage, the molecular weight of the protein was reduced to 
about 20.5 kDa. lane 1: Protein Ladder 10-250 kDa (New England BioLabs, UK), lane 2: protein 
solution prior to cleavage, lane 3: protein solution after cleavage, but prior to passing through the 
Nickel column, lane 4: protein solution after passing though the Nickel column and eluted out in the 
flow-through, lane WA: Elution of the contaminating protein by washing the column with Nickel 
Buffer A, lane WB: Elution of the contaminating protein by washing the column with Nickel Buffer B. 
 
CHAPTER V 
192 
 
  
Figure 3.23: Elution profile HsLARP4(111-287) D139A from the Heparin columns washed by Heparin 
Buffer A, and eluted with a Heparin Buffer B gradient. Protein elution was monitored by UV 
absorbance at 280nm. Distinct peak of UV absorbance was formed from fraction C1 to fraction D5. 
Blue curve: Ultraviolet Absorbance; Green curve: Heparin Buffer B concentration. 
 
 
Figure 3.24: SDS PAGE analysis of fraction A8 to D4 from the Heparin columns, showing that 
HsLARP4(111-287) D139A, of about 20.5 kDa was found predominantly from fraction C3 to D3. First 
lane: Protein Ladder 10-250 kDa (New England BioLabs, UK), lane FT: Flow-through of protein 
solution after passing through the double Heparin column, lane A8: Fraction A8, lane B4: Fraction B4, 
lane B12: Fraction B12, lane C4: Fraction C4, lane C7: Fraction C7, lane C11: Fraction C11, lane D2: 
Fraction D2, lane D4: Fraction D4. 
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Figure 3.25: Elution profile HsLARP4(111-287) D139A from the Size Exclusion column washed with 
NMR/ITC buffer. Protein elution was monitored by UV absorbance at 280nm. A major peak of UV 
absorbance was visible from fraction E5 to fraction F5. Blue curve: Ultraviolet Absorbance; Green 
curve: NMR/ITC buffer concentration. 
 
 
Figure 3.26: SDS PAGE analysis of fraction C4 to F9 from the size exclusion column, showing that 
HsLARP4(111-287) D139A of about 20.5 kDa after removal of HisTag by TEV protease, was found 
predominantly from fraction E5 to F5. First lane: Protein Ladder 10-250 kDa (New England BioLabs, 
UK), lane Tot.: Sample prior 3rd round of purification, lane B12: Fraction B12, lane C4: Fraction C4, 
lane C8: Fraction C8, lane C12: Fraction C12, lane D9: Fraction D9, lane D11: Fraction D11, lane E7: 
Fraction E7, lane E12: Fraction E12, lane F6: Fraction F6, lane F9: Fraction F9. 
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HsLARP4(111-287) M160A. Figure 3.27 shows the elution profile of 
HsLARP4(111-287) M160A from Nickel Column, with the peak occurring from 
fraction A5 to C2. SDS-PAGE analysis (Figure 3.28) confirmed the presence of the 
protein from fraction B2 to C1.  
Manual purification through Nickel column after TEV cleavage removed the 
His-tag, TEV protease and contaminating protein. In Figure 3.29, the size of the 
protein reduced from about 23.1 kDa to 20.5 kDa after TEV cleavage.  
Purification through Heparin columns removed nucleic acids contaminants. 
Figure 3.30 shows elution profile from Heparin Column, with the peak occurring 
from fraction B12 to D3. SDS-PAGE analysis (Figure 3.31) confirmed the presence of 
the protein from fraction C3 to D1.  
Finally, in order to eliminate last residues of contaminants, size exclusion 
column (SEC) purification was performed. Figure 3.32 shows the elution profile from 
SEC, with a major peak occurring from fraction E6 to F6. According to SDS-PAGE 
analysis (Figure 3.33), only the fractions from E6 to F6 were collected. 
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Figure 3.27: Elution profile HsLARP4(111-287) M160A from Nickel affinity column using a gradient of 
Nickel buffer B following a wash with Nickel buffer A. Protein elution was monitored by UV 
absorbance at 280nm. Distinct peak of UV absorbance was observed from fraction A5 to C2. Blue 
curve: Ultraviolet Absorbance; Green curve: Nickel Buffer B concentration. 
 
 
Figure 3.28: SDS PAGE analysis of fraction A4 to C6 from the Nickel column, showing that 
HsLARP4(111-287) M160, of about 23.1 kDa, was found predominantly from fraction B2 to C2. First 
lane: Protein Ladder 10-250 kDa (New England BioLabs, UK), lane Ins.: Insoluble cell fraction after 
sonication and centrifugation, lane Sol.: Soluble cell fraction after sonication and centrifugation lane 
FT: Flow-through from Nickel column, lane 5: Fraction collected after washing the column with 
Nickel buffer A, lane A4: Fraction A4, lane A10: Fraction A10, lane B2: Fraction B2, lane B5: Fraction 
B5, lane B7: Fraction B7, lane B10: Fraction B10, lane C1: Fraction C1, lane C4: Fraction C4, lane C6: 
Fraction C6. 
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Figure 3.29: SDS-PAGE analysis of the protein solution after the 2nd round of purification through 
the Nickel affinity column after the removal of His-tag by TEV protease. Prior to TEV cleavage, the 
protein was about 23.1 kDa. After TEV cleavage, the molecular weight of the protein was reduced to 
about 20.5 kDa. lane 1: Protein Ladder 10-250 kDa (New England BioLabs, UK), lane 2: protein 
solution prior to cleavage, lane 3: protein solution after cleavage, but prior to passing through the 
Nickel column, lane 4: protein solution after passing though the Nickel column and eluted out in the 
flow-through, lane WA: Elution of the contaminating protein by washing the column with Nickel 
Buffer A, lane WB: Elution of the contaminating protein by washing the column with Nickel Buffer B. 
 
  
Figure 3.30: Elution profile HsLARP4(111-287) M160A from the Heparin columns washed with 
Heparin Buffer A, and eluted with a Heparin Buffer B gradient. Protein elution was monitored by UV 
absorbance at 280nm . Distinct peak of UV absorbance was formed from fraction B12 to fraction D3. 
Blue curve: Ultraviolet Absorbance; Green curve: Heparin Buffer B concentration. 
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Figure 3.31: SDS PAGE analysis of fraction A5 to E4 from the Heparin columns, showing that 
HsLARP4(111-287) M160A, of about 20.5 kDa was found predominantly from fraction C3 to D1. First 
lane: Protein Ladder 10-250 kDa (New England BioLabs, UK), lane FT: Flow-through of protein 
solution after passing through the double Heparin column, lane A5: Fraction A5, lane B3: Fraction B3, 
lane B11: Fraction B11, lane C3: Fraction C3, lane C7: Fraction C7, lane D1: Fraction D1, lane D4: 
Fraction D4, lane D8: Fraction D8, lane E4: Fraction E4. 
 
 
Figure 3.32: Elution profile HsLARP4(111-287) M160A from the Size Exclusion column washed with 
NMR/ITC buffer. Protein elution was monitored by UV absorbance at 280nm. A major peak of UV 
absorbance was visible from fraction E6 to fraction F6. Blue curve: Ultraviolet Absorbance; Green 
curve: NMR/ITC buffer concentration. 
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Figure 3.33: SDS PAGE analysis of fraction B5 to F4 from the size exclusion column, showing that 
HsLARP4(111-287) M160A of about 20.5 kDa after removal of HisTag by TEV protease, was found 
predominantly from fraction E6 to F6. First lane: Protein Ladder 10-250 kDa (New England BioLabs, 
UK), lane Tot.: Sample prior 3rd round of purification, lane B5: Fraction B5, lane D8: Fraction D8, lane 
D12: Fraction D12, lane E5: Fraction E5, lane E8: Fraction E8, lane F2: Fraction F2, lane F3: Fraction 
F3, lane F4: Fraction F4. 
 
 
1D 1H Nuclear Magnetic Resonance of HsLARP4(111-287) & the mutants. 
1D 1H-NMR was performed on HsLARP4(111-287), HsLARP4(111-287) Q126A, 
HsLARP4(111-287) D139A and HsLARP4(111-287) M160A to ascertain whether the 
purified proteins were folded properly.  
A simple one-dimensional proton experiment, the most basic spectrum in 
NMR spectroscopy, already contains a great amount of information. An unfolded 
protein shows a small dispersion of the amide backbone chemical shift1. 
Particularly, the appearance of intensities at chemical shifts near 8.3 ppm is an 
excellent indicator for a disordered protein, as this is a region of backbone amides 
in random-coil configuration. On the other hand signal dispersion  beyond 8.5 ppm 
(8.5–11 ppm) proves a protein to be folded2. Because of the different chemical 
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enviroment, and thus, the varying shielding effect, the resonances of the single 
protons will be distributed over a wide range of frequencies  
In the NMR spectra of Figure 3.34, the presence of good chemical shift 
dispersion indicates that HsLARP4(111-287) and the three mutants assumed a 
folded structure in solution. Furthermore the 3 spectra appeared similar to each 
other, with minor differences in the chemical shift of some residues. This indicates 
that all the proteins could be folded in the same way, with minor differences in the 
local conformation.  
 
 
Figure 3.34: NMR spectra of HsLARP4(111-287) wild-type (Blue), mutant Q126A (Red), mutant 
D139A(Green) and mutant M160A (Pink). 
 
 
 
Study of interaction between HsLARP4(111-287) protein and polyA-15 RNA 
using Isothermal Titration Calorimetry (ITC). ITC experiments were conducted to 
study the interaction of HsLARP4(111-287) and mutants HsLARP4(111-287) Q126A, 
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HsLARP4(111-287) D139A and HsLARP4(111-287) M160A with poly-A15 RNA.  In the 
ITC experiment of HsLARP(111-303) wild-type and poly-A15 RNA, binding occurs as 
one event centered on a molar ratio of 1 (Figure 2.4 of section 2.2). Further analysis 
revealed that LARP4(111-303) interacts with A(15) with a Kd of 714 nM, with 
entropically driven binding (Table 2.1 of section 2.2). When the protein in the cell 
was replaced with HsLARP4(111-287) Q126A, HsLARP4(111-287) D139A and 
HsLARP4(111-287) M160A, respectively, the interaction with poly-A15 RNA 
dramatically changed. Particularly, for all the three mutants the ITC experiments 
showed the absence of a binding curve, indicating that the proteins were no longer 
able to interact with the RNA (Figures 3.35, 3.36).  
 
 
Figure 3.35. (A) Plot of heat of interaction for each injection of poly-A15 into cell containing mutant 
HsLARP4(111-287) Q126A. Peaks below the baseline indicate exothermic reactions. Peaks above the 
baseline indicate endothermic reactions. (B) Binding curve of wild-type HsLARP4(111-287) Q126A to 
poly-A15 RNA, fitted using the MicroCal-Origin 7.0, which integrates the peaks formed by the heat of 
interaction in (A). 
B 
A 
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Figure 3.36. (A) Plot of heat of interaction for each injection of poly-A15 into cell containing mutant 
HsLARP4(111-287) D139A. Peaks below the baseline indicate exothermic reactions. Peaks above the 
baseline indicate endothermic reactions. (B) Binding curve of wild-type HsLARP4(111-287) D139A to 
poly-A15 RNA, fitted using the MicroCal-Origin 7.0, which integrates the peaks formed by the heat of 
interaction in (A). (C) Plot of heat of interaction for each injection of poly-A15 into cell containing 
mutant HsLARP4(111-287) M160A. (D) Binding curve of wild-type HsLARP4(111-287) M160A to poly-
A15 RNA, fitted using the MicroCal-Origin 7.0, which integrates the peaks formed by the heat of 
interaction in (C). 
 
3.3 Conclusions 
 
In summary, the cloning and large scale production of HsLARP4(111-
287)Q126A, HsLARP4(111-287)D139A and HsLARP4(111-287)M160 were successful 
performed ad shown in section 3.2. 1D 1H-NMR revealed that the three mutants 
assumed a folding. finally ITC experiments showed that of HsLARP4(111-287)Q126A, 
HsLARP4(111-287)D139A and HsLARP4(111-287)M160 were not able to interact 
with polyA-15 RNA. These results suggest that the mutation from residues Q126, 
D139 and M160 of HsLARP4(111-287) to Alanine interfered with the mechanism of 
C 
A 
B D 
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interaction with polyA-15 RNA, hence, resulting in the loss of the binding affinity. 
Therefore, these residues may probably play a key role for the protein activity. 
 
3.4 Materials and Methods 
 
Cloning of plasmid encoding for HsLARP4 mutants. cDNA encoding for 
HsLARP4 cDNA nucleotide 111 to287 (HsLARP4(111-287)), Histidine-Tag (His-Tag) 
and Tobacco Etch Virus (TEV) cleavage site, were inserted into Novagen pETDuet-1 
plasmid (Merck, Germany), and transformed into KRX cells. The plasmids were 
extracted using PureYieldTM Miniprep (Promega, USA) and used as template for 
point-mutation. The three selected residues were mutated to Alanine through the 
Polymerase Chain Reaction (PCR) using primers in Figure 3.37. PCR was performed 
using the mixture composition reported in Table 3.1 and parameters reported in 
Table 3.2. After PCR, the templates were digested using 1μL DpnI (New England 
BioLabs, UK). 
 
  
 
 
 
Figure 3.37. Primers used for point mutation to generate the plasmids encoding for desired 
HsLARP4(111-287) mutants. Primers were designed to mutate Q126, D139 and M160 residues of 
HsLARP4(111-287) wild-type to Alanine through modifying the nucleotides of the corresponding 
codons. 
 
 
122-tgtctgaagaaacaattagaattctgtttttcacgagaaaatttgtcaaaggatctttacttgata-143 155-acagttgccaacatggaagaaataaaa-164 
  5’tgtctgaagaaagcattagaattctgt 3’ 
  3’acagacttctttcgtaatcttaagaca 5’  
                                         5’aatttgtcaaaggctctttacttgata 3’  
                                         3’ttaaacagtttccgagaaatgaactat 5’ 
                                                                             5’acagttgccaacgccgaagaaataaaa 3’                             
                                                                             3’tgtcaacggttgcggcttctttatttt 5’ 
HsLARP4 cDNA 
Q126A Forward Primer
Q126A Reverse Primer
D139A Forward Primer
D139A Reverse Primer
M160A Forward Primer
M160A Reverse Primer
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Components 
Volume 
(μL) 
Template (100ng/μl) – Plasmids encoding for Wild-type HsLARP4(111-
287) 
1 
Forward primer (10μM) (Sigma-Aldrich, USA) 1 
Reverse primer (10μM) (Sigma-Aldrich, USA) 1 
dNTPs mix (25mM) (MP Biomedicals, United Kingdom) 0.4 
10x cloned PFU reaction buffer  (Agilent Technologies, USA) 5 
Hot-start PFU turbo DNA polymerase (Agilent Technologies, USA) 1 
Nuclease-free water 40.6 
Table 3.1: Polymerase Chain Reaction Mixture Composition for Point Mutation 
 
 
Programme Temperature (oC) Duration  Cycle 
Polymerase activation 95 2 minutes 1 
Denaturation 95 30 seconds  
30 Annealing 55 30 seconds 
Elongation 72 6 minutes 
Ending 72 10 minutes 1 
Table 3.2: Polymerase Chain Reaction parameters for Point Mutation to generate plasmids encoding 
for HsLARP4 mutants 
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Expression test of HsLARP4 proteins and the mutants. Plasmids reported in 
Figure 3.37 were transformed into E.coli KRX and Rosetta2 cells. Isolated colony was 
inoculated into 5 ml Luria-Bertani broth (Table 3.3) with 10 μg/ml ampicillin for KRX 
cells and with 10 μg/ml ampicillin and 34 μg/ml chloramphenicol for Rosetta2 cells, 
and incubated until broth became turbid. 500μL culture was used as “Pre-induction 
sample”. The rest were induced with 1 mM Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) (Calbiochem, USA) and 0.1% L-Rhamnose (Sigma-Aldrich, USA) for KRX cells 
and 1 mM IPTG for Rosetta2 cells, and incubated at 37 °C for three hours or 18 °C 
overnight. 500 μL culture was used as “Post-induction sample”. The rest were 
pelleted at 13200 rpm, re-suspended in 100 µL Nickel-buffer-A (Table 3.4) and 
sonicated for two seconds at amplitude of 12 microns for five times, with 20 
seconds rest on ice between each sonication. The suspension was centrifuged at 
13200 rpm for five minutes. 100 μL supernatant was used as “Soluble fraction 
sample”. The pellet was re-suspended in 60 μL 2% SDS solution and used as 
“Insoluble fraction sample”. The samples were analyzed using Sodium Dodecyl 
Sulfate polyacrylamide gel electrophoresis (SDS-PAGE). 
 
Components Amount / L 
Tryptone Microbial Media (Fisher Chemical, UK) 10 g 
Yeast Extract (Oxoid, UK) 5 g 
Sodium Chloride (Fisher Scientific, USA) 10 g 
Table 3.3: Composition of Luria Bertani (LB) Broth 
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Large scale production of HsLARP4(111-287) and the mutants. 1 mL 1 mM 
IPTG was added to 1 litre of Rosetta2 cells with an OD600 of 0.6 , and incubated at 
18 °C overnight. It was centrifuged at 5000 rpm for 20 minutes, with the 
supernatant discarded, and the pellet resuspended in 30 ml Nickel buffer A (Table 
3.4), 700 µL phenylmethanesulfonylfluoride (Sigma-Aldrich, USA) and 0.1 g 
lysozyme (Sigma-Aldrich, USA). Pulse-sonication of five seconds at amplitude of 10-
14 microns, and six seconds rest on ice was done for five minutes, and repeated 
again. After centrifuging at 18,000 rpm for 45 minutes, the supernatant was filtered 
with a 0.5 µm filter and injected into a Nickel column on the Akta system (GE 
Healthcare, UK). Following Nickel buffer A wash with 10 column volumes (CV), the 
protein was eluted with a linear gradient from 0 up to 80% of buffer B (Table 3.5) in 
25 CV. Eluent was treated with 1.5 ml 0.05 mg/ml TEV protease, followed by 4 °C 
overnight buffer exchange with Dialysis-buffer in Spectra/Por® membrane (MWCO: 
6-8000) (Spectrum Laboratories, US). Nickel column chromatography was manually 
repeated, followed by buffer exchange using Dialysis-buffer (Table 3.6). Heparin 
column chromatography was performed using Heparin buffers A and B (Table 3.7) 
eluting LARP4 by a linear gradient of buffer B gradient from 0 up to 100% of buffer B 
(Table 3.8) in 30 CV After 4 °C overnight buffer exchange with NMR/ITC buffer 
(Table 3.9), LARP4 proteins were purified using Size Exclusion Column (SEC) using 
the NMR/ITC buffer isocratically. Fractions corresponding to the peak of the protein 
were collected reaching a volume around 2 ml. Protein concentration was done 
using Vivaspin20 column (Sartorius Stedim Biotech, Germany). Nuclear Magnetic 
Resonance (NMR) spectroscopy was used to assess the correct fold of the purified 
proteins. 
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Components Amount / L 
Tris-base (Fisher Scientific, UK) 6.06 g 
Sodium Chloride (Fisher Scientific, USA) 8.77 g 
Imidazole (Acros Organic, Belgium) 0.68 g 
Glycerol (Fisher Scientific, USA) 50 g 
Milli-Q water (Millipore, USA) Top up to 1L 
Table 3.4: Composition of Nickel Buffer A (pH: 8) 
 
 
Components Amount / L 
Tris-base (Fisher Scientific, UK) 6.06 g 
Sodium Chloride (Fisher Scientific, USA) 8.77 g 
Imidazole (Acros Organic, Belgium) 34.04 g 
Glycerol (Fisher Scientific, USA) 50 g 
Milli-Q water (Millipore, USA) Top up to 1L 
Table 3.5: Composition of Nickel Buffer B (pH: 8) 
 
 
Components Amount / 4L 
Tris-base (Fisher Scientific, UK) 9.69 g 
Potassium Chloride (Fisher Scientific, UK) 29 g 
Dithiothreitol (Thermo Scientific, USA) 0.6 g 
EDTA (Fisher Scientific, UK) 0.3 g 
Milli-Q water (Millipore, USA) Top up to 1L 
Table 3.6: Composition of Dialysis Buffer (pH: 8) 
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Components Amount / L 
Tris-base (Fisher Scientific, UK) 6.06 g 
Glycerol (Fisher Scientific, USA) 100 g 
Milli-Q water (Millipore, USA) Top up to 1L 
Table 3.7: Composition of Heparin Buffer A (pH: 7.25) 
 
 
Components Amount / L 
Tris-base (Fisher Scientific, UK) 6.06 g 
Glycerol (Fisher Scientific, USA) 100 g 
Potassium Chloride (Fisher Scientific, UK) 149.08 g 
Milli-Q water (Millipore, USA) Top up to 1L 
Table 3.8: Composition of Heparin Buffer B (pH: 7.25) 
 
 
Components Amount/ 4L 
Tris-base (Fisher Scientific, UK) 9.71 g 
Potassium Chloride (Fisher Scientific, UK) 29.82 g 
Dithiothreitol (Thermo Scientific, USA) 0.3 g 
EDTA (Fisher Scientific, UK) 0.62 g 
Milli-Q water (Millipore, USA) Top up to 1L 
Table 3.9 :Composition of NMR/ITC Buffer (pH: 7.25) 
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Study of interaction between HsLARP4(111-287) mutants and poly-A15 
RNA using Isothermal Titration Calorimetry (ITC). Using the iTC200 system (GE 
Healthcare, UK), 20 computer-controlled injections of 2 µL RNA (10-20 µM) were 
injected into the cell containing the protein (80-160 µM), with an interval of three 
minutes between each injection at 298 K. Both RNA and protein were dissolved in 
NMR/ITC buffer (Table 3.9). Heat data obtained from the titration were fitted to a 
theoretical binding curve using the software, MicroCalOrigin7.0.  
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